id	sid	tid	token	lemma	pos
bjp-29940	1	1	introduction	introduction	NOUN
bjp-29940	1	2	hepatitis	hepatitis	PROPN
bjp-29940	1	3	c	c	PROPN
bjp-29940	1	4	virus	virus	PROPN
bjp-29940	1	5	(	(	PUNCT
bjp-29940	1	6	hcv	hcv	NOUN
bjp-29940	1	7	)	)	PUNCT
bjp-29940	1	8	infection	infection	NOUN
bjp-29940	1	9	is	be	AUX
bjp-29940	1	10	a	a	DET
bjp-29940	1	11	globally	globally	ADV
bjp-29940	1	12	prevalent	prevalent	ADJ
bjp-29940	1	13	disease	disease	NOUN
bjp-29940	1	14	that	that	PRON
bjp-29940	1	15	affects	affect	VERB
bjp-29940	1	16	about	about	ADV
bjp-29940	1	17	170	170	NUM
bjp-29940	1	18	million	million	NUM
bjp-29940	1	19	individuals	individual	NOUN
bjp-29940	1	20	(	(	PUNCT
bjp-29940	1	21	negro	negro	NOUN
bjp-29940	1	22	and	and	CCONJ
bjp-29940	1	23	alberti	alberti	PROPN
bjp-29940	1	24	,	,	PUNCT
bjp-29940	1	25	2011	2011	NUM
bjp-29940	1	26	)	)	PUNCT
bjp-29940	1	27	.	.	PUNCT
bjp-29940	2	1	it	it	PRON
bjp-29940	2	2	is	be	AUX
bjp-29940	2	3	a	a	DET
bjp-29940	2	4	major	major	ADJ
bjp-29940	2	5	cause	cause	NOUN
bjp-29940	2	6	of	of	ADP
bjp-29940	2	7	liver	liver	NOUN
bjp-29940	2	8	cell	cell	NOUN
bjp-29940	2	9	failure	failure	NOUN
bjp-29940	2	10	and	and	CCONJ
bjp-29940	2	11	hepatocellular	hepatocellular	ADJ
bjp-29940	2	12	carcinoma	carcinoma	NOUN
bjp-29940	2	13	,	,	PUNCT
bjp-29940	2	14	accounting	account	VERB
bjp-29940	2	15	for	for	ADP
bjp-29940	2	16	about	about	ADV
bjp-29940	2	17	350,000	350,000	NUM
bjp-29940	2	18	deaths	death	NOUN
bjp-29940	2	19	annually	annually	ADV
bjp-29940	2	20	(	(	PUNCT
bjp-29940	2	21	armstrong	armstrong	PROPN
bjp-29940	2	22	et	et	PROPN
bjp-29940	2	23	al	al	PROPN
bjp-29940	2	24	.	.	PROPN
bjp-29940	2	25	,	,	PUNCT
bjp-29940	2	26	2006	2006	NUM
bjp-29940	2	27	;	;	PUNCT
bjp-29940	2	28	hanafiah	hanafiah	PROPN
bjp-29940	2	29	et	et	PROPN
bjp-29940	2	30	al	al	PROPN
bjp-29940	2	31	.	.	PROPN
bjp-29940	2	32	,	,	PUNCT
bjp-29940	2	33	2013	2013	NUM
bjp-29940	2	34	)	)	PUNCT
bjp-29940	2	35	.	.	PUNCT
bjp-29940	3	1	seven	seven	NUM
bjp-29940	3	2	genotypes	genotype	NOUN
bjp-29940	3	3	of	of	ADP
bjp-29940	3	4	hcv	hcv	NOUN
bjp-29940	3	5	have	have	AUX
bjp-29940	3	6	been	be	AUX
bjp-29940	3	7	identified	identify	VERB
bjp-29940	3	8	.	.	PUNCT
bjp-29940	4	1	of	of	ADP
bjp-29940	4	2	them	they	PRON
bjp-29940	4	3	,	,	PUNCT
bjp-29940	4	4	genotype	genotype	NOUN
bjp-29940	4	5	1	1	NUM
bjp-29940	4	6	is	be	AUX
bjp-29940	4	7	the	the	DET
bjp-29940	4	8	most	most	ADV
bjp-29940	4	9	prevalent	prevalent	ADJ
bjp-29940	4	10	infection	infection	NOUN
bjp-29940	4	11	worldwide	worldwide	ADV
bjp-29940	4	12	(	(	PUNCT
bjp-29940	4	13	smith	smith	PROPN
bjp-29940	4	14	et	et	PROPN
bjp-29940	4	15	al	al	PROPN
bjp-29940	4	16	.	.	PROPN
bjp-29940	4	17	,	,	PUNCT
bjp-29940	4	18	2014	2014	NUM
bjp-29940	4	19	)	)	PUNCT
bjp-29940	4	20	,	,	PUNCT
bjp-29940	4	21	while	while	SCONJ
bjp-29940	4	22	genotype	genotype	NOUN
bjp-29940	4	23	4	4	NUM
bjp-29940	4	24	accounts	account	NOUN
bjp-29940	4	25	for	for	ADP
bjp-29940	4	26	20	20	NUM
bjp-29940	4	27	%	%	NOUN
bjp-29940	4	28	of	of	ADP
bjp-29940	4	29	the	the	DET
bjp-29940	4	30	global	global	ADJ
bjp-29940	4	31	burden	burden	NOUN
bjp-29940	4	32	of	of	ADP
bjp-29940	4	33	hcv	hcv	NOUN
bjp-29940	4	34	infection	infection	NOUN
bjp-29940	4	35	,	,	PUNCT
bjp-29940	4	36	with	with	ADP
bjp-29940	4	37	a	a	DET
bjp-29940	4	38	high	high	ADJ
bjp-29940	4	39	prevalence	prevalence	NOUN
bjp-29940	4	40	in	in	ADP
bjp-29940	4	41	the	the	DET
bjp-29940	4	42	middle	middle	PROPN
bjp-29940	4	43	east	east	PROPN
bjp-29940	4	44	and	and	CCONJ
bjp-29940	4	45	central	central	ADJ
bjp-29940	4	46	and	and	CCONJ
bjp-29940	4	47	north	north	NOUN
bjp-29940	4	48	africa	africa	PROPN
bjp-29940	4	49	(	(	PUNCT
bjp-29940	4	50	cornberg	cornberg	PROPN
bjp-29940	4	51	et	et	PROPN
bjp-29940	4	52	al	al	PROPN
bjp-29940	4	53	.	.	PROPN
bjp-29940	4	54	,	,	PUNCT
bjp-29940	4	55	2011	2011	NUM
bjp-29940	4	56	;	;	PUNCT
bjp-29940	4	57	kamal	kamal	PROPN
bjp-29940	4	58	,	,	PUNCT
bjp-29940	4	59	2011	2011	NUM
bjp-29940	4	60	)	)	PUNCT
bjp-29940	4	61	.	.	PUNCT
bjp-29940	5	1	multiple	multiple	ADJ
bjp-29940	5	2	factors	factor	NOUN
bjp-29940	5	3	affect	affect	VERB
bjp-29940	5	4	patients	patient	NOUN
bjp-29940	5	5	'	'	PART
bjp-29940	5	6	response	response	NOUN
bjp-29940	5	7	to	to	ADP
bjp-29940	5	8	antiviral	antiviral	ADJ
bjp-29940	5	9	therapy	therapy	NOUN
bjp-29940	5	10	including	include	VERB
bjp-29940	5	11	viral	viral	ADJ
bjp-29940	5	12	genotype	genotype	NOUN
bjp-29940	5	13	,	,	PUNCT
bjp-29940	5	14	viral	viral	ADJ
bjp-29940	5	15	load	load	NOUN
bjp-29940	5	16	,	,	PUNCT
bjp-29940	5	17	host	host	NOUN
bjp-29940	5	18	genetics	genetic	NOUN
bjp-29940	5	19	,	,	PUNCT
bjp-29940	5	20	and	and	CCONJ
bjp-29940	5	21	patients	patient	NOUN
bjp-29940	5	22	'	'	PART
bjp-29940	5	23	demographics	demographic	NOUN
bjp-29940	5	24	(	(	PUNCT
bjp-29940	5	25	ghany	ghany	NOUN
bjp-29940	5	26	et	et	PROPN
bjp-29940	5	27	al	al	PROPN
bjp-29940	5	28	.	.	PROPN
bjp-29940	5	29	,	,	PUNCT
bjp-29940	5	30	2009	2009	NUM
bjp-29940	5	31	;	;	PUNCT
bjp-29940	5	32	thompson	thompson	PROPN
bjp-29940	5	33	et	et	PROPN
bjp-29940	5	34	al	al	PROPN
bjp-29940	5	35	.	.	PROPN
bjp-29940	5	36	,	,	PUNCT
bjp-29940	5	37	2010	2010	NUM
bjp-29940	5	38	)	)	PUNCT
bjp-29940	5	39	.	.	PUNCT
bjp-29940	6	1	current	current	ADJ
bjp-29940	6	2	treatment	treatment	NOUN
bjp-29940	6	3	options	option	NOUN
bjp-29940	6	4	for	for	ADP
bjp-29940	6	5	hcv	hcv	NOUN
bjp-29940	6	6	genotype	genotype	NOUN
bjp-29940	6	7	4	4	NUM
bjp-29940	6	8	include	include	VERB
bjp-29940	6	9	the	the	DET
bjp-29940	6	10	ns5b	ns5b	ADJ
bjp-29940	6	11	polymerase	polymerase	NOUN
bjp-29940	6	12	inhibitor	inhibitor	NOUN
bjp-29940	6	13	(	(	PUNCT
bjp-29940	6	14	sofosbuvir	sofosbuvir	PROPN
bjp-29940	6	15	)	)	PUNCT
bjp-29940	6	16	or	or	CCONJ
bjp-29940	6	17	ns3	ns3	NOUN
bjp-29940	6	18	protease	protease	NOUN
bjp-29940	6	19	inhibitor	inhibitor	NOUN
bjp-29940	6	20	(	(	PUNCT
bjp-29940	6	21	simeprevir	simeprevir	PROPN
bjp-29940	6	22	)	)	PUNCT
bjp-29940	6	23	plus	plus	CCONJ
bjp-29940	6	24	peginterferon	peginterferon	NOUN
bjp-29940	6	25	-	-	PUNCT
bjp-29940	6	26	alfa	alfa	NOUN
bjp-29940	6	27	and	and	CCONJ
bjp-29940	6	28	ribavirin	ribavirin	NOUN
bjp-29940	6	29	(	(	PUNCT
bjp-29940	6	30	peg	peg	NOUN
bjp-29940	6	31	-	-	PUNCT
bjp-29940	6	32	ifn	ifn	NOUN
bjp-29940	6	33	/	/	SYM
bjp-29940	6	34	rbv	rbv	NOUN
bjp-29940	6	35	)	)	PUNCT
bjp-29940	6	36	(	(	PUNCT
bjp-29940	6	37	pawlotsky	pawlotsky	PROPN
bjp-29940	6	38	et	et	PROPN
bjp-29940	6	39	al	al	PROPN
bjp-29940	6	40	.	.	PROPN
bjp-29940	6	41	,	,	PUNCT
bjp-29940	6	42	2015	2015	NUM
bjp-29940	6	43	)	)	PUNCT
bjp-29940	6	44	.	.	PUNCT
bjp-29940	7	1	however	however	ADV
bjp-29940	7	2	,	,	PUNCT
bjp-29940	7	3	the	the	DET
bjp-29940	7	4	increased	increase	VERB
bjp-29940	7	5	incidence	incidence	NOUN
bjp-29940	7	6	of	of	ADP
bjp-29940	7	7	adverse	adverse	ADJ
bjp-29940	7	8	events	event	NOUN
bjp-29940	7	9	associated	associate	VERB
bjp-29940	7	10	with	with	ADP
bjp-29940	7	11	interferon	interferon	NOUN
bjp-29940	7	12	-	-	PUNCT
bjp-29940	7	13	based	base	VERB
bjp-29940	7	14	regimens	regimen	NOUN
bjp-29940	7	15	triggered	trigger	VERB
bjp-29940	7	16	the	the	DET
bjp-29940	7	17	development	development	NOUN
bjp-29940	7	18	of	of	ADP
bjp-29940	7	19	interferon	interferon	ADJ
bjp-29940	7	20	-	-	PUNCT
bjp-29940	7	21	free	free	ADJ
bjp-29940	7	22	therapeutic	therapeutic	ADJ
bjp-29940	7	23	combinations	combination	NOUN
bjp-29940	7	24	(	(	PUNCT
bjp-29940	7	25	hézode	hézode	NOUN
bjp-29940	7	26	et	et	PROPN
bjp-29940	7	27	al	al	PROPN
bjp-29940	7	28	.	.	PROPN
bjp-29940	7	29	,	,	PUNCT
bjp-29940	7	30	2014	2014	NUM
bjp-29940	7	31	)	)	PUNCT
bjp-29940	7	32	.	.	PUNCT
bjp-29940	8	1	in	in	ADP
bjp-29940	8	2	vitro	vitro	X
bjp-29940	8	3	studies	study	NOUN
bjp-29940	8	4	show	show	VERB
bjp-29940	8	5	that	that	SCONJ
bjp-29940	8	6	daclatasvir	daclatasvir	PROPN
bjp-29940	8	7	,	,	PUNCT
bjp-29940	8	8	an	an	DET
bjp-29940	8	9	ns5a	ns5a	ADJ
bjp-29940	8	10	inhibitor	inhibitor	NOUN
bjp-29940	8	11	,	,	PUNCT
bjp-29940	8	12	has	have	VERB
bjp-29940	8	13	a	a	DET
bjp-29940	8	14	pan	pan	ADJ
bjp-29940	8	15	-	-	ADJ
bjp-29940	8	16	genotypic	genotypic	ADJ
bjp-29940	8	17	activity	activity	NOUN
bjp-29940	8	18	with	with	ADP
bjp-29940	8	19	picomolar	picomolar	ADJ
bjp-29940	8	20	potency	potency	NOUN
bjp-29940	8	21	and	and	CCONJ
bjp-29940	8	22	pharmacokinetic	pharmacokinetic	ADJ
bjp-29940	8	23	characteristics	characteristic	NOUN
bjp-29940	8	24	allowing	allow	VERB
bjp-29940	8	25	for	for	ADP
bjp-29940	8	26	single	single	ADJ
bjp-29940	8	27	daily	daily	ADJ
bjp-29940	8	28	dosage	dosage	NOUN
bjp-29940	8	29	regimens	regimen	NOUN
bjp-29940	8	30	(	(	PUNCT
bjp-29940	8	31	fridell	fridell	INTJ
bjp-29940	8	32	et	et	PROPN
bjp-29940	8	33	al	al	PROPN
bjp-29940	8	34	.	.	PROPN
bjp-29940	8	35	,	,	PUNCT
bjp-29940	8	36	2011	2011	NUM
bjp-29940	8	37	;	;	PUNCT
bjp-29940	8	38	wang	wang	PROPN
bjp-29940	8	39	et	et	PROPN
bjp-29940	8	40	al	al	PROPN
bjp-29940	8	41	.	.	PROPN
bjp-29940	8	42	,	,	PUNCT
bjp-29940	8	43	2012	2012	NUM
bjp-29940	8	44	)	)	PUNCT
bjp-29940	8	45	.	.	PUNCT
bjp-29940	9	1	it	it	PRON
bjp-29940	9	2	acts	act	VERB
bjp-29940	9	3	via	via	ADP
bjp-29940	9	4	inhibiting	inhibit	VERB
bjp-29940	9	5	the	the	DET
bjp-29940	9	6	ns3	ns3	NOUN
bjp-29940	9	7	protease	protease	NOUN
bjp-29940	9	8	enzyme	enzyme	NOUN
bjp-29940	9	9	and	and	CCONJ
bjp-29940	9	10	therefore	therefore	ADV
bjp-29940	9	11	,	,	PUNCT
bjp-29940	9	12	preventing	prevent	VERB
bjp-29940	9	13	ns5a	ns5a	ADJ
bjp-29940	9	14	hyperphosphorylation	hyperphosphorylation	NOUN
bjp-29940	9	15	,	,	PUNCT
bjp-29940	9	16	leading	lead	VERB
bjp-29940	9	17	to	to	ADP
bjp-29940	9	18	inhibition	inhibition	NOUN
bjp-29940	9	19	of	of	ADP
bjp-29940	9	20	viral	viral	ADJ
bjp-29940	9	21	replication	replication	NOUN
bjp-29940	9	22	complex	complex	ADJ
bjp-29940	9	23	formation	formation	NOUN
bjp-29940	9	24	(	(	PUNCT
bjp-29940	9	25	lee	lee	PROPN
bjp-29940	9	26	et	et	PROPN
bjp-29940	9	27	al	al	PROPN
bjp-29940	9	28	.	.	PROPN
bjp-29940	9	29	,	,	PUNCT
bjp-29940	9	30	2011	2011	NUM
bjp-29940	9	31	;	;	PUNCT
bjp-29940	9	32	qiu	qiu	PROPN
bjp-29940	9	33	et	et	PROPN
bjp-29940	9	34	al	al	PROPN
bjp-29940	9	35	.	.	PROPN
bjp-29940	9	36	,	,	PUNCT
bjp-29940	9	37	2011	2011	NUM
bjp-29940	9	38	)	)	PUNCT
bjp-29940	9	39	.	.	PUNCT
bjp-29940	10	1	phase	phase	NOUN
bjp-29940	10	2	ii	ii	PROPN
bjp-29940	10	3	clinical	clinical	ADJ
bjp-29940	10	4	trials	trial	NOUN
bjp-29940	10	5	showed	show	VERB
bjp-29940	10	6	that	that	SCONJ
bjp-29940	10	7	the	the	DET
bjp-29940	10	8	combination	combination	NOUN
bjp-29940	10	9	of	of	ADP
bjp-29940	10	10	daclatasvir	daclatasvir	NOUN
bjp-29940	10	11	(	(	PUNCT
bjp-29940	10	12	60	60	NUM
bjp-29940	10	13	mg	mg	NUM
bjp-29940	10	14	)	)	PUNCT
bjp-29940	10	15	with	with	ADP
bjp-29940	10	16	peg	peg	NOUN
bjp-29940	10	17	-	-	PUNCT
bjp-29940	10	18	ifn	ifn	NOUN
bjp-29940	10	19	/	/	SYM
bjp-29940	10	20	rbv	rbv	NOUN
bjp-29940	10	21	exhibited	exhibit	VERB
bjp-29940	10	22	more	more	ADJ
bjp-29940	10	23	a	a	DET
bjp-29940	10	24	journal	journal	NOUN
bjp-29940	10	25	of	of	ADP
bjp-29940	10	26	the	the	DET
bjp-29940	10	27	bangladesh	bangladesh	NOUN
bjp-29940	10	28	pharmacological	pharmacological	ADJ
bjp-29940	10	29	society	society	NOUN
bjp-29940	10	30	(	(	PUNCT
bjp-29940	10	31	bdps	bdps	NOUN
bjp-29940	10	32	)	)	PUNCT
bjp-29940	10	33	bangladesh	bangladesh	PROPN
bjp-29940	10	34	j	j	PROPN
bjp-29940	10	35	pharmacol	pharmacol	PROPN
bjp-29940	10	36	2017	2017	NUM
bjp-29940	10	37	;	;	PUNCT
bjp-29940	10	38	12	12	NUM
bjp-29940	10	39	:	:	SYM
bjp-29940	10	40	12	12	NUM
bjp-29940	10	41	-	-	SYM
bjp-29940	10	42	22	22	NUM
bjp-29940	10	43	journal	journal	NOUN
bjp-29940	10	44	homepage	homepage	NOUN
bjp-29940	10	45	:	:	PUNCT
bjp-29940	10	46	www.banglajol.info	www.banglajol.info	PROPN
bjp-29940	10	47	abstracted	abstract	VERB
bjp-29940	10	48	/	/	SYM
bjp-29940	10	49	indexed	index	VERB
bjp-29940	10	50	in	in	ADP
bjp-29940	10	51	academic	academic	ADJ
bjp-29940	10	52	search	search	NOUN
bjp-29940	10	53	complete	complete	ADJ
bjp-29940	10	54	,	,	PUNCT
bjp-29940	10	55	asia	asia	PROPN
bjp-29940	10	56	journals	journal	NOUN
bjp-29940	10	57	online	online	ADV
bjp-29940	10	58	,	,	PUNCT
bjp-29940	10	59	bangladesh	bangladesh	NOUN
bjp-29940	10	60	journals	journal	NOUN
bjp-29940	10	61	online	online	ADV
bjp-29940	10	62	,	,	PUNCT
bjp-29940	10	63	biological	biological	ADJ
bjp-29940	10	64	abstracts	abstract	NOUN
bjp-29940	10	65	,	,	PUNCT
bjp-29940	10	66	biosis	biosis	NOUN
bjp-29940	10	67	previews	preview	NOUN
bjp-29940	10	68	,	,	PUNCT
bjp-29940	10	69	cab	cab	NOUN
bjp-29940	10	70	abstracts	abstract	NOUN
bjp-29940	10	71	,	,	PUNCT
bjp-29940	10	72	current	current	ADJ
bjp-29940	10	73	abstracts	abstract	NOUN
bjp-29940	10	74	,	,	PUNCT
bjp-29940	10	75	directory	directory	NOUN
bjp-29940	10	76	of	of	ADP
bjp-29940	10	77	open	open	ADJ
bjp-29940	10	78	access	access	NOUN
bjp-29940	10	79	journals	journal	NOUN
bjp-29940	10	80	,	,	PUNCT
bjp-29940	10	81	embase	embase	NOUN
bjp-29940	10	82	/	/	SYM
bjp-29940	10	83	excerpta	excerpta	NOUN
bjp-29940	10	84	medica	medica	NOUN
bjp-29940	10	85	,	,	PUNCT
bjp-29940	10	86	google	google	PROPN
bjp-29940	10	87	scholar	scholar	NOUN
bjp-29940	10	88	,	,	PUNCT
bjp-29940	10	89	hinari	hinari	X
bjp-29940	10	90	(	(	PUNCT
bjp-29940	10	91	who	who	PRON
bjp-29940	10	92	)	)	PUNCT
bjp-29940	10	93	,	,	PUNCT
bjp-29940	10	94	international	international	ADJ
bjp-29940	10	95	pharmaceutical	pharmaceutical	ADJ
bjp-29940	10	96	abstracts	abstract	NOUN
bjp-29940	10	97	,	,	PUNCT
bjp-29940	10	98	open	open	ADJ
bjp-29940	10	99	j	j	PROPN
bjp-29940	10	100	-	-	PUNCT
bjp-29940	10	101	gate	gate	NOUN
bjp-29940	10	102	,	,	PUNCT
bjp-29940	10	103	science	science	NOUN
bjp-29940	10	104	citation	citation	NOUN
bjp-29940	10	105	index	index	NOUN
bjp-29940	10	106	expanded	expand	VERB
bjp-29940	10	107	,	,	PUNCT
bjp-29940	10	108	scopus	scopus	NOUN
bjp-29940	10	109	and	and	CCONJ
bjp-29940	10	110	social	social	ADJ
bjp-29940	10	111	sciences	sciences	PROPN
bjp-29940	10	112	citation	citation	NOUN
bjp-29940	10	113	index	index	NOUN
bjp-29940	10	114	;	;	PUNCT
bjp-29940	10	115	issn	issn	PROPN
bjp-29940	10	116	:	:	PUNCT
bjp-29940	10	117	1991	1991	NUM
bjp-29940	10	118	-	-	PUNCT
bjp-29940	10	119	0088	0088	NUM
bjp-29940	10	120	abstract	abstract	ADJ
bjp-29940	10	121	clinical	clinical	ADJ
bjp-29940	10	122	trials	trial	NOUN
bjp-29940	10	123	evaluating	evaluate	VERB
bjp-29940	10	124	the	the	DET
bjp-29940	10	125	safety	safety	NOUN
bjp-29940	10	126	and	and	CCONJ
bjp-29940	10	127	efficacy	efficacy	NOUN
bjp-29940	10	128	of	of	ADP
bjp-29940	10	129	daclatasvir	daclatasvir	PROPN
bjp-29940	10	130	for	for	ADP
bjp-29940	10	131	chronic	chronic	ADJ
bjp-29940	10	132	hepatitis	hepatitis	PROPN
bjp-29940	10	133	c	c	PROPN
bjp-29940	10	134	virus	virus	NOUN
bjp-29940	10	135	(	(	PUNCT
bjp-29940	10	136	hcv	hcv	NOUN
bjp-29940	10	137	)	)	PUNCT
bjp-29940	10	138	genotype	genotype	NOUN
bjp-29940	10	139	4	4	NUM
bjp-29940	10	140	infection	infection	NOUN
bjp-29940	10	141	are	be	AUX
bjp-29940	10	142	scarce	scarce	ADJ
bjp-29940	10	143	and	and	CCONJ
bjp-29940	10	144	yet	yet	ADV
bjp-29940	10	145	with	with	ADP
bjp-29940	10	146	small	small	ADJ
bjp-29940	10	147	sample	sample	NOUN
bjp-29940	10	148	sizes	size	NOUN
bjp-29940	10	149	.	.	PUNCT
bjp-29940	11	1	therefore	therefore	ADV
bjp-29940	11	2	,	,	PUNCT
bjp-29940	11	3	we	we	PRON
bjp-29940	11	4	conducted	conduct	VERB
bjp-29940	11	5	this	this	DET
bjp-29940	11	6	systematic	systematic	ADJ
bjp-29940	11	7	review	review	NOUN
bjp-29940	11	8	to	to	PART
bjp-29940	11	9	investigate	investigate	VERB
bjp-29940	11	10	the	the	DET
bjp-29940	11	11	efficacy	efficacy	NOUN
bjp-29940	11	12	of	of	ADP
bjp-29940	11	13	daclatasvir	daclatasvir	PROPN
bjp-29940	11	14	in	in	ADP
bjp-29940	11	15	hcv	hcv	PROPN
bjp-29940	11	16	genotype	genotype	NOUN
bjp-29940	11	17	4	4	NUM
bjp-29940	11	18	treatment	treatment	NOUN
bjp-29940	11	19	.	.	PUNCT
bjp-29940	12	1	a	a	DET
bjp-29940	12	2	computer	computer	NOUN
bjp-29940	12	3	literature	literature	NOUN
bjp-29940	12	4	search	search	NOUN
bjp-29940	12	5	of	of	ADP
bjp-29940	12	6	pubmed	pubmed	PROPN
bjp-29940	12	7	,	,	PUNCT
bjp-29940	12	8	scopus	scopus	PROPN
bjp-29940	12	9	,	,	PUNCT
bjp-29940	12	10	embase	embase	PROPN
bjp-29940	12	11	,	,	PUNCT
bjp-29940	12	12	ovid	ovid	PROPN
bjp-29940	12	13	,	,	PUNCT
bjp-29940	12	14	web	web	NOUN
bjp-29940	12	15	of	of	ADP
bjp-29940	12	16	knowledge	knowledge	NOUN
bjp-29940	12	17	,	,	PUNCT
bjp-29940	12	18	and	and	CCONJ
bjp-29940	12	19	cochrane	cochrane	PROPN
bjp-29940	12	20	central	central	NOUN
bjp-29940	12	21	was	be	AUX
bjp-29940	12	22	conducted	conduct	VERB
bjp-29940	12	23	.	.	PUNCT
bjp-29940	13	1	we	we	PRON
bjp-29940	13	2	selected	select	VERB
bjp-29940	13	3	studies	study	NOUN
bjp-29940	13	4	comparing	compare	VERB
bjp-29940	13	5	daclatasvir	daclatasvir	NOUN
bjp-29940	13	6	plus	plus	CCONJ
bjp-29940	13	7	peginterferon	peginterferon	NOUN
bjp-29940	13	8	-	-	PUNCT
bjp-29940	13	9	alfa	alfa	NOUN
bjp-29940	13	10	/	/	SYM
bjp-29940	13	11	ribavirin	ribavirin	NOUN
bjp-29940	13	12	versus	versus	ADP
bjp-29940	13	13	placebo	placebo	NOUN
bjp-29940	13	14	plus	plus	CCONJ
bjp-29940	13	15	peginterferon	peginterferon	NOUN
bjp-29940	13	16	-	-	PUNCT
bjp-29940	13	17	alfa/	alfa/	NUM
bjp-29940	13	18	ribavirin	ribavirin	NOUN
bjp-29940	13	19	in	in	ADP
bjp-29940	13	20	patients	patient	NOUN
bjp-29940	13	21	with	with	ADP
bjp-29940	13	22	hcv	hcv	NOUN
bjp-29940	13	23	genotype	genotype	NOUN
bjp-29940	13	24	4	4	NUM
bjp-29940	13	25	infection	infection	NOUN
bjp-29940	13	26	.	.	PUNCT
bjp-29940	14	1	pooling	pool	VERB
bjp-29940	14	2	data	datum	NOUN
bjp-29940	14	3	from	from	ADP
bjp-29940	14	4	two	two	NUM
bjp-29940	14	5	randomized	randomized	ADJ
bjp-29940	14	6	controlled	control	VERB
bjp-29940	14	7	trials	trial	NOUN
bjp-29940	14	8	(	(	PUNCT
bjp-29940	14	9	n	n	NOUN
bjp-29940	14	10	=	=	SYM
bjp-29940	14	11	154	154	NUM
bjp-29940	14	12	patients	patient	NOUN
bjp-29940	14	13	)	)	PUNCT
bjp-29940	14	14	showed	show	VERB
bjp-29940	14	15	that	that	SCONJ
bjp-29940	14	16	daclatasvir	daclatasvir	PROPN
bjp-29940	14	17	/	/	SYM
bjp-29940	14	18	peginterferon	peginterferon	PROPN
bjp-29940	14	19	/	/	SYM
bjp-29940	14	20	ribavirin	ribavirin	NOUN
bjp-29940	14	21	treatment	treatment	NOUN
bjp-29940	14	22	achieved	achieve	VERB
bjp-29940	14	23	a	a	DET
bjp-29940	14	24	moderate	moderate	ADJ
bjp-29940	14	25	sustained	sustained	ADJ
bjp-29940	14	26	virologic	virologic	ADJ
bjp-29940	14	27	response	response	NOUN
bjp-29940	14	28	rate	rate	NOUN
bjp-29940	14	29	of	of	ADP
bjp-29940	14	30	76	76	NUM
bjp-29940	14	31	%	%	NOUN
bjp-29940	14	32	after	after	ADP
bjp-29940	14	33	12	12	NUM
bjp-29940	14	34	weeks	week	NOUN
bjp-29940	14	35	and	and	CCONJ
bjp-29940	14	36	of	of	ADP
bjp-29940	14	37	79	79	NUM
bjp-29940	14	38	%	%	NOUN
bjp-29940	14	39	after	after	ADP
bjp-29940	14	40	24	24	NUM
bjp-29940	14	41	weeks	week	NOUN
bjp-29940	14	42	.	.	PUNCT
bjp-29940	15	1	the	the	DET
bjp-29940	15	2	daclatasvir	daclatasvir	PROPN
bjp-29940	15	3	containing	contain	VERB
bjp-29940	15	4	regimen	regiman	NOUN
bjp-29940	15	5	was	be	AUX
bjp-29940	15	6	superior	superior	ADJ
bjp-29940	15	7	to	to	ADP
bjp-29940	15	8	the	the	DET
bjp-29940	15	9	placebo	placebo	NOUN
bjp-29940	15	10	containing	contain	VERB
bjp-29940	15	11	regimen	regiman	NOUN
bjp-29940	15	12	in	in	ADP
bjp-29940	15	13	terms	term	NOUN
bjp-29940	15	14	of	of	ADP
bjp-29940	15	15	virologic	virologic	ADJ
bjp-29940	15	16	response	response	NOUN
bjp-29940	15	17	rates	rate	NOUN
bjp-29940	15	18	after	after	ADP
bjp-29940	15	19	12	12	NUM
bjp-29940	15	20	weeks	week	NOUN
bjp-29940	15	21	(	(	PUNCT
bjp-29940	15	22	rr=1.9	rr=1.9	PROPN
bjp-29940	15	23	%	%	NOUN
bjp-29940	15	24	ci	ci	NOUN
bjp-29940	15	25	1.3	1.3	NUM
bjp-29940	15	26	to	to	ADP
bjp-29940	15	27	2.6	2.6	NUM
bjp-29940	15	28	)	)	PUNCT
bjp-29940	15	29	and	and	CCONJ
bjp-29940	15	30	24	24	NUM
bjp-29940	15	31	weeks	week	NOUN
bjp-29940	15	32	(	(	PUNCT
bjp-29940	15	33	rr=1.8	rr=1.8	ADP
bjp-29940	15	34	%	%	NOUN
bjp-29940	15	35	ci	ci	NOUN
bjp-29940	15	36	1.3	1.3	NUM
bjp-29940	15	37	to	to	ADP
bjp-29940	15	38	2.5	2.5	NUM
bjp-29940	15	39	)	)	PUNCT
bjp-29940	15	40	.	.	PUNCT
bjp-29940	16	1	more	more	ADV
bjp-29940	16	2	effective	effective	ADJ
bjp-29940	16	3	regimens	regimen	NOUN
bjp-29940	16	4	are	be	AUX
bjp-29940	16	5	needed	need	VERB
bjp-29940	16	6	for	for	ADP
bjp-29940	16	7	hcv	hcv	NOUN
bjp-29940	16	8	genotype	genotype	NOUN
bjp-29940	16	9	4	4	NUM
bjp-29940	16	10	.	.	PUNCT
bjp-29940	17	1	article	article	NOUN
bjp-29940	17	2	info	info	NOUN
bjp-29940	17	3	received	receive	VERB
bjp-29940	17	4	:	:	PUNCT
bjp-29940	17	5	10	10	NUM
bjp-29940	17	6	october	october	NOUN
bjp-29940	17	7	2016	2016	NUM
bjp-29940	17	8	accepted	accept	VERB
bjp-29940	17	9	:	:	PUNCT
bjp-29940	17	10	13	13	NUM
bjp-29940	17	11	february	february	PROPN
bjp-29940	17	12	2017	2017	NUM
bjp-29940	17	13	available	available	ADJ
bjp-29940	17	14	online	online	ADV
bjp-29940	17	15	:	:	PUNCT
bjp-29940	17	16	1	1	NUM
bjp-29940	17	17	march	march	PROPN
bjp-29940	17	18	2017	2017	NUM
bjp-29940	17	19	doi	doi	NOUN
bjp-29940	17	20	:	:	PUNCT
bjp-29940	17	21	10.3329	10.3329	NUM
bjp-29940	17	22	/	/	SYM
bjp-29940	17	23	bjp.v12i1.29940	bjp.v12i1.29940	PROPN
bjp-29940	17	24	cite	cite	VERB
bjp-29940	17	25	this	this	DET
bjp-29940	17	26	article	article	NOUN
bjp-29940	17	27	:	:	PUNCT
bjp-29940	17	28	ahmed	ahmed	PROPN
bjp-29940	17	29	h	h	PROPN
bjp-29940	17	30	,	,	PUNCT
bjp-29940	17	31	abushouk	abushouk	PROPN
bjp-29940	17	32	ai	ai	VERB
bjp-29940	17	33	,	,	PUNCT
bjp-29940	17	34	gadelkarim	gadelkarim	PROPN
bjp-29940	17	35	m	m	PROPN
bjp-29940	17	36	,	,	PUNCT
bjp-29940	17	37	mohamed	mohamed	PROPN
bjp-29940	17	38	a	a	PROPN
bjp-29940	17	39	,	,	PUNCT
bjp-29940	17	40	gabr	gabr	ADP
bjp-29940	17	41	m	m	PROPN
bjp-29940	17	42	,	,	PUNCT
bjp-29940	17	43	negida	negida	PROPN
bjp-29940	17	44	a.	a.	NOUN
bjp-29940	17	45	efficacy	efficacy	NOUN
bjp-29940	17	46	of	of	ADP
bjp-29940	17	47	daclatasvir	daclatasvir	PROPN
bjp-29940	17	48	plus	plus	CCONJ
bjp-29940	17	49	peginterferon	peginterferon	PROPN
bjp-29940	17	50	alfa	alfa	NOUN
bjp-29940	17	51	and	and	CCONJ
bjp-29940	17	52	ribavirin	ribavirin	NOUN
bjp-29940	17	53	for	for	ADP
bjp-29940	17	54	patients	patient	NOUN
bjp-29940	17	55	with	with	ADP
bjp-29940	17	56	chronic	chronic	ADJ
bjp-29940	17	57	hepatitis	hepatitis	NOUN
bjp-29940	17	58	c	c	PROPN
bjp-29940	17	59	genotype	genotype	NOUN
bjp-29940	17	60	4	4	NUM
bjp-29940	17	61	infection	infection	NOUN
bjp-29940	17	62	.	.	PUNCT
bjp-29940	18	1	bangladesh	bangladesh	PROPN
bjp-29940	18	2	j	j	PROPN
bjp-29940	18	3	pharmacol	pharmacol	PROPN
bjp-29940	18	4	.	.	PROPN
bjp-29940	19	1	2017	2017	NUM
bjp-29940	19	2	;	;	PUNCT
bjp-29940	19	3	12	12	NUM
bjp-29940	19	4	:	:	SYM
bjp-29940	19	5	12	12	NUM
bjp-29940	19	6	-	-	SYM
bjp-29940	19	7	22	22	NUM
bjp-29940	19	8	.	.	PUNCT
bjp-29940	19	9	efficacy	efficacy	NOUN
bjp-29940	19	10	of	of	ADP
bjp-29940	19	11	daclatasvir	daclatasvir	PROPN
bjp-29940	19	12	plus	plus	CCONJ
bjp-29940	19	13	peginterferon	peginterferon	PROPN
bjp-29940	19	14	alfa	alfa	NOUN
bjp-29940	19	15	and	and	CCONJ
bjp-29940	19	16	ribavirin	ribavirin	NOUN
bjp-29940	19	17	for	for	ADP
bjp-29940	19	18	patients	patient	NOUN
bjp-29940	19	19	with	with	ADP
bjp-29940	19	20	chronic	chronic	ADJ
bjp-29940	19	21	hepatitis	hepatitis	NOUN
bjp-29940	19	22	c	c	PROPN
bjp-29940	19	23	genotype	genotype	NOUN
bjp-29940	19	24	4	4	NUM
bjp-29940	19	25	infection	infection	NOUN
bjp-29940	19	26	hussien	hussien	PROPN
bjp-29940	19	27	ahmed1	ahmed1	PROPN
bjp-29940	19	28	,	,	PUNCT
bjp-29940	19	29	abdelrahman	abdelrahman	NOUN
bjp-29940	19	30	ibrahim	ibrahim	PROPN
bjp-29940	19	31	abushouk2	abushouk2	PROPN
bjp-29940	19	32	,	,	PUNCT
bjp-29940	19	33	mohamed	mohamed	PROPN
bjp-29940	19	34	gadelkarim3	gadelkarim3	PROPN
bjp-29940	19	35	,	,	PUNCT
bjp-29940	19	36	arwa	arwa	PROPN
bjp-29940	19	37	mohamed1	mohamed1	PROPN
bjp-29940	19	38	,	,	PUNCT
bjp-29940	19	39	mohamed	mohamed	PROPN
bjp-29940	19	40	gabr1	gabr1	PROPN
bjp-29940	19	41	and	and	CCONJ
bjp-29940	19	42	ahmed	ahme	VERB
bjp-29940	19	43	negida1	negida1	PROPN
bjp-29940	19	44	1faculty	1faculty	NUM
bjp-29940	19	45	of	of	ADP
bjp-29940	19	46	medicine	medicine	NOUN
bjp-29940	19	47	,	,	PUNCT
bjp-29940	19	48	zagazig	zagazig	PROPN
bjp-29940	19	49	university	university	PROPN
bjp-29940	19	50	,	,	PUNCT
bjp-29940	19	51	el	el	PROPN
bjp-29940	19	52	-	-	PUNCT
bjp-29940	19	53	sharkia	sharkia	PROPN
bjp-29940	19	54	,	,	PUNCT
bjp-29940	19	55	egypt	egypt	PROPN
bjp-29940	19	56	;	;	PUNCT
bjp-29940	19	57	2faculty	2faculty	NUM
bjp-29940	19	58	of	of	ADP
bjp-29940	19	59	medicine	medicine	NOUN
bjp-29940	19	60	,	,	PUNCT
bjp-29940	19	61	ain	ain	PROPN
bjp-29940	19	62	shams	shams	PROPN
bjp-29940	19	63	university	university	PROPN
bjp-29940	19	64	,	,	PUNCT
bjp-29940	19	65	cairo	cairo	PROPN
bjp-29940	19	66	,	,	PUNCT
bjp-29940	19	67	egypt	egypt	PROPN
bjp-29940	19	68	;	;	PUNCT
bjp-29940	19	69	3faculty	3faculty	NUM
bjp-29940	19	70	of	of	ADP
bjp-29940	19	71	medicine	medicine	NOUN
bjp-29940	19	72	,	,	PUNCT
bjp-29940	19	73	alexandria	alexandria	PROPN
bjp-29940	19	74	university	university	PROPN
bjp-29940	19	75	,	,	PUNCT
bjp-29940	19	76	alexandria	alexandria	PROPN
bjp-29940	19	77	,	,	PUNCT
bjp-29940	19	78	egypt	egypt	PROPN
bjp-29940	19	79	.	.	PUNCT
bjp-29940	20	1	m	m	VERB
bjp-29940	20	2	et	et	PROPN
bjp-29940	20	3	aan	aan	PROPN
bjp-29940	20	4	al	al	PROPN
bjp-29940	20	5	ys	ys	PROPN
bjp-29940	20	6	is	be	AUX
bjp-29940	20	7	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	http://www.bioxbio.com/if/html/bangl-j-pharmacol.html	NOUN
bjp-29940	20	8	efficacy	efficacy	NOUN
bjp-29940	20	9	than	than	ADP
bjp-29940	20	10	peg	peg	NOUN
bjp-29940	20	11	-	-	PUNCT
bjp-29940	20	12	ifn	ifn	NOUN
bjp-29940	20	13	/	/	SYM
bjp-29940	20	14	rbv	rbv	NOUN
bjp-29940	20	15	alone	alone	ADJ
bjp-29940	20	16	with	with	ADP
bjp-29940	20	17	a	a	DET
bjp-29940	20	18	similar	similar	ADJ
bjp-29940	20	19	safety	safety	NOUN
bjp-29940	20	20	profile	profile	NOUN
bjp-29940	20	21	and	and	CCONJ
bjp-29940	20	22	allowed	allow	VERB
bjp-29940	20	23	for	for	ADP
bjp-29940	20	24	a	a	DET
bjp-29940	20	25	shorter	short	ADJ
bjp-29940	20	26	treatment	treatment	NOUN
bjp-29940	20	27	duration	duration	NOUN
bjp-29940	20	28	(	(	PUNCT
bjp-29940	20	29	dore	dore	PROPN
bjp-29940	20	30	et	et	PROPN
bjp-29940	20	31	al	al	PROPN
bjp-29940	20	32	.	.	PROPN
bjp-29940	20	33	,	,	PUNCT
bjp-29940	20	34	2015	2015	NUM
bjp-29940	20	35	;	;	PUNCT
bjp-29940	20	36	hezode	hezode	PROPN
bjp-29940	20	37	et	et	PROPN
bjp-29940	20	38	al	al	PROPN
bjp-29940	20	39	.	.	PROPN
bjp-29940	20	40	,	,	PUNCT
bjp-29940	20	41	2015	2015	NUM
bjp-29940	20	42	)	)	PUNCT
bjp-29940	20	43	.	.	PUNCT
bjp-29940	21	1	moreover	moreover	ADV
bjp-29940	21	2	,	,	PUNCT
bjp-29940	21	3	addition	addition	NOUN
bjp-29940	21	4	of	of	ADP
bjp-29940	21	5	asunaprevir	asunaprevir	PROPN
bjp-29940	21	6	to	to	ADP
bjp-29940	21	7	the	the	DET
bjp-29940	21	8	former	former	ADJ
bjp-29940	21	9	regimen	regiman	NOUN
bjp-29940	21	10	of	of	ADP
bjp-29940	21	11	daclatasvir	daclatasvir	NOUN
bjp-29940	21	12	plus	plus	CCONJ
bjp-29940	21	13	peg	peg	NOUN
bjp-29940	21	14	-	-	PUNCT
bjp-29940	21	15	ifn	ifn	NOUN
bjp-29940	21	16	/	/	SYM
bjp-29940	21	17	rbv	rbv	NOUN
bjp-29940	21	18	achieved	achieve	VERB
bjp-29940	21	19	a	a	DET
bjp-29940	21	20	sustained	sustained	ADJ
bjp-29940	21	21	virologic	virologic	ADJ
bjp-29940	21	22	response	response	NOUN
bjp-29940	21	23	rate	rate	NOUN
bjp-29940	21	24	(	(	PUNCT
bjp-29940	21	25	svr	svr	PROPN
bjp-29940	21	26	)	)	PUNCT
bjp-29940	21	27	of	of	ADP
bjp-29940	21	28	100	100	NUM
bjp-29940	21	29	%	%	NOUN
bjp-29940	21	30	after	after	ADP
bjp-29940	21	31	12	12	NUM
bjp-29940	21	32	weeks	week	NOUN
bjp-29940	21	33	of	of	ADP
bjp-29940	21	34	treatment	treatment	NOUN
bjp-29940	21	35	(	(	PUNCT
bjp-29940	21	36	jensen	jensen	PROPN
bjp-29940	21	37	et	et	PROPN
bjp-29940	21	38	al	al	PROPN
bjp-29940	21	39	.	.	PROPN
bjp-29940	21	40	,	,	PUNCT
bjp-29940	21	41	2015	2015	NUM
bjp-29940	21	42	)	)	PUNCT
bjp-29940	21	43	.	.	PUNCT
bjp-29940	22	1	although	although	SCONJ
bjp-29940	22	2	more	more	ADJ
bjp-29940	22	3	than	than	ADP
bjp-29940	22	4	90	90	NUM
bjp-29940	22	5	%	%	NOUN
bjp-29940	22	6	of	of	ADP
bjp-29940	22	7	hcv	hcv	NOUN
bjp-29940	22	8	infections	infection	NOUN
bjp-29940	22	9	in	in	ADP
bjp-29940	22	10	the	the	DET
bjp-29940	22	11	middle	middle	PROPN
bjp-29940	22	12	east	east	PROPN
bjp-29940	22	13	and	and	CCONJ
bjp-29940	22	14	africa	africa	PROPN
bjp-29940	22	15	are	be	AUX
bjp-29940	22	16	of	of	ADP
bjp-29940	22	17	genotype	genotype	NOUN
bjp-29940	22	18	4	4	NUM
bjp-29940	22	19	(	(	PUNCT
bjp-29940	22	20	karoney	karoney	NOUN
bjp-29940	22	21	and	and	CCONJ
bjp-29940	22	22	siika	siika	NOUN
bjp-29940	22	23	,	,	PUNCT
bjp-29940	22	24	2013	2013	NUM
bjp-29940	22	25	)	)	PUNCT
bjp-29940	22	26	,	,	PUNCT
bjp-29940	22	27	studies	study	NOUN
bjp-29940	22	28	assessing	assess	VERB
bjp-29940	22	29	the	the	DET
bjp-29940	22	30	efficacy	efficacy	NOUN
bjp-29940	22	31	of	of	ADP
bjp-29940	22	32	daclatasvir	daclatasvir	PROPN
bjp-29940	22	33	in	in	ADP
bjp-29940	22	34	patients	patient	NOUN
bjp-29940	22	35	with	with	ADP
bjp-29940	22	36	hcv	hcv	NOUN
bjp-29940	22	37	genotype	genotype	NOUN
bjp-29940	22	38	4	4	NUM
bjp-29940	22	39	are	be	AUX
bjp-29940	22	40	scarce	scarce	ADJ
bjp-29940	22	41	and	and	CCONJ
bjp-29940	22	42	yet	yet	ADV
bjp-29940	22	43	with	with	ADP
bjp-29940	22	44	small	small	ADJ
bjp-29940	22	45	sample	sample	NOUN
bjp-29940	22	46	sizes	size	NOUN
bjp-29940	22	47	.	.	PUNCT
bjp-29940	23	1	therefore	therefore	ADV
bjp-29940	23	2	,	,	PUNCT
bjp-29940	23	3	we	we	PRON
bjp-29940	23	4	conducted	conduct	VERB
bjp-29940	23	5	this	this	DET
bjp-29940	23	6	systematic	systematic	ADJ
bjp-29940	23	7	review	review	NOUN
bjp-29940	23	8	and	and	CCONJ
bjp-29940	23	9	meta	meta	NOUN
bjp-29940	23	10	-	-	PUNCT
bjp-29940	23	11	analysis	analysis	NOUN
bjp-29940	23	12	to	to	PART
bjp-29940	23	13	investigate	investigate	VERB
bjp-29940	23	14	the	the	DET
bjp-29940	23	15	efficacy	efficacy	NOUN
bjp-29940	23	16	of	of	ADP
bjp-29940	23	17	daclatasvir	daclatasvir	PROPN
bjp-29940	23	18	in	in	ADP
bjp-29940	23	19	treating	treat	VERB
bjp-29940	23	20	patients	patient	NOUN
bjp-29940	23	21	with	with	ADP
bjp-29940	23	22	hcv	hcv	NOUN
bjp-29940	23	23	genotype	genotype	NOUN
bjp-29940	23	24	4	4	NUM
bjp-29940	23	25	.	.	PUNCT
bjp-29940	23	26	materials	material	NOUN
bjp-29940	23	27	and	and	CCONJ
bjp-29940	23	28	methods	method	NOUN
bjp-29940	23	29	we	we	PRON
bjp-29940	23	30	followed	follow	VERB
bjp-29940	23	31	the	the	DET
bjp-29940	23	32	prisma	prisma	NOUN
bjp-29940	23	33	statement	statement	NOUN
bjp-29940	23	34	guidelines	guideline	NOUN
bjp-29940	23	35	during	during	ADP
bjp-29940	23	36	the	the	DET
bjp-29940	23	37	preparation	preparation	NOUN
bjp-29940	23	38	of	of	ADP
bjp-29940	23	39	this	this	DET
bjp-29940	23	40	systematic	systematic	ADJ
bjp-29940	23	41	review	review	NOUN
bjp-29940	23	42	and	and	CCONJ
bjp-29940	23	43	metaanalysis	metaanalysis	NOUN
bjp-29940	23	44	(	(	PUNCT
bjp-29940	23	45	moher	moher	PROPN
bjp-29940	23	46	,	,	PUNCT
bjp-29940	23	47	2009	2009	NUM
bjp-29940	23	48	)	)	PUNCT
bjp-29940	23	49	.	.	PUNCT
bjp-29940	24	1	criteria	criterion	NOUN
bjp-29940	24	2	for	for	ADP
bjp-29940	24	3	selecting	select	VERB
bjp-29940	24	4	studies	study	NOUN
bjp-29940	24	5	to	to	ADP
bjp-29940	24	6	this	this	DET
bjp-29940	24	7	review	review	NOUN
bjp-29940	24	8	we	we	PRON
bjp-29940	24	9	used	use	VERB
bjp-29940	24	10	the	the	DET
bjp-29940	24	11	following	follow	VERB
bjp-29940	24	12	inclusion	inclusion	NOUN
bjp-29940	24	13	criteria	criterion	NOUN
bjp-29940	24	14	:	:	PUNCT
bjp-29940	24	15	a	a	X
bjp-29940	24	16	)	)	PUNCT
bjp-29940	24	17	population	population	NOUN
bjp-29940	24	18	:	:	PUNCT
bjp-29940	24	19	cirrhotic	cirrhotic	ADJ
bjp-29940	24	20	or	or	CCONJ
bjp-29940	24	21	non	non	ADJ
bjp-29940	24	22	-	-	ADJ
bjp-29940	24	23	cirrhotic	cirrhotic	ADJ
bjp-29940	24	24	adult	adult	NOUN
bjp-29940	24	25	patients	patient	NOUN
bjp-29940	24	26	with	with	ADP
bjp-29940	24	27	chronic	chronic	ADJ
bjp-29940	24	28	hcv	hcv	NOUN
bjp-29940	24	29	genotype-4	genotype-4	PROPN
bjp-29940	24	30	infection	infection	NOUN
bjp-29940	24	31	,	,	PUNCT
bjp-29940	24	32	b	b	NOUN
bjp-29940	24	33	)	)	PUNCT
bjp-29940	24	34	intervention	intervention	NOUN
bjp-29940	24	35	:	:	PUNCT
bjp-29940	24	36	20	20	NUM
bjp-29940	24	37	mg	mg	NOUN
bjp-29940	24	38	and/	and/	NOUN
bjp-29940	24	39	or	or	CCONJ
bjp-29940	24	40	60	60	NUM
bjp-29940	24	41	mg	mg	NOUN
bjp-29940	24	42	of	of	ADP
bjp-29940	24	43	daclatasvir	daclatasvir	NOUN
bjp-29940	24	44	plus	plus	CCONJ
bjp-29940	24	45	peg	peg	NOUN
bjp-29940	24	46	-	-	PUNCT
bjp-29940	24	47	ifn	ifn	PROPN
bjp-29940	24	48	/	/	SYM
bjp-29940	24	49	rbv	rbv	NOUN
bjp-29940	24	50	(	(	PUNCT
bjp-29940	24	51	triple	triple	ADJ
bjp-29940	24	52	regimen	regiman	NOUN
bjp-29940	24	53	)	)	PUNCT
bjp-29940	24	54	,	,	PUNCT
bjp-29940	24	55	c	c	X
bjp-29940	24	56	)	)	PUNCT
bjp-29940	24	57	comparator	comparator	NOUN
bjp-29940	24	58	:	:	PUNCT
bjp-29940	24	59	placebo	placebo	NOUN
bjp-29940	24	60	plus	plus	CCONJ
bjp-29940	24	61	peg	peg	NOUN
bjp-29940	24	62	-	-	PUNCT
bjp-29940	24	63	ifn	ifn	NOUN
bjp-29940	24	64	/	/	SYM
bjp-29940	24	65	rbv	rbv	NOUN
bjp-29940	24	66	(	(	PUNCT
bjp-29940	24	67	dual	dual	ADJ
bjp-29940	24	68	regimen	regimen	NOUN
bjp-29940	24	69	)	)	PUNCT
bjp-29940	24	70	,	,	PUNCT
bjp-29940	24	71	d	d	X
bjp-29940	24	72	)	)	PUNCT
bjp-29940	24	73	efficacy	efficacy	NOUN
bjp-29940	24	74	outcomes	outcome	NOUN
bjp-29940	24	75	:	:	PUNCT
bjp-29940	24	76	measured	measure	VERB
bjp-29940	24	77	in	in	ADP
bjp-29940	24	78	virologic	virologic	ADJ
bjp-29940	24	79	response	response	NOUN
bjp-29940	24	80	rates	rate	NOUN
bjp-29940	24	81	,	,	PUNCT
bjp-29940	24	82	and	and	CCONJ
bjp-29940	24	83	e	e	X
bjp-29940	24	84	)	)	PUNCT
bjp-29940	24	85	study	study	NOUN
bjp-29940	24	86	design	design	NOUN
bjp-29940	24	87	:	:	PUNCT
bjp-29940	24	88	randomized	randomize	VERB
bjp-29940	24	89	controlled	control	VERB
bjp-29940	24	90	trials	trial	NOUN
bjp-29940	24	91	.	.	PUNCT
bjp-29940	25	1	we	we	PRON
bjp-29940	25	2	excluded	exclude	VERB
bjp-29940	25	3	:	:	PUNCT
bjp-29940	25	4	a	a	X
bjp-29940	25	5	)	)	PUNCT
bjp-29940	25	6	non	non	ADJ
bjp-29940	25	7	-	-	ADJ
bjp-29940	25	8	randomized	randomized	ADJ
bjp-29940	25	9	trials	trial	NOUN
bjp-29940	25	10	,	,	PUNCT
bjp-29940	25	11	b	b	X
bjp-29940	25	12	)	)	PUNCT
bjp-29940	25	13	studies	study	NOUN
bjp-29940	25	14	comparing	compare	VERB
bjp-29940	25	15	the	the	DET
bjp-29940	25	16	efficacy	efficacy	NOUN
bjp-29940	25	17	of	of	ADP
bjp-29940	25	18	daclatasvir	daclatasvir	PROPN
bjp-29940	25	19	with	with	ADP
bjp-29940	25	20	other	other	ADJ
bjp-29940	25	21	direct	direct	ADJ
bjp-29940	25	22	antiviral	antiviral	ADJ
bjp-29940	25	23	agents	agent	NOUN
bjp-29940	25	24	,	,	PUNCT
bjp-29940	25	25	c	c	X
bjp-29940	25	26	)	)	PUNCT
bjp-29940	25	27	in	in	ADP
bjp-29940	25	28	vitro	vitro	X
bjp-29940	25	29	and	and	CCONJ
bjp-29940	25	30	animal	animal	NOUN
bjp-29940	25	31	studies	study	NOUN
bjp-29940	25	32	,	,	PUNCT
bjp-29940	25	33	d	d	X
bjp-29940	25	34	)	)	PUNCT
bjp-29940	25	35	studies	study	NOUN
bjp-29940	25	36	including	include	VERB
bjp-29940	25	37	patients	patient	NOUN
bjp-29940	25	38	,	,	PUNCT
bjp-29940	25	39	co	co	VERB
bjp-29940	25	40	-	-	VERB
bjp-29940	25	41	infected	infected	ADJ
bjp-29940	25	42	with	with	ADP
bjp-29940	25	43	hepatitis	hepatitis	PROPN
bjp-29940	25	44	b	b	PROPN
bjp-29940	25	45	virusor	virusor	NOUN
bjp-29940	25	46	immunodeficiency	immunodeficiency	NOUN
bjp-29940	25	47	virus	virus	NOUN
bjp-29940	25	48	,	,	PUNCT
bjp-29940	25	49	and	and	CCONJ
bjp-29940	25	50	e	e	X
bjp-29940	25	51	)	)	PUNCT
bjp-29940	25	52	studies	study	NOUN
bjp-29940	25	53	whose	whose	DET
bjp-29940	25	54	data	datum	NOUN
bjp-29940	25	55	were	be	AUX
bjp-29940	25	56	unreliable	unreliable	ADJ
bjp-29940	25	57	for	for	ADP
bjp-29940	25	58	analysis	analysis	NOUN
bjp-29940	25	59	.	.	PUNCT
bjp-29940	26	1	literature	literature	NOUN
bjp-29940	26	2	search	search	NOUN
bjp-29940	26	3	strategy	strategy	NOUN
bjp-29940	26	4	we	we	PRON
bjp-29940	26	5	searched	search	VERB
bjp-29940	26	6	pubmed	pubmed	PROPN
bjp-29940	26	7	,	,	PUNCT
bjp-29940	26	8	scopus	scopus	PROPN
bjp-29940	26	9	,	,	PUNCT
bjp-29940	26	10	embase	embase	PROPN
bjp-29940	26	11	,	,	PUNCT
bjp-29940	26	12	ovid	ovid	PROPN
bjp-29940	26	13	,	,	PUNCT
bjp-29940	26	14	web	web	NOUN
bjp-29940	26	15	of	of	ADP
bjp-29940	26	16	knowledge	knowledge	NOUN
bjp-29940	26	17	,	,	PUNCT
bjp-29940	26	18	and	and	CCONJ
bjp-29940	26	19	cochrane	cochrane	PROPN
bjp-29940	26	20	central	central	PROPN
bjp-29940	26	21	through	through	ADP
bjp-29940	26	22	march	march	PROPN
bjp-29940	26	23	,	,	PUNCT
bjp-29940	26	24	2016	2016	NUM
bjp-29940	26	25	using	use	VERB
bjp-29940	26	26	relevant	relevant	ADJ
bjp-29940	26	27	keywords	keyword	NOUN
bjp-29940	26	28	(	(	PUNCT
bjp-29940	26	29	daclatasvir	daclatasvir	NOUN
bjp-29940	26	30	or	or	CCONJ
bjp-29940	26	31	bms-790052	bms-790052	NOUN
bjp-29940	26	32	or	or	CCONJ
bjp-29940	26	33	ns5a	ns5a	ADJ
bjp-29940	26	34	inhibitor	inhibitor	NOUN
bjp-29940	26	35	)	)	PUNCT
bjp-29940	26	36	.	.	PUNCT
bjp-29940	27	1	no	no	DET
bjp-29940	27	2	language	language	NOUN
bjp-29940	27	3	restrictions	restriction	NOUN
bjp-29940	27	4	were	be	AUX
bjp-29940	27	5	imposed	impose	VERB
bjp-29940	27	6	.	.	PUNCT
bjp-29940	28	1	we	we	PRON
bjp-29940	28	2	also	also	ADV
bjp-29940	28	3	manually	manually	ADV
bjp-29940	28	4	searched	search	VERB
bjp-29940	28	5	the	the	DET
bjp-29940	28	6	reference	reference	NOUN
bjp-29940	28	7	list	list	NOUN
bjp-29940	28	8	of	of	ADP
bjp-29940	28	9	included	include	VERB
bjp-29940	28	10	studies	study	NOUN
bjp-29940	28	11	for	for	ADP
bjp-29940	28	12	any	any	DET
bjp-29940	28	13	missing	miss	VERB
bjp-29940	28	14	citations	citation	NOUN
bjp-29940	28	15	.	.	PUNCT
bjp-29940	29	1	screening	screen	VERB
bjp-29940	29	2	of	of	ADP
bjp-29940	29	3	records	record	NOUN
bjp-29940	29	4	duplications	duplication	NOUN
bjp-29940	29	5	between	between	ADP
bjp-29940	29	6	databases	database	NOUN
bjp-29940	29	7	were	be	AUX
bjp-29940	29	8	removed	remove	VERB
bjp-29940	29	9	and	and	CCONJ
bjp-29940	29	10	finally	finally	ADV
bjp-29940	29	11	,	,	PUNCT
bjp-29940	29	12	retrieved	retrieve	VERB
bjp-29940	29	13	references	reference	NOUN
bjp-29940	29	14	were	be	AUX
bjp-29940	29	15	screened	screen	VERB
bjp-29940	29	16	for	for	ADP
bjp-29940	29	17	randomized	randomized	ADJ
bjp-29940	29	18	controlled	control	VERB
bjp-29940	29	19	trials	trial	NOUN
bjp-29940	29	20	comparing	compare	VERB
bjp-29940	29	21	daclatasvir	daclatasvir	NOUN
bjp-29940	29	22	plus	plus	CCONJ
bjp-29940	29	23	pegifn	pegifn	NOUN
bjp-29940	29	24	/	/	SYM
bjp-29940	29	25	rbv	rbv	NOUN
bjp-29940	29	26	versus	versus	ADP
bjp-29940	29	27	placebo	placebo	NOUN
bjp-29940	29	28	plus	plus	CCONJ
bjp-29940	29	29	peg	peg	NOUN
bjp-29940	29	30	-	-	PUNCT
bjp-29940	29	31	ifn	ifn	NOUN
bjp-29940	29	32	/	/	SYM
bjp-29940	29	33	rbv	rbv	NOUN
bjp-29940	29	34	.	.	PUNCT
bjp-29940	30	1	references	reference	NOUN
bjp-29940	30	2	were	be	AUX
bjp-29940	30	3	screened	screen	VERB
bjp-29940	30	4	in	in	ADP
bjp-29940	30	5	two	two	NUM
bjp-29940	30	6	steps	step	NOUN
bjp-29940	30	7	:	:	PUNCT
bjp-29940	30	8	the	the	DET
bjp-29940	30	9	first	first	ADJ
bjp-29940	30	10	step	step	NOUN
bjp-29940	30	11	was	be	AUX
bjp-29940	30	12	to	to	ADP
bjp-29940	30	13	screen	screen	NOUN
bjp-29940	30	14	titles	title	NOUN
bjp-29940	30	15	/	/	SYM
bjp-29940	30	16	abstracts	abstract	NOUN
bjp-29940	30	17	for	for	ADP
bjp-29940	30	18	eligibility	eligibility	NOUN
bjp-29940	30	19	and	and	CCONJ
bjp-29940	30	20	the	the	DET
bjp-29940	30	21	second	second	ADJ
bjp-29940	30	22	step	step	NOUN
bjp-29940	30	23	was	be	AUX
bjp-29940	30	24	to	to	PART
bjp-29940	30	25	screen	screen	VERB
bjp-29940	30	26	full	full	ADJ
bjp-29940	30	27	text	text	NOUN
bjp-29940	30	28	articles	article	NOUN
bjp-29940	30	29	of	of	ADP
bjp-29940	30	30	eligible	eligible	ADJ
bjp-29940	30	31	abstracts	abstract	NOUN
bjp-29940	30	32	.	.	PUNCT
bjp-29940	31	1	data	datum	NOUN
bjp-29940	31	2	extraction	extraction	NOUN
bjp-29940	31	3	two	two	NUM
bjp-29940	31	4	independent	independent	ADJ
bjp-29940	31	5	authors	author	NOUN
bjp-29940	31	6	(	(	PUNCT
bjp-29940	31	7	ha	ha	INTJ
bjp-29940	31	8	and	and	CCONJ
bjp-29940	31	9	am	be	AUX
bjp-29940	31	10	)	)	PUNCT
bjp-29940	31	11	extracted	extract	VERB
bjp-29940	31	12	data	datum	NOUN
bjp-29940	31	13	using	use	VERB
bjp-29940	31	14	an	an	DET
bjp-29940	31	15	online	online	ADJ
bjp-29940	31	16	data	data	NOUN
bjp-29940	31	17	extraction	extraction	NOUN
bjp-29940	31	18	form	form	NOUN
bjp-29940	31	19	.	.	PUNCT
bjp-29940	32	1	disagreements	disagreement	NOUN
bjp-29940	32	2	were	be	AUX
bjp-29940	32	3	resolved	resolve	VERB
bjp-29940	32	4	through	through	ADP
bjp-29940	32	5	discussion	discussion	NOUN
bjp-29940	32	6	and	and	CCONJ
bjp-29940	32	7	consensus	consensus	NOUN
bjp-29940	32	8	among	among	ADP
bjp-29940	32	9	the	the	DET
bjp-29940	32	10	reviewers	reviewer	NOUN
bjp-29940	32	11	.	.	PUNCT
bjp-29940	33	1	the	the	DET
bjp-29940	33	2	extracted	extract	VERB
bjp-29940	33	3	data	datum	NOUN
bjp-29940	33	4	included	include	VERB
bjp-29940	33	5	the	the	DET
bjp-29940	33	6	following	follow	VERB
bjp-29940	33	7	domains	domain	NOUN
bjp-29940	33	8	:	:	PUNCT
bjp-29940	33	9	a	a	X
bjp-29940	33	10	)	)	PUNCT
bjp-29940	33	11	characteristics	characteristic	NOUN
bjp-29940	33	12	of	of	ADP
bjp-29940	33	13	study	study	NOUN
bjp-29940	33	14	design	design	NOUN
bjp-29940	33	15	,	,	PUNCT
bjp-29940	33	16	b	b	X
bjp-29940	33	17	)	)	PUNCT
bjp-29940	33	18	baseline	baseline	NOUN
bjp-29940	33	19	criteria	criterion	NOUN
bjp-29940	33	20	of	of	ADP
bjp-29940	33	21	included	include	VERB
bjp-29940	33	22	population	population	NOUN
bjp-29940	33	23	and	and	CCONJ
bjp-29940	33	24	c	c	X
bjp-29940	33	25	)	)	PUNCT
bjp-29940	33	26	study	study	NOUN
bjp-29940	33	27	outcomes	outcome	NOUN
bjp-29940	33	28	.	.	PUNCT
bjp-29940	34	1	primary	primary	ADJ
bjp-29940	34	2	efficacy	efficacy	NOUN
bjp-29940	34	3	measure	measure	VERB
bjp-29940	34	4	the	the	DET
bjp-29940	34	5	efficacy	efficacy	NOUN
bjp-29940	34	6	of	of	ADP
bjp-29940	34	7	antiviral	antiviral	ADJ
bjp-29940	34	8	treatment	treatment	NOUN
bjp-29940	34	9	was	be	AUX
bjp-29940	34	10	assessed	assess	VERB
bjp-29940	34	11	by	by	ADP
bjp-29940	34	12	svr	svr	PROPN
bjp-29940	34	13	and	and	CCONJ
bjp-29940	34	14	relapse	relapse	NOUN
bjp-29940	34	15	rate	rate	NOUN
bjp-29940	34	16	.	.	PUNCT
bjp-29940	35	1	svr	svr	PROPN
bjp-29940	35	2	is	be	AUX
bjp-29940	35	3	defined	define	VERB
bjp-29940	35	4	as	as	ADP
bjp-29940	35	5	patients	patient	NOUN
bjp-29940	35	6	with	with	ADP
bjp-29940	35	7	undetectable	undetectable	ADJ
bjp-29940	35	8	hcv	hcv	X
bjp-29940	35	9	rna	rna	NOUN
bjp-29940	35	10	level	level	NOUN
bjp-29940	35	11	at	at	ADP
bjp-29940	35	12	12	12	NUM
bjp-29940	35	13	or	or	CCONJ
bjp-29940	35	14	24	24	NUM
bjp-29940	35	15	weeks	week	NOUN
bjp-29940	35	16	after	after	ADP
bjp-29940	35	17	cessation	cessation	NOUN
bjp-29940	35	18	of	of	ADP
bjp-29940	35	19	treatment	treatment	NOUN
bjp-29940	35	20	,	,	PUNCT
bjp-29940	35	21	while	while	SCONJ
bjp-29940	35	22	relapse	relapse	NOUN
bjp-29940	35	23	rate	rate	NOUN
bjp-29940	35	24	is	be	AUX
bjp-29940	35	25	defined	define	VERB
bjp-29940	35	26	as	as	ADP
bjp-29940	35	27	detectable	detectable	ADJ
bjp-29940	35	28	hcv	hcv	X
bjp-29940	35	29	rna	rna	NOUN
bjp-29940	35	30	level	level	NOUN
bjp-29940	35	31	during	during	ADP
bjp-29940	35	32	follow	follow	NOUN
bjp-29940	35	33	-	-	PUNCT
bjp-29940	35	34	up	up	NOUN
bjp-29940	35	35	after	after	ADP
bjp-29940	35	36	achieving	achieve	VERB
bjp-29940	35	37	undetectable	undetectable	ADJ
bjp-29940	35	38	levels	level	NOUN
bjp-29940	35	39	at	at	ADP
bjp-29940	35	40	any	any	DET
bjp-29940	35	41	point	point	NOUN
bjp-29940	35	42	of	of	ADP
bjp-29940	35	43	treatment	treatment	NOUN
bjp-29940	35	44	.	.	PUNCT
bjp-29940	36	1	secondary	secondary	ADJ
bjp-29940	36	2	efficacy	efficacy	NOUN
bjp-29940	36	3	measures	measure	VERB
bjp-29940	36	4	the	the	DET
bjp-29940	36	5	secondary	secondary	ADJ
bjp-29940	36	6	efficacy	efficacy	NOUN
bjp-29940	36	7	measures	measure	NOUN
bjp-29940	36	8	included	include	VERB
bjp-29940	36	9	:	:	PUNCT
bjp-29940	36	10	rapid	rapid	ADJ
bjp-29940	36	11	virologic	virologic	ADJ
bjp-29940	36	12	response	response	NOUN
bjp-29940	36	13	rate	rate	NOUN
bjp-29940	36	14	(	(	PUNCT
bjp-29940	36	15	rvr	rvr	NOUN
bjp-29940	36	16	)	)	PUNCT
bjp-29940	37	1	[	[	X
bjp-29940	37	2	defined	define	VERB
bjp-29940	37	3	as	as	ADP
bjp-29940	37	4	undetectable	undetectable	ADJ
bjp-29940	37	5	hcv	hcv	X
bjp-29940	37	6	rna	rna	NOUN
bjp-29940	37	7	at	at	ADP
bjp-29940	37	8	week	week	NOUN
bjp-29940	37	9	4	4	NUM
bjp-29940	37	10	of	of	ADP
bjp-29940	37	11	treatment	treatment	NOUN
bjp-29940	37	12	]	]	PUNCT
bjp-29940	37	13	,	,	PUNCT
bjp-29940	37	14	extended	extend	VERB
bjp-29940	37	15	rapid	rapid	ADJ
bjp-29940	37	16	virological	virological	ADJ
bjp-29940	37	17	response	response	NOUN
bjp-29940	37	18	(	(	PUNCT
bjp-29940	37	19	ervr)[defined	ervr)[define	VERB
bjp-29940	37	20	as	as	ADP
bjp-29940	37	21	hcv	hcv	PROPN
bjp-29940	37	22	rna	rna	PROPN
bjp-29940	37	23	<	<	X
bjp-29940	37	24	1015	1015	NUM
bjp-29940	37	25	iu	iu	ADP
bjp-29940	37	26	/	/	SYM
bjp-29940	37	27	ml	ml	NOUN
bjp-29940	37	28	at	at	ADP
bjp-29940	37	29	weeks	week	NOUN
bjp-29940	37	30	4	4	NUM
bjp-29940	37	31	and	and	CCONJ
bjp-29940	37	32	12	12	NUM
bjp-29940	37	33	of	of	ADP
bjp-29940	37	34	treatment	treatment	NOUN
bjp-29940	37	35	]	]	PUNCT
bjp-29940	37	36	,	,	PUNCT
bjp-29940	37	37	complete	complete	ADJ
bjp-29940	37	38	early	early	ADJ
bjp-29940	37	39	virological	virological	ADJ
bjp-29940	37	40	response	response	NOUN
bjp-29940	37	41	(	(	PUNCT
bjp-29940	37	42	cevr)[defined	cevr)[define	VERB
bjp-29940	37	43	as	as	ADP
bjp-29940	37	44	≥2	≥2	PROPN
bjp-29940	37	45	log10	log10	PROPN
bjp-29940	37	46	reduction	reduction	NOUN
bjp-29940	37	47	from	from	ADP
bjp-29940	37	48	baseline	baseline	PROPN
bjp-29940	37	49	hcv	hcv	PROPN
bjp-29940	37	50	rna	rna	PROPN
bjp-29940	37	51	and	and	CCONJ
bjp-29940	37	52	the	the	DET
bjp-29940	37	53	virus	virus	NOUN
bjp-29940	37	54	is	be	AUX
bjp-29940	37	55	undetectable	undetectable	ADJ
bjp-29940	37	56	]	]	PUNCT
bjp-29940	37	57	,	,	PUNCT
bjp-29940	37	58	and	and	CCONJ
bjp-29940	37	59	end	end	NOUN
bjp-29940	37	60	of	of	ADP
bjp-29940	37	61	treatment	treatment	NOUN
bjp-29940	37	62	response	response	NOUN
bjp-29940	37	63	(	(	PUNCT
bjp-29940	37	64	eotr	eotr	NOUN
bjp-29940	37	65	)	)	PUNCT
bjp-29940	38	1	[	[	X
bjp-29940	38	2	defined	define	VERB
bjp-29940	38	3	as	as	ADP
bjp-29940	38	4	undetectable	undetectable	ADJ
bjp-29940	38	5	hcv	hcv	X
bjp-29940	38	6	rna	rna	NOUN
bjp-29940	38	7	at	at	ADP
bjp-29940	38	8	the	the	DET
bjp-29940	38	9	end	end	NOUN
bjp-29940	38	10	of	of	ADP
bjp-29940	38	11	treatment	treatment	NOUN
bjp-29940	38	12	]	]	PUNCT
bjp-29940	38	13	(	(	PUNCT
bjp-29940	38	14	lindsay	lindsay	PROPN
bjp-29940	38	15	,	,	PUNCT
bjp-29940	38	16	1997	1997	NUM
bjp-29940	38	17	;	;	PUNCT
bjp-29940	38	18	yu	yu	PROPN
bjp-29940	38	19	et	et	PROPN
bjp-29940	38	20	al	al	PROPN
bjp-29940	38	21	.	.	PROPN
bjp-29940	38	22	,	,	PUNCT
bjp-29940	38	23	2007	2007	NUM
bjp-29940	38	24	)	)	PUNCT
bjp-29940	38	25	.	.	PUNCT
bjp-29940	39	1	risk	risk	NOUN
bjp-29940	39	2	of	of	ADP
bjp-29940	39	3	bias	bias	NOUN
bjp-29940	39	4	assessment	assessment	NOUN
bjp-29940	39	5	the	the	DET
bjp-29940	39	6	risk	risk	NOUN
bjp-29940	39	7	of	of	ADP
bjp-29940	39	8	bias	bias	NOUN
bjp-29940	39	9	of	of	ADP
bjp-29940	39	10	the	the	DET
bjp-29940	39	11	retrieved	retrieve	VERB
bjp-29940	39	12	clinical	clinical	ADJ
bjp-29940	39	13	trials	trial	NOUN
bjp-29940	39	14	was	be	AUX
bjp-29940	39	15	assessed	assess	VERB
bjp-29940	39	16	according	accord	VERB
bjp-29940	39	17	to	to	ADP
bjp-29940	39	18	the	the	DET
bjp-29940	39	19	cochrane	cochrane	PROPN
bjp-29940	39	20	handbook	handbook	NOUN
bjp-29940	39	21	of	of	ADP
bjp-29940	39	22	systematic	systematic	ADJ
bjp-29940	39	23	reviews	review	NOUN
bjp-29940	39	24	of	of	ADP
bjp-29940	39	25	interventions	intervention	NOUN
bjp-29940	39	26	5.1.0	5.1.0	PROPN
bjp-29940	39	27	(	(	PUNCT
bjp-29940	39	28	updated	update	VERB
bjp-29940	39	29	march	march	NOUN
bjp-29940	39	30	,	,	PUNCT
bjp-29940	39	31	2011	2011	NUM
bjp-29940	39	32	)	)	PUNCT
bjp-29940	39	33	by	by	ADP
bjp-29940	39	34	two	two	NUM
bjp-29940	39	35	independent	independent	ADJ
bjp-29940	39	36	reviewers	reviewer	NOUN
bjp-29940	39	37	.	.	PUNCT
bjp-29940	40	1	any	any	DET
bjp-29940	40	2	discrepancies	discrepancy	NOUN
bjp-29940	40	3	between	between	ADP
bjp-29940	40	4	the	the	DET
bjp-29940	40	5	two	two	NUM
bjp-29940	40	6	assessors	assessor	NOUN
bjp-29940	40	7	were	be	AUX
bjp-29940	40	8	resolved	resolve	VERB
bjp-29940	40	9	through	through	ADP
bjp-29940	40	10	discussion	discussion	NOUN
bjp-29940	40	11	with	with	ADP
bjp-29940	40	12	a	a	DET
bjp-29940	40	13	third	third	ADJ
bjp-29940	40	14	assessor	assessor	NOUN
bjp-29940	40	15	.	.	PUNCT
bjp-29940	41	1	data	datum	NOUN
bjp-29940	41	2	synthesis	synthesis	NOUN
bjp-29940	41	3	study	study	NOUN
bjp-29940	41	4	outcomes	outcome	NOUN
bjp-29940	41	5	were	be	AUX
bjp-29940	41	6	pooled	pool	VERB
bjp-29940	41	7	as	as	ADP
bjp-29940	41	8	a	a	DET
bjp-29940	41	9	risk	risk	NOUN
bjp-29940	41	10	ratio	ratio	NOUN
bjp-29940	41	11	(	(	PUNCT
bjp-29940	41	12	rr	rr	NOUN
bjp-29940	41	13	)	)	PUNCT
bjp-29940	41	14	in	in	ADP
bjp-29940	41	15	a	a	DET
bjp-29940	41	16	fixed	fix	VERB
bjp-29940	41	17	effect	effect	NOUN
bjp-29940	41	18	model	model	NOUN
bjp-29940	41	19	meta	meta	ADJ
bjp-29940	41	20	-	-	PUNCT
bjp-29940	41	21	analysis	analysis	NOUN
bjp-29940	41	22	using	use	VERB
bjp-29940	41	23	mantel	mantel	NOUN
bjp-29940	41	24	-	-	PUNCT
bjp-29940	41	25	haenszel	haenszel	NOUN
bjp-29940	41	26	method	method	NOUN
bjp-29940	41	27	.	.	PUNCT
bjp-29940	42	1	a	a	DET
bjp-29940	42	2	subgroup	subgroup	NOUN
bjp-29940	42	3	analysis	analysis	NOUN
bjp-29940	42	4	,	,	PUNCT
bjp-29940	42	5	according	accord	VERB
bjp-29940	42	6	to	to	ADP
bjp-29940	42	7	daclatasvir	daclatasvir	PROPN
bjp-29940	42	8	dose	dose	PROPN
bjp-29940	42	9	,	,	PUNCT
bjp-29940	42	10	was	be	AUX
bjp-29940	42	11	conducted	conduct	VERB
bjp-29940	42	12	whenever	whenever	SCONJ
bjp-29940	42	13	possible	possible	ADJ
bjp-29940	42	14	.	.	PUNCT
bjp-29940	43	1	for	for	ADP
bjp-29940	43	2	all	all	DET
bjp-29940	43	3	outcomes	outcome	NOUN
bjp-29940	43	4	,	,	PUNCT
bjp-29940	43	5	effect	effect	NOUN
bjp-29940	43	6	estimates	estimate	NOUN
bjp-29940	43	7	of	of	ADP
bjp-29940	43	8	the	the	DET
bjp-29940	43	9	two	two	NUM
bjp-29940	43	10	doses	dose	NOUN
bjp-29940	43	11	(	(	PUNCT
bjp-29940	43	12	20	20	NUM
bjp-29940	43	13	vs	vs	ADP
bjp-29940	43	14	60	60	NUM
bjp-29940	43	15	mg	mg	NOUN
bjp-29940	43	16	)	)	PUNCT
bjp-29940	43	17	were	be	AUX
bjp-29940	43	18	compared	compare	VERB
bjp-29940	43	19	by	by	ADP
bjp-29940	43	20	chi	chi	ADJ
bjp-29940	43	21	-	-	PUNCT
bjp-29940	43	22	square	square	ADJ
bjp-29940	43	23	test	test	NOUN
bjp-29940	43	24	.	.	PUNCT
bjp-29940	44	1	all	all	DET
bjp-29940	44	2	analyses	analysis	NOUN
bjp-29940	44	3	were	be	AUX
bjp-29940	44	4	conducted	conduct	VERB
bjp-29940	44	5	by	by	ADP
bjp-29940	44	6	revman	revman	ADJ
bjp-29940	44	7	software	software	NOUN
bjp-29940	44	8	version	version	NOUN
bjp-29940	44	9	5.3	5.3	NUM
bjp-29940	44	10	for	for	ADP
bjp-29940	44	11	windows	window	NOUN
bjp-29940	44	12	.	.	PUNCT
bjp-29940	45	1	assessment	assessment	NOUN
bjp-29940	45	2	of	of	ADP
bjp-29940	45	3	heterogeneity	heterogeneity	NOUN
bjp-29940	45	4	heterogeneity	heterogeneity	NOUN
bjp-29940	45	5	was	be	AUX
bjp-29940	45	6	assessed	assess	VERB
bjp-29940	45	7	using	use	VERB
bjp-29940	45	8	the	the	DET
bjp-29940	45	9	chi	chi	ADJ
bjp-29940	45	10	-	-	PUNCT
bjp-29940	45	11	square	square	ADJ
bjp-29940	45	12	test	test	NOUN
bjp-29940	45	13	and	and	CCONJ
bjp-29940	45	14	extent	extent	NOUN
bjp-29940	45	15	was	be	AUX
bjp-29940	45	16	measure	measure	NOUN
bjp-29940	45	17	using	use	VERB
bjp-29940	45	18	the	the	DET
bjp-29940	45	19	i	i	PROPN
bjp-29940	45	20	-	-	PUNCT
bjp-29940	45	21	square	square	ADJ
bjp-29940	45	22	tests	test	NOUN
bjp-29940	45	23	.	.	PUNCT
bjp-29940	46	1	publication	publication	NOUN
bjp-29940	46	2	bias	bias	NOUN
bjp-29940	46	3	according	accord	VERB
bjp-29940	46	4	to	to	ADP
bjp-29940	46	5	egger	egger	NOUN
bjp-29940	46	6	and	and	CCONJ
bjp-29940	46	7	colleagues	colleague	NOUN
bjp-29940	46	8	,	,	PUNCT
bjp-29940	46	9	the	the	DET
bjp-29940	46	10	assessment	assessment	NOUN
bjp-29940	46	11	of	of	ADP
bjp-29940	46	12	publication	publication	NOUN
bjp-29940	46	13	bias	bias	NOUN
bjp-29940	46	14	is	be	AUX
bjp-29940	46	15	not	not	PART
bjp-29940	46	16	reliable	reliable	ADJ
bjp-29940	46	17	for	for	ADP
bjp-29940	46	18	less	less	ADJ
bjp-29940	46	19	than	than	ADP
bjp-29940	46	20	10	10	NUM
bjp-29940	46	21	pooled	pool	VERB
bjp-29940	46	22	studies	study	NOUN
bjp-29940	46	23	.	.	PUNCT
bjp-29940	47	1	therefore	therefore	ADV
bjp-29940	47	2	,	,	PUNCT
bjp-29940	47	3	in	in	ADP
bjp-29940	47	4	the	the	DET
bjp-29940	47	5	present	present	ADJ
bjp-29940	47	6	study	study	NOUN
bjp-29940	47	7	,	,	PUNCT
bjp-29940	47	8	we	we	PRON
bjp-29940	47	9	could	could	AUX
bjp-29940	47	10	not	not	PART
bjp-29940	47	11	assess	assess	VERB
bjp-29940	47	12	the	the	DET
bjp-29940	47	13	existence	existence	NOUN
bjp-29940	47	14	of	of	ADP
bjp-29940	47	15	publication	publication	NOUN
bjp-29940	47	16	bias	bias	NOUN
bjp-29940	47	17	by	by	ADP
bjp-29940	47	18	egger	egger	NOUN
bjp-29940	47	19	’s	’s	PART
bjp-29940	47	20	test	test	NOUN
bjp-29940	47	21	for	for	ADP
bjp-29940	47	22	funnel	funnel	NOUN
bjp-29940	47	23	plot	plot	NOUN
bjp-29940	47	24	asymmetry	asymmetry	NOUN
bjp-29940	47	25	(	(	PUNCT
bjp-29940	47	26	egger	egger	NOUN
bjp-29940	47	27	et	et	PROPN
bjp-29940	47	28	al	al	PROPN
bjp-29940	47	29	.	.	PROPN
bjp-29940	47	30	,	,	PUNCT
bjp-29940	47	31	1997	1997	NUM
bjp-29940	47	32	;	;	PUNCT
bjp-29940	47	33	terrin	terrin	NOUN
bjp-29940	47	34	et	et	PROPN
bjp-29940	47	35	al	al	PROPN
bjp-29940	47	36	.	.	PROPN
bjp-29940	47	37	,	,	PUNCT
bjp-29940	47	38	2003	2003	NUM
bjp-29940	47	39	)	)	PUNCT
bjp-29940	47	40	.	.	PUNCT
bjp-29940	48	1	bangladesh	bangladesh	PROPN
bjp-29940	48	2	j	j	PROPN
bjp-29940	48	3	pharmacol	pharmacol	PROPN
bjp-29940	48	4	2017	2017	NUM
bjp-29940	48	5	;	;	PUNCT
bjp-29940	48	6	12	12	NUM
bjp-29940	48	7	:	:	SYM
bjp-29940	48	8	12	12	NUM
bjp-29940	48	9	-	-	SYM
bjp-29940	48	10	22	22	NUM
bjp-29940	48	11	13	13	NUM
bjp-29940	48	12	results	result	NOUN
bjp-29940	48	13	search	search	NOUN
bjp-29940	48	14	results	result	NOUN
bjp-29940	48	15	our	our	PRON
bjp-29940	48	16	search	search	NOUN
bjp-29940	48	17	retrieved	retrieve	VERB
bjp-29940	48	18	1,856	1,856	NUM
bjp-29940	48	19	unique	unique	ADJ
bjp-29940	48	20	citations	citation	NOUN
bjp-29940	48	21	.	.	PUNCT
bjp-29940	49	1	of	of	ADP
bjp-29940	49	2	them	they	PRON
bjp-29940	49	3	,	,	PUNCT
bjp-29940	49	4	36	36	NUM
bjp-29940	49	5	records	record	NOUN
bjp-29940	49	6	were	be	AUX
bjp-29940	49	7	eligible	eligible	ADJ
bjp-29940	49	8	for	for	ADP
bjp-29940	49	9	full	full	ADJ
bjp-29940	49	10	text	text	NOUN
bjp-29940	49	11	screening	screening	NOUN
bjp-29940	49	12	.	.	PUNCT
bjp-29940	50	1	finally	finally	ADV
bjp-29940	50	2	,	,	PUNCT
bjp-29940	50	3	34	34	NUM
bjp-29940	50	4	articles	article	NOUN
bjp-29940	50	5	were	be	AUX
bjp-29940	50	6	excluded	exclude	VERB
bjp-29940	50	7	and	and	CCONJ
bjp-29940	50	8	two	two	NUM
bjp-29940	50	9	randomized	randomized	ADJ
bjp-29940	50	10	controlled	control	VERB
bjp-29940	50	11	trials	trial	NOUN
bjp-29940	50	12	(	(	PUNCT
bjp-29940	50	13	with	with	ADP
bjp-29940	50	14	a	a	DET
bjp-29940	50	15	total	total	NOUN
bjp-29940	50	16	of	of	ADP
bjp-29940	50	17	154	154	NUM
bjp-29940	50	18	hcv	hcv	NOUN
bjp-29940	50	19	genotype	genotype	NOUN
bjp-29940	50	20	4	4	NUM
bjp-29940	50	21	patients	patient	NOUN
bjp-29940	50	22	)	)	PUNCT
bjp-29940	50	23	were	be	AUX
bjp-29940	50	24	included	include	VERB
bjp-29940	50	25	in	in	ADP
bjp-29940	50	26	the	the	DET
bjp-29940	50	27	final	final	ADJ
bjp-29940	50	28	analysis	analysis	NOUN
bjp-29940	50	29	(	(	PUNCT
bjp-29940	50	30	figure	figure	NOUN
bjp-29940	50	31	1	1	NUM
bjp-29940	50	32	)	)	PUNCT
bjp-29940	50	33	.	.	PUNCT
bjp-29940	51	1	risk	risk	NOUN
bjp-29940	51	2	of	of	ADP
bjp-29940	51	3	bias	bias	NOUN
bjp-29940	51	4	in	in	ADP
bjp-29940	51	5	included	include	VERB
bjp-29940	51	6	studies	study	NOUN
bjp-29940	51	7	the	the	DET
bjp-29940	51	8	risk	risk	NOUN
bjp-29940	51	9	of	of	ADP
bjp-29940	51	10	bias	bias	NOUN
bjp-29940	51	11	in	in	ADP
bjp-29940	51	12	included	include	VERB
bjp-29940	51	13	studies	study	NOUN
bjp-29940	51	14	was	be	AUX
bjp-29940	51	15	low	low	ADJ
bjp-29940	51	16	according	accord	VERB
bjp-29940	51	17	to	to	ADP
bjp-29940	51	18	the	the	DET
bjp-29940	51	19	cochrane	cochrane	NOUN
bjp-29940	51	20	risk	risk	NOUN
bjp-29940	51	21	of	of	ADP
bjp-29940	51	22	bias	bias	NOUN
bjp-29940	51	23	assessment	assessment	NOUN
bjp-29940	51	24	tool	tool	NOUN
bjp-29940	51	25	.	.	PUNCT
bjp-29940	52	1	the	the	DET
bjp-29940	52	2	summary	summary	NOUN
bjp-29940	52	3	of	of	ADP
bjp-29940	52	4	risk	risk	NOUN
bjp-29940	52	5	of	of	ADP
bjp-29940	52	6	bias	bias	NOUN
bjp-29940	52	7	assessment	assessment	NOUN
bjp-29940	52	8	domains	domain	NOUN
bjp-29940	52	9	and	and	CCONJ
bjp-29940	52	10	authors	author	NOUN
bjp-29940	52	11	’	’	PART
bjp-29940	52	12	judgments	judgment	NOUN
bjp-29940	52	13	with	with	ADP
bjp-29940	52	14	justifications	justification	NOUN
bjp-29940	52	15	are	be	AUX
bjp-29940	52	16	shown	show	VERB
bjp-29940	52	17	in	in	ADP
bjp-29940	52	18	the	the	DET
bjp-29940	52	19	supplementary	supplementary	ADJ
bjp-29940	52	20	data	datum	NOUN
bjp-29940	52	21	in	in	ADP
bjp-29940	52	22	page	page	NOUN
bjp-29940	52	23	22	22	NUM
bjp-29940	52	24	.	.	PUNCT
bjp-29940	53	1	our	our	PRON
bjp-29940	53	2	analysis	analysis	NOUN
bjp-29940	53	3	included	include	VERB
bjp-29940	53	4	154	154	NUM
bjp-29940	53	5	patients	patient	NOUN
bjp-29940	53	6	with	with	ADP
bjp-29940	53	7	hcv	hcv	NOUN
bjp-29940	53	8	genotype	genotype	NOUN
bjp-29940	53	9	4	4	NUM
bjp-29940	53	10	(	(	PUNCT
bjp-29940	53	11	daclatasvir	daclatasvir	NOUN
bjp-29940	53	12	:	:	PUNCT
bjp-29940	53	13	106	106	NUM
bjp-29940	53	14	patients	patient	NOUN
bjp-29940	53	15	and	and	CCONJ
bjp-29940	53	16	placebo	placebo	NOUN
bjp-29940	53	17	:	:	PUNCT
bjp-29940	53	18	48	48	NUM
bjp-29940	53	19	patients	patient	NOUN
bjp-29940	53	20	)	)	PUNCT
bjp-29940	53	21	.	.	PUNCT
bjp-29940	54	1	baseline	baseline	PROPN
bjp-29940	54	2	characteristics	characteristic	NOUN
bjp-29940	54	3	of	of	ADP
bjp-29940	54	4	each	each	DET
bjp-29940	54	5	study	study	NOUN
bjp-29940	54	6	population	population	NOUN
bjp-29940	54	7	are	be	AUX
bjp-29940	54	8	shown	show	VERB
bjp-29940	54	9	in	in	ADP
bjp-29940	54	10	table	table	NOUN
bjp-29940	54	11	i	i	PRON
bjp-29940	54	12	and	and	CCONJ
bjp-29940	54	13	the	the	DET
bjp-29940	54	14	summary	summary	NOUN
bjp-29940	54	15	of	of	ADP
bjp-29940	54	16	included	include	VERB
bjp-29940	54	17	studies	study	NOUN
bjp-29940	54	18	and	and	CCONJ
bjp-29940	54	19	their	their	PRON
bjp-29940	54	20	main	main	ADJ
bjp-29940	54	21	results	result	NOUN
bjp-29940	54	22	are	be	AUX
bjp-29940	54	23	shown	show	VERB
bjp-29940	54	24	in	in	ADP
bjp-29940	54	25	table	table	NOUN
bjp-29940	54	26	ii	ii	PROPN
bjp-29940	54	27	.	.	PUNCT
bjp-29940	55	1	sustained	sustain	VERB
bjp-29940	55	2	virologic	virologic	ADJ
bjp-29940	55	3	response	response	NOUN
bjp-29940	55	4	rate	rate	NOUN
bjp-29940	55	5	(	(	PUNCT
bjp-29940	55	6	svr	svr	PROPN
bjp-29940	55	7	)	)	PUNCT
bjp-29940	55	8	the	the	DET
bjp-29940	55	9	daclatasvir	daclatasvir	PROPN
bjp-29940	55	10	plus	plus	CCONJ
bjp-29940	55	11	peg	peg	NOUN
bjp-29940	55	12	-	-	PUNCT
bjp-29940	55	13	ifn	ifn	NOUN
bjp-29940	55	14	/	/	SYM
bjp-29940	55	15	rbv	rbv	NOUN
bjp-29940	55	16	treatment	treatment	NOUN
bjp-29940	55	17	achieved	achieve	VERB
bjp-29940	55	18	a	a	DET
bjp-29940	55	19	svr	svr	NOUN
bjp-29940	55	20	of	of	ADP
bjp-29940	55	21	76	76	NUM
bjp-29940	55	22	%	%	NOUN
bjp-29940	55	23	(	(	PUNCT
bjp-29940	55	24	81/106	81/106	NUM
bjp-29940	55	25	)	)	PUNCT
bjp-29940	55	26	after	after	ADP
bjp-29940	55	27	12	12	NUM
bjp-29940	55	28	weeks	week	NOUN
bjp-29940	55	29	and	and	CCONJ
bjp-29940	55	30	79	79	NUM
bjp-29940	55	31	%	%	NOUN
bjp-29940	55	32	(	(	PUNCT
bjp-29940	55	33	84/106	84/106	NUM
bjp-29940	55	34	)	)	PUNCT
bjp-29940	55	35	after	after	ADP
bjp-29940	55	36	24	24	NUM
bjp-29940	55	37	weeks	week	NOUN
bjp-29940	55	38	.	.	PUNCT
bjp-29940	56	1	compared	compare	VERB
bjp-29940	56	2	with	with	ADP
bjp-29940	56	3	the	the	DET
bjp-29940	56	4	svr	svr	PROPN
bjp-29940	56	5	rate	rate	NOUN
bjp-29940	56	6	in	in	ADP
bjp-29940	56	7	the	the	DET
bjp-29940	56	8	placebo	placebo	NOUN
bjp-29940	56	9	plus	plus	CCONJ
bjp-29940	56	10	peg	peg	NOUN
bjp-29940	56	11	-	-	PUNCT
bjp-29940	56	12	ifn	ifn	NOUN
bjp-29940	56	13	/	/	SYM
bjp-29940	56	14	rbv	rbv	NOUN
bjp-29940	56	15	group	group	NOUN
bjp-29940	56	16	,	,	PUNCT
bjp-29940	56	17	the	the	DET
bjp-29940	56	18	daclatasvir	daclatasvir	NOUN
bjp-29940	56	19	containing	contain	VERB
bjp-29940	56	20	(	(	PUNCT
bjp-29940	56	21	triple	triple	ADJ
bjp-29940	56	22	)	)	PUNCT
bjp-29940	56	23	regimen	regiman	NOUN
bjp-29940	56	24	was	be	AUX
bjp-29940	56	25	superior	superior	ADJ
bjp-29940	56	26	after	after	ADP
bjp-29940	56	27	12	12	NUM
bjp-29940	56	28	weeks	week	NOUN
bjp-29940	56	29	(	(	PUNCT
bjp-29940	56	30	rr=	rr=	NOUN
bjp-29940	56	31	1.9	1.9	NUM
bjp-29940	56	32	%	%	NOUN
bjp-29940	56	33	ci	ci	NOUN
bjp-29940	57	1	[	[	X
bjp-29940	57	2	1.3	1.3	NUM
bjp-29940	57	3	to	to	ADP
bjp-29940	57	4	2.6	2.6	NUM
bjp-29940	57	5	]	]	PUNCT
bjp-29940	57	6	,	,	PUNCT
bjp-29940	57	7	p=0.0002	p=0.0002	PROPN
bjp-29940	57	8	;	;	PUNCT
bjp-29940	57	9	figure	figure	NOUN
bjp-29940	57	10	2a	2a	NUM
bjp-29940	57	11	)	)	PUNCT
bjp-29940	57	12	.	.	PUNCT
bjp-29940	58	1	pooled	pool	VERB
bjp-29940	58	2	studies	study	NOUN
bjp-29940	58	3	were	be	AUX
bjp-29940	58	4	homogenous	homogenous	ADJ
bjp-29940	58	5	(	(	PUNCT
bjp-29940	58	6	p	p	X
bjp-29940	58	7	=	=	NOUN
bjp-29940	58	8	0.87	0.87	NUM
bjp-29940	58	9	;	;	PUNCT
bjp-29940	58	10	i²	i²	NOUN
bjp-29940	58	11	=	=	PUNCT
bjp-29940	58	12	0	0	NUM
bjp-29940	58	13	%	%	NOUN
bjp-29940	58	14	)	)	PUNCT
bjp-29940	58	15	.	.	PUNCT
bjp-29940	59	1	the	the	DET
bjp-29940	59	2	svr	svr	PROPN
bjp-29940	59	3	after	after	ADP
bjp-29940	59	4	24	24	NUM
bjp-29940	59	5	weeks	week	NOUN
bjp-29940	59	6	was	be	AUX
bjp-29940	59	7	also	also	ADV
bjp-29940	59	8	higher	high	ADJ
bjp-29940	59	9	in	in	ADP
bjp-29940	59	10	the	the	DET
bjp-29940	59	11	triple	triple	ADJ
bjp-29940	59	12	regimen	regimen	NOUN
bjp-29940	59	13	group	group	NOUN
bjp-29940	59	14	(	(	PUNCT
bjp-29940	59	15	rr=	rr=	PROPN
bjp-29940	59	16	1.8	1.8	NUM
bjp-29940	59	17	%	%	NOUN
bjp-29940	59	18	ci	ci	NOUN
bjp-29940	60	1	[	[	X
bjp-29940	60	2	1.3	1.3	NUM
bjp-29940	60	3	to	to	ADP
bjp-29940	60	4	2.5	2.5	NUM
bjp-29940	60	5	]	]	PUNCT
bjp-29940	60	6	,	,	PUNCT
bjp-29940	60	7	p=0.0002	p=0.0002	PROPN
bjp-29940	60	8	;	;	PUNCT
bjp-29940	60	9	figure	figure	NOUN
bjp-29940	60	10	2b	2b	NOUN
bjp-29940	60	11	)	)	PUNCT
bjp-29940	60	12	.	.	PUNCT
bjp-29940	61	1	pooled	pool	VERB
bjp-29940	61	2	studies	study	NOUN
bjp-29940	61	3	were	be	AUX
bjp-29940	61	4	homogenous	homogenous	ADJ
bjp-29940	61	5	(	(	PUNCT
bjp-29940	61	6	p	p	X
bjp-29940	61	7	=	=	NOUN
bjp-29940	61	8	0.45	0.45	NUM
bjp-29940	61	9	;	;	PUNCT
bjp-29940	61	10	i²	i²	NOUN
bjp-29940	61	11	=	=	SYM
bjp-29940	61	12	0	0	NUM
bjp-29940	61	13	%	%	NOUN
bjp-29940	61	14	)	)	PUNCT
bjp-29940	61	15	.	.	PUNCT
bjp-29940	62	1	relapse	relapse	NOUN
bjp-29940	62	2	rate	rate	NOUN
bjp-29940	62	3	the	the	DET
bjp-29940	62	4	relapse	relapse	NOUN
bjp-29940	62	5	rate	rate	NOUN
bjp-29940	62	6	was	be	AUX
bjp-29940	62	7	lower	low	ADJ
bjp-29940	62	8	in	in	ADP
bjp-29940	62	9	the	the	DET
bjp-29940	62	10	triple	triple	ADJ
bjp-29940	62	11	regimen	regimen	NOUN
bjp-29940	62	12	group	group	NOUN
bjp-29940	62	13	,	,	PUNCT
bjp-29940	62	14	compared	compare	VERB
bjp-29940	62	15	to	to	ADP
bjp-29940	62	16	the	the	DET
bjp-29940	62	17	dual	dual	ADJ
bjp-29940	62	18	regimen	regimen	NOUN
bjp-29940	62	19	group	group	NOUN
bjp-29940	62	20	(	(	PUNCT
bjp-29940	62	21	rr=	rr=	NOUN
bjp-29940	62	22	0.2	0.2	NUM
bjp-29940	62	23	%	%	NOUN
bjp-29940	62	24	ci	ci	NOUN
bjp-29940	63	1	[	[	X
bjp-29940	63	2	0.1	0.1	NUM
bjp-29940	63	3	to	to	PART
bjp-29940	63	4	0.5	0.5	NUM
bjp-29940	63	5	]	]	PUNCT
bjp-29940	63	6	,	,	PUNCT
bjp-29940	63	7	p=0.002	p=0.002	NOUN
bjp-29940	63	8	;	;	PUNCT
bjp-29940	63	9	figure	figure	NOUN
bjp-29940	63	10	3a	3a	NUM
bjp-29940	63	11	)	)	PUNCT
bjp-29940	63	12	.	.	PUNCT
bjp-29940	64	1	pooled	pool	VERB
bjp-29940	64	2	studies	study	NOUN
bjp-29940	64	3	were	be	AUX
bjp-29940	64	4	homogenous	homogenous	ADJ
bjp-29940	64	5	(	(	PUNCT
bjp-29940	64	6	p=0.032	p=0.032	NUM
bjp-29940	64	7	;	;	PUNCT
bjp-29940	64	8	i²=	i²=	NOUN
bjp-29940	64	9	13	13	NUM
bjp-29940	64	10	%	%	NOUN
bjp-29940	64	11	)	)	PUNCT
bjp-29940	64	12	.	.	PUNCT
bjp-29940	65	1	rapid	rapid	ADJ
bjp-29940	65	2	virologic	virologic	ADJ
bjp-29940	65	3	response	response	NOUN
bjp-29940	65	4	rate	rate	NOUN
bjp-29940	65	5	(	(	PUNCT
bjp-29940	65	6	rvr	rvr	NOUN
bjp-29940	65	7	)	)	PUNCT
bjp-29940	65	8	daclatasvir	daclatasvir	PROPN
bjp-29940	65	9	plus	plus	CCONJ
bjp-29940	65	10	peg	peg	NOUN
bjp-29940	65	11	-	-	PUNCT
bjp-29940	65	12	ifn	ifn	NOUN
bjp-29940	65	13	/	/	SYM
bjp-29940	65	14	rbv	rbv	PROPN
bjp-29940	65	15	group	group	NOUN
bjp-29940	65	16	was	be	AUX
bjp-29940	65	17	superior	superior	ADJ
bjp-29940	65	18	to	to	ADP
bjp-29940	65	19	placebo	placebo	NOUN
bjp-29940	65	20	plus	plus	CCONJ
bjp-29940	65	21	peg	peg	NOUN
bjp-29940	65	22	-	-	PUNCT
bjp-29940	65	23	ifn	ifn	NOUN
bjp-29940	65	24	/	/	SYM
bjp-29940	65	25	rbv	rbv	NOUN
bjp-29940	65	26	group	group	NOUN
bjp-29940	65	27	in	in	ADP
bjp-29940	65	28	terms	term	NOUN
bjp-29940	65	29	of	of	ADP
bjp-29940	65	30	rvr	rvr	NOUN
bjp-29940	65	31	(	(	PUNCT
bjp-29940	65	32	rr=	rr=	NOUN
bjp-29940	65	33	6.6	6.6	NUM
bjp-29940	65	34	%	%	NOUN
bjp-29940	65	35	ci	ci	NOUN
bjp-29940	66	1	[	[	X
bjp-29940	66	2	3.1	3.1	NUM
bjp-29940	66	3	to	to	PART
bjp-29940	66	4	14.2	14.2	NUM
bjp-29940	66	5	]	]	PUNCT
bjp-29940	66	6	,	,	PUNCT
bjp-29940	66	7	p<0.0001	p<0.0001	NOUN
bjp-29940	66	8	;	;	PUNCT
bjp-29940	66	9	figure	figure	NOUN
bjp-29940	66	10	3b	3b	NUM
bjp-29940	66	11	)	)	PUNCT
bjp-29940	66	12	.	.	PUNCT
bjp-29940	67	1	pooled	pool	VERB
bjp-29940	67	2	studies	study	NOUN
bjp-29940	67	3	were	be	AUX
bjp-29940	67	4	homogenous	homogenous	ADJ
bjp-29940	67	5	(	(	PUNCT
bjp-29940	67	6	p	p	X
bjp-29940	67	7	=	=	NOUN
bjp-29940	67	8	0.80	0.80	NUM
bjp-29940	67	9	;	;	PUNCT
bjp-29940	67	10	i²	i²	NOUN
bjp-29940	67	11	=	=	SYM
bjp-29940	67	12	0	0	NUM
bjp-29940	67	13	%	%	NOUN
bjp-29940	67	14	)	)	PUNCT
bjp-29940	67	15	.	.	PUNCT
bjp-29940	68	1	extended	extend	VERB
bjp-29940	68	2	rapid	rapid	ADJ
bjp-29940	68	3	virologic	virologic	ADJ
bjp-29940	68	4	response	response	NOUN
bjp-29940	68	5	rate	rate	NOUN
bjp-29940	68	6	(	(	PUNCT
bjp-29940	68	7	ervr	ervr	NOUN
bjp-29940	68	8	)	)	PUNCT
bjp-29940	68	9	daclatasvir	daclatasvir	PROPN
bjp-29940	68	10	plus	plus	CCONJ
bjp-29940	68	11	peg	peg	NOUN
bjp-29940	68	12	-	-	PUNCT
bjp-29940	68	13	ifn	ifn	NOUN
bjp-29940	68	14	/	/	SYM
bjp-29940	68	15	rbv	rbv	PROPN
bjp-29940	68	16	group	group	NOUN
bjp-29940	68	17	was	be	AUX
bjp-29940	68	18	superior	superior	ADJ
bjp-29940	68	19	to	to	ADP
bjp-29940	68	20	placebo	placebo	NOUN
bjp-29940	68	21	plus	plus	CCONJ
bjp-29940	68	22	peg	peg	NOUN
bjp-29940	68	23	-	-	PUNCT
bjp-29940	68	24	ifn	ifn	NOUN
bjp-29940	68	25	/	/	SYM
bjp-29940	68	26	rbv	rbv	NOUN
bjp-29940	68	27	group	group	NOUN
bjp-29940	68	28	in	in	ADP
bjp-29940	68	29	terms	term	NOUN
bjp-29940	68	30	of	of	ADP
bjp-29940	68	31	ervr	ervr	NOUN
bjp-29940	68	32	(	(	PUNCT
bjp-29940	68	33	rr=5.3	rr=5.3	PROPN
bjp-29940	68	34	%	%	NOUN
bjp-29940	68	35	ci	ci	NOUN
bjp-29940	69	1	[	[	X
bjp-29940	69	2	2.6	2.6	NUM
bjp-29940	69	3	to	to	PART
bjp-29940	69	4	10.7	10.7	NUM
bjp-29940	69	5	]	]	PUNCT
bjp-29940	69	6	,	,	PUNCT
bjp-29940	69	7	p<0.0001	p<0.0001	NOUN
bjp-29940	69	8	;	;	PUNCT
bjp-29940	69	9	figure	figure	NOUN
bjp-29940	69	10	4a	4a	NUM
bjp-29940	69	11	)	)	PUNCT
bjp-29940	69	12	.	.	PUNCT
bjp-29940	70	1	pooled	pool	VERB
bjp-29940	70	2	studies	study	NOUN
bjp-29940	70	3	were	be	AUX
bjp-29940	70	4	homogenous	homogenous	ADJ
bjp-29940	70	5	(	(	PUNCT
bjp-29940	70	6	p	p	X
bjp-29940	70	7	=	=	NOUN
bjp-29940	70	8	0.89	0.89	NUM
bjp-29940	70	9	;	;	PUNCT
bjp-29940	70	10	i²	i²	NOUN
bjp-29940	70	11	=	=	SYM
bjp-29940	70	12	0	0	NUM
bjp-29940	70	13	%	%	NOUN
bjp-29940	70	14	)	)	PUNCT
bjp-29940	70	15	.	.	PUNCT
bjp-29940	71	1	complete	complete	ADJ
bjp-29940	71	2	early	early	ADJ
bjp-29940	71	3	virologic	virologic	ADJ
bjp-29940	71	4	response	response	NOUN
bjp-29940	71	5	rate	rate	NOUN
bjp-29940	71	6	(	(	PUNCT
bjp-29940	71	7	cevr	cevr	PROPN
bjp-29940	71	8	)	)	PUNCT
bjp-29940	71	9	daclatasvir	daclatasvir	PROPN
bjp-29940	71	10	plus	plus	CCONJ
bjp-29940	71	11	peg	peg	NOUN
bjp-29940	71	12	-	-	PUNCT
bjp-29940	71	13	ifn	ifn	NOUN
bjp-29940	71	14	/	/	SYM
bjp-29940	71	15	rbv	rbv	PROPN
bjp-29940	71	16	group	group	NOUN
bjp-29940	71	17	was	be	AUX
bjp-29940	71	18	superior	superior	ADJ
bjp-29940	71	19	to	to	ADP
bjp-29940	71	20	placebo	placebo	NOUN
bjp-29940	71	21	plus	plus	CCONJ
bjp-29940	71	22	peg	peg	NOUN
bjp-29940	71	23	-	-	PUNCT
bjp-29940	71	24	ifn	ifn	NOUN
bjp-29940	71	25	/	/	SYM
bjp-29940	71	26	rbv	rbv	NOUN
bjp-29940	71	27	group	group	NOUN
bjp-29940	71	28	in	in	ADP
bjp-29940	71	29	terms	term	NOUN
bjp-29940	71	30	of	of	ADP
bjp-29940	71	31	crvr	crvr	NOUN
bjp-29940	71	32	(	(	PUNCT
bjp-29940	71	33	rr=	rr=	PROPN
bjp-29940	71	34	1.7	1.7	NUM
bjp-29940	71	35	%	%	NOUN
bjp-29940	71	36	ci	ci	NOUN
bjp-29940	72	1	[	[	X
bjp-29940	72	2	1.3	1.3	NUM
bjp-29940	72	3	to	to	ADP
bjp-29940	72	4	2.3	2.3	NUM
bjp-29940	72	5	]	]	PUNCT
bjp-29940	72	6	,	,	PUNCT
bjp-29940	72	7	p	p	PROPN
bjp-29940	72	8	=	=	PROPN
bjp-29940	72	9	0.0002	0.0002	NUM
bjp-29940	72	10	;	;	PUNCT
bjp-29940	72	11	figure	figure	NOUN
bjp-29940	72	12	4b	4b	PROPN
bjp-29940	72	13	)	)	PUNCT
bjp-29940	72	14	.	.	PUNCT
bjp-29940	73	1	pooled	pool	VERB
bjp-29940	73	2	studies	study	NOUN
bjp-29940	73	3	were	be	AUX
bjp-29940	73	4	homogenous	homogenous	ADJ
bjp-29940	73	5	(	(	PUNCT
bjp-29940	73	6	p	p	X
bjp-29940	73	7	=	=	NOUN
bjp-29940	73	8	0.81	0.81	NUM
bjp-29940	73	9	;	;	PUNCT
bjp-29940	73	10	i²	i²	NOUN
bjp-29940	73	11	=	=	SYM
bjp-29940	73	12	0	0	NUM
bjp-29940	73	13	%	%	NOUN
bjp-29940	73	14	)	)	PUNCT
bjp-29940	73	15	.	.	PUNCT
bjp-29940	74	1	end	end	NOUN
bjp-29940	74	2	of	of	ADP
bjp-29940	74	3	treatment	treatment	NOUN
bjp-29940	74	4	viral	viral	ADJ
bjp-29940	74	5	response	response	NOUN
bjp-29940	74	6	(	(	PUNCT
bjp-29940	74	7	eotr	eotr	NOUN
bjp-29940	74	8	)	)	PUNCT
bjp-29940	74	9	daclatasvir	daclatasvir	NOUN
bjp-29940	74	10	plus	plus	CCONJ
bjp-29940	74	11	peg	peg	NOUN
bjp-29940	74	12	-	-	PUNCT
bjp-29940	74	13	ifn	ifn	NOUN
bjp-29940	74	14	/	/	SYM
bjp-29940	74	15	rbv	rbv	PROPN
bjp-29940	74	16	group	group	NOUN
bjp-29940	74	17	was	be	AUX
bjp-29940	74	18	superior	superior	ADJ
bjp-29940	74	19	to	to	ADP
bjp-29940	74	20	placebo	placebo	NOUN
bjp-29940	74	21	plus	plus	CCONJ
bjp-29940	74	22	peg	peg	NOUN
bjp-29940	74	23	-	-	PUNCT
bjp-29940	74	24	ifn	ifn	NOUN
bjp-29940	74	25	/	/	SYM
bjp-29940	74	26	rbv	rbv	NOUN
bjp-29940	74	27	group	group	NOUN
bjp-29940	74	28	in	in	ADP
bjp-29940	74	29	terms	term	NOUN
bjp-29940	74	30	of	of	ADP
bjp-29940	74	31	eotr	eotr	NOUN
bjp-29940	74	32	pubmed	pubmed	PROPN
bjp-29940	74	33	n	n	PROPN
bjp-29940	74	34	=	=	PROPN
bjp-29940	74	35	389	389	NUM
bjp-29940	74	36	ovid	ovid	PROPN
bjp-29940	74	37	n	n	PROPN
bjp-29940	74	38	=	=	SYM
bjp-29940	74	39	216	216	NUM
bjp-29940	74	40	cochrane	cochrane	NOUN
bjp-29940	74	41	n	n	NOUN
bjp-29940	74	42	=	=	SYM
bjp-29940	74	43	65	65	NUM
bjp-29940	74	44	web	web	NOUN
bjp-29940	74	45	of	of	ADP
bjp-29940	74	46	science	science	NOUN
bjp-29940	74	47	n	n	NOUN
bjp-29940	74	48	=	=	SYM
bjp-29940	74	49	758	758	NUM
bjp-29940	74	50	scopus	scopus	NOUN
bjp-29940	74	51	n	n	NOUN
bjp-29940	74	52	=	=	SYM
bjp-29940	74	53	873	873	NUM
bjp-29940	74	54	embase	embase	NOUN
bjp-29940	74	55	n	n	PROPN
bjp-29940	74	56	=	=	SYM
bjp-29940	74	57	636	636	NUM
bjp-29940	74	58	1344	1344	NUM
bjp-29940	74	59	of	of	ADP
bjp-29940	74	60	records	record	NOUN
bjp-29940	74	61	excluded	exclude	VERB
bjp-29940	74	62	by	by	ADP
bjp-29940	74	63	title	title	NOUN
bjp-29940	74	64	screening	screen	VERB
bjp-29940	74	65	476	476	NUM
bjp-29940	74	66	articles	article	NOUN
bjp-29940	74	67	excluded	exclude	VERB
bjp-29940	74	68	by	by	ADP
bjp-29940	74	69	abstract	abstract	ADJ
bjp-29940	74	70	screening	screen	VERB
bjp-29940	74	71	34	34	NUM
bjp-29940	74	72	articles	article	NOUN
bjp-29940	74	73	excluded	exclude	VERB
bjp-29940	74	74	by	by	ADP
bjp-29940	74	75	full	full	ADJ
bjp-29940	74	76	text	text	NOUN
bjp-29940	74	77	screening	screen	VERB
bjp-29940	74	78	n	n	PROPN
bjp-29940	74	79	=	=	SYM
bjp-29940	74	80	4	4	NUM
bjp-29940	74	81	resistance	resistance	NOUN
bjp-29940	74	82	analysis	analysis	NOUN
bjp-29940	74	83	n	n	NOUN
bjp-29940	74	84	=	=	SYM
bjp-29940	74	85	7	7	NUM
bjp-29940	74	86	conference	conference	NOUN
bjp-29940	74	87	abstract	abstract	NOUN
bjp-29940	74	88	n	n	NOUN
bjp-29940	74	89	=	=	SYM
bjp-29940	74	90	10	10	NUM
bjp-29940	74	91	other	other	ADJ
bjp-29940	74	92	drug	drug	NOUN
bjp-29940	74	93	combination	combination	NOUN
bjp-29940	74	94	n	n	NOUN
bjp-29940	74	95	=	=	SYM
bjp-29940	74	96	13	13	NUM
bjp-29940	74	97	review	review	NOUN
bjp-29940	74	98	article	article	NOUN
bjp-29940	74	99	1856	1856	NUM
bjp-29940	74	100	unique	unique	ADJ
bjp-29940	74	101	citation	citation	NOUN
bjp-29940	74	102	after	after	ADP
bjp-29940	74	103	removing	remove	VERB
bjp-29940	74	104	duplication	duplication	NOUN
bjp-29940	74	105	512	512	NUM
bjp-29940	74	106	article	article	NOUN
bjp-29940	74	107	eligible	eligible	ADJ
bjp-29940	74	108	for	for	ADP
bjp-29940	74	109	abstract	abstract	ADJ
bjp-29940	74	110	screening	screen	VERB
bjp-29940	74	111	36	36	NUM
bjp-29940	74	112	article	article	NOUN
bjp-29940	74	113	eligible	eligible	ADJ
bjp-29940	74	114	for	for	ADP
bjp-29940	74	115	full	full	ADJ
bjp-29940	74	116	text	text	NOUN
bjp-29940	74	117	screening	screen	VERB
bjp-29940	74	118	2	2	NUM
bjp-29940	74	119	article	article	NOUN
bjp-29940	74	120	eligible	eligible	ADJ
bjp-29940	74	121	for	for	ADP
bjp-29940	74	122	meta	meta	ADJ
bjp-29940	74	123	-	-	PUNCT
bjp-29940	74	124	analysis	analysis	NOUN
bjp-29940	74	125	figure	figure	NOUN
bjp-29940	74	126	1	1	NUM
bjp-29940	74	127	:	:	PUNCT
bjp-29940	74	128	flow	flow	NOUN
bjp-29940	74	129	diagram	diagram	NOUN
bjp-29940	74	130	of	of	ADP
bjp-29940	74	131	search	search	NOUN
bjp-29940	74	132	strategy	strategy	NOUN
bjp-29940	74	133	and	and	CCONJ
bjp-29940	74	134	study	study	NOUN
bjp-29940	74	135	selection	selection	NOUN
bjp-29940	74	136	14	14	NUM
bjp-29940	74	137	bangladesh	bangladesh	PROPN
bjp-29940	74	138	j	j	PROPN
bjp-29940	74	139	pharmacol	pharmacol	PROPN
bjp-29940	74	140	2017	2017	NUM
bjp-29940	74	141	;	;	PUNCT
bjp-29940	74	142	12	12	NUM
bjp-29940	74	143	:	:	SYM
bjp-29940	74	144	12	12	NUM
bjp-29940	74	145	-	-	SYM
bjp-29940	74	146	22	22	NUM
bjp-29940	74	147	t	t	PROPN
bjp-29940	74	148	a	a	DET
bjp-29940	74	149	b	b	X
bjp-29940	74	150	le	le	X
bjp-29940	75	1	i	i	NOUN
bjp-29940	75	2	b	b	PROPN
bjp-29940	75	3	a	a	DET
bjp-29940	75	4	se	se	X
bjp-29940	75	5	li	li	PROPN
bjp-29940	75	6	n	n	PROPN
bjp-29940	75	7	e	e	PROPN
bjp-29940	75	8	ch	ch	NOUN
bjp-29940	75	9	a	a	DET
bjp-29940	75	10	ra	ra	NOUN
bjp-29940	76	1	ct	ct	NUM
bjp-29940	76	2	e	e	PROPN
bjp-29940	76	3	ri	ri	PROPN
bjp-29940	76	4	st	st	PROPN
bjp-29940	76	5	ic	ic	PROPN
bjp-29940	76	6	s	s	PROPN
bjp-29940	76	7	o	o	X
bjp-29940	76	8	f	f	X
bjp-29940	76	9	th	th	X
bjp-29940	76	10	e	e	NOUN
bjp-29940	76	11	in	in	ADP
bjp-29940	76	12	cl	cl	NOUN
bjp-29940	76	13	u	u	NOUN
bjp-29940	76	14	d	d	X
bjp-29940	76	15	e	e	X
bjp-29940	76	16	d	d	NOUN
bjp-29940	76	17	p	p	X
bjp-29940	76	18	o	o	X
bjp-29940	76	19	p	p	X
bjp-29940	76	20	u	u	X
bjp-29940	76	21	la	la	X
bjp-29940	76	22	ti	ti	X
bjp-29940	76	23	o	o	NOUN
bjp-29940	76	24	n	n	CCONJ
bjp-29940	77	1	i	i	PRON
bjp-29940	77	2	n	n	VERB
bjp-29940	77	3	t	t	NOUN
bjp-29940	77	4	h	h	NOUN
bjp-29940	77	5	e	e	PROPN
bjp-29940	77	6	a	a	PRON
bjp-29940	77	7	n	n	ADV
bjp-29940	77	8	a	a	DET
bjp-29940	77	9	ly	ly	X
bjp-29940	77	10	si	si	NOUN
bjp-29940	77	11	s	s	X
bjp-29940	77	12	s	s	PROPN
bjp-29940	77	13	tu	tu	PROPN
bjp-29940	77	14	d	d	X
bjp-29940	77	15	y	y	PROPN
bjp-29940	77	16	g	g	PROPN
bjp-29940	77	17	ro	ro	PROPN
bjp-29940	77	18	u	u	PROPN
bjp-29940	77	19	p	p	PROPN
bjp-29940	77	20	n	n	CCONJ
bjp-29940	77	21	a	a	DET
bjp-29940	77	22	g	g	NOUN
bjp-29940	77	23	e	e	X
bjp-29940	77	24	(	(	PUNCT
bjp-29940	77	25	y	y	PROPN
bjp-29940	77	26	ea	ea	PROPN
bjp-29940	77	27	r	r	NOUN
bjp-29940	77	28	)	)	PUNCT
bjp-29940	77	29	s	s	PART
bjp-29940	78	1	ex	ex	PRON
bjp-29940	78	2	c	c	NOUN
bjp-29940	78	3	ir	ir	PROPN
bjp-29940	78	4	rh	rh	NOUN
bjp-29940	78	5	o	o	NOUN
bjp-29940	78	6	si	si	PROPN
bjp-29940	79	1	s	s	X
bjp-29940	79	2	h	h	NOUN
bjp-29940	79	3	c	c	NOUN
bjp-29940	79	4	v	v	NOUN
bjp-29940	79	5	-r	-r	INTJ
bjp-29940	79	6	n	n	ADV
bjp-29940	79	7	a	a	DET
bjp-29940	79	8	il	il	PROPN
bjp-29940	79	9	28	28	NUM
bjp-29940	79	10	b	b	PROPN
bjp-29940	79	11	g	g	PROPN
bjp-29940	79	12	t	t	PROPN
bjp-29940	79	13	(	(	PUNCT
bjp-29940	79	14	rs	rs	PROPN
bjp-29940	79	15	12	12	NUM
bjp-29940	79	16	9	9	NUM
bjp-29940	79	17	79	79	NUM
bjp-29940	79	18	86	86	NUM
bjp-29940	79	19	0	0	NUM
bjp-29940	79	20	)	)	PUNCT
bjp-29940	79	21	,	,	PUNCT
bjp-29940	79	22	n	n	PROPN
bjp-29940	79	23	(	(	PUNCT
bjp-29940	79	24	%	%	NOUN
bjp-29940	79	25	)	)	PUNCT
bjp-29940	80	1	h	h	NOUN
bjp-29940	81	1	c	c	NOUN
bjp-29940	81	2	v	v	NOUN
bjp-29940	81	3	g	g	PROPN
bjp-29940	81	4	en	en	INTJ
bjp-29940	81	5	o	o	NOUN
bjp-29940	81	6	ty	ty	INTJ
bjp-29940	81	7	p	p	PROPN
bjp-29940	81	8	e	e	PROPN
bjp-29940	81	9	,	,	PUNCT
bjp-29940	81	10	n	n	PROPN
bjp-29940	81	11	(	(	PUNCT
bjp-29940	81	12	%	%	NOUN
bjp-29940	81	13	)	)	PUNCT
bjp-29940	81	14	g	g	NOUN
bjp-29940	81	15	en	en	INTJ
bjp-29940	81	16	o	o	NOUN
bjp-29940	81	17	ty	ty	INTJ
bjp-29940	82	1	p	p	X
bjp-29940	82	2	e	e	NOUN
bjp-29940	82	3	1	1	NUM
bjp-29940	82	4	h	h	NOUN
bjp-29940	82	5	c	c	NOUN
bjp-29940	82	6	v	v	NOUN
bjp-29940	82	7	g	g	PROPN
bjp-29940	82	8	en	en	INTJ
bjp-29940	82	9	o	o	NOUN
bjp-29940	82	10	ty	ty	INTJ
bjp-29940	82	11	p	p	PROPN
bjp-29940	82	12	e	e	PROPN
bjp-29940	82	13	,	,	PUNCT
bjp-29940	82	14	n	n	PROPN
bjp-29940	82	15	(	(	PUNCT
bjp-29940	82	16	%	%	NOUN
bjp-29940	82	17	)	)	PUNCT
bjp-29940	82	18	g	g	NOUN
bjp-29940	82	19	en	en	INTJ
bjp-29940	82	20	o	o	NOUN
bjp-29940	82	21	ty	ty	INTJ
bjp-29940	83	1	p	p	X
bjp-29940	83	2	e	e	PROPN
bjp-29940	83	3	4	4	NUM
bjp-29940	83	4	bm	bm	VERB
bjp-29940	83	5	i	i	PRON
bjp-29940	83	6	≥	≥	VERB
bjp-29940	83	7	30	30	NUM
bjp-29940	83	8	k	k	NOUN
bjp-29940	83	9	g	g	PROPN
bjp-29940	83	10	/	/	SYM
bjp-29940	83	11	m	m	PROPN
bjp-29940	83	12	2	2	NUM
bjp-29940	83	13	,	,	PUNCT
bjp-29940	83	14	n	n	PROPN
bjp-29940	83	15	(	(	PUNCT
bjp-29940	83	16	%	%	NOUN
bjp-29940	83	17	)	)	PUNCT
bjp-29940	83	18	m	m	PROPN
bjp-29940	83	19	ed	ed	PROPN
bjp-29940	83	20	ia	ia	PROPN
bjp-29940	83	21	n	n	CCONJ
bjp-29940	83	22	(	(	PUNCT
bjp-29940	83	23	r	r	NOUN
bjp-29940	83	24	an	an	DET
bjp-29940	83	25	g	g	NOUN
bjp-29940	83	26	e	e	NOUN
bjp-29940	83	27	)	)	PUNCT
bjp-29940	83	28	m	m	VERB
bjp-29940	83	29	al	al	PROPN
bjp-29940	83	30	e	e	PROPN
bjp-29940	83	31	,	,	PUNCT
bjp-29940	83	32	n	n	PROPN
bjp-29940	83	33	(	(	PUNCT
bjp-29940	83	34	%	%	NOUN
bjp-29940	83	35	)	)	PUNCT
bjp-29940	84	1	r	r	NOUN
bjp-29940	84	2	ep	ep	NOUN
bjp-29940	84	3	o	o	INTJ
bjp-29940	84	4	rt	rt	PROPN
bjp-29940	84	5	ed	ed	PROPN
bjp-29940	84	6	n	n	ADP
bjp-29940	84	7	o	o	X
bjp-29940	84	8	t	t	NOUN
bjp-29940	84	9	re	re	NOUN
bjp-29940	84	10	p	p	PROPN
bjp-29940	84	11	o	o	X
bjp-29940	84	12	rt	rt	PROPN
bjp-29940	85	1	ed	ed	NOUN
bjp-29940	85	2	l	l	PROPN
bjp-29940	85	3	o	o	NOUN
bjp-29940	85	4	g	g	NOUN
bjp-29940	85	5	1	1	NUM
bjp-29940	85	6	0	0	NUM
bjp-29940	85	7	iu	iu	PROPN
bjp-29940	85	8	/	/	SYM
bjp-29940	85	9	m	m	PROPN
bjp-29940	85	10	l	l	NOUN
bjp-29940	85	11	,	,	PUNCT
bjp-29940	85	12	m	m	VERB
bjp-29940	85	13	ea	ea	NOUN
bjp-29940	85	14	n	n	CCONJ
bjp-29940	85	15	(	(	PUNCT
bjp-29940	85	16	s	s	NOUN
bjp-29940	85	17	d	d	NOUN
bjp-29940	85	18	)	)	PUNCT
bjp-29940	86	1	≥8	≥8	ADP
bjp-29940	86	2	00	00	NUM
bjp-29940	86	3	0	0	NUM
bjp-29940	86	4	00	00	PUNCT
bjp-29940	86	5	iu	iu	PROPN
bjp-29940	86	6	/	/	SYM
bjp-29940	86	7	m	m	PROPN
bjp-29940	86	8	l	l	NOUN
bjp-29940	86	9	,	,	PUNCT
bjp-29940	86	10	n	n	PROPN
bjp-29940	86	11	(	(	PUNCT
bjp-29940	86	12	%	%	NOUN
bjp-29940	86	13	)	)	PUNCT
bjp-29940	87	1	c	c	NOUN
bjp-29940	88	1	c	c	NOUN
bjp-29940	88	2	c	c	PROPN
bjp-29940	88	3	t	t	PROPN
bjp-29940	88	4	t	t	PROPN
bjp-29940	88	5	t	t	PROPN
bjp-29940	88	6	1a	1a	X
bjp-29940	88	7	1b	1b	NUM
bjp-29940	88	8	4	4	NUM
bjp-29940	88	9	u	u	NOUN
bjp-29940	88	10	n	n	X
bjp-29940	88	11	sp	sp	ADP
bjp-29940	88	12	ec	ec	PROPN
bjp-29940	88	13	if	if	SCONJ
bjp-29940	88	14	i	i	PRON
bjp-29940	88	15	ed	ed	NOUN
bjp-29940	88	16	4a	4a	NUM
bjp-29940	88	17	,	,	PUNCT
bjp-29940	88	18	c	c	NOUN
bjp-29940	88	19	,	,	PUNCT
bjp-29940	88	20	o	o	NOUN
bjp-29940	88	21	r	r	NOUN
bjp-29940	88	22	d	d	X
bjp-29940	88	23	4e	4e	NOUN
bjp-29940	88	24	4f	4f	NUM
bjp-29940	88	25	4h	4h	NUM
bjp-29940	88	26	h	h	PROPN
bjp-29940	88	27	ez	ez	PROPN
bjp-29940	88	28	o	o	PROPN
bjp-29940	89	1	d	d	X
bjp-29940	89	2	e	e	X
bjp-29940	89	3	et	et	PROPN
bjp-29940	89	4	a	a	DET
bjp-29940	89	5	l.	l.	PROPN
bjp-29940	89	6	20	20	NUM
bjp-29940	89	7	15	15	NUM
bjp-29940	89	8	d	d	NOUN
bjp-29940	89	9	ac	ac	NOUN
bjp-29940	89	10	la	la	PROPN
bjp-29940	89	11	ta	ta	X
bjp-29940	89	12	sv	sv	PROPN
bjp-29940	89	13	ir	ir	PROPN
bjp-29940	90	1	+	+	CCONJ
bjp-29940	90	2	p	p	ADJ
bjp-29940	90	3	eg	eg	NOUN
bjp-29940	90	4	in	in	ADP
bjp-29940	90	5	te	te	PROPN
bjp-29940	90	6	rf	rf	VERB
bjp-29940	91	1	er	er	INTJ
bjp-29940	91	2	o	o	X
bjp-29940	91	3	n	n	INTJ
bjp-29940	91	4	al	al	PROPN
bjp-29940	91	5	fa	fa	PROPN
bjp-29940	91	6	/	/	SYM
bjp-29940	91	7	ri	ri	PROPN
bjp-29940	92	1	b	b	PROPN
bjp-29940	92	2	av	av	PROPN
bjp-29940	92	3	ir	ir	PROPN
bjp-29940	92	4	in	in	ADP
bjp-29940	92	5	82	82	NUM
bjp-29940	92	6	48	48	NUM
bjp-29940	92	7	.5	.5	NUM
bjp-29940	92	8	(	(	PUNCT
bjp-29940	92	9	2	2	NUM
bjp-29940	92	10	07	07	NUM
bjp-29940	92	11	1	1	NUM
bjp-29940	92	12	)	)	PUNCT
bjp-29940	92	13	61	61	NUM
bjp-29940	92	14	(	(	PUNCT
bjp-29940	92	15	7	7	NUM
bjp-29940	92	16	4	4	NUM
bjp-29940	92	17	.	.	NOUN
bjp-29940	92	18	4	4	NUM
bjp-29940	92	19	)	)	PUNCT
bjp-29940	92	20	9	9	NUM
bjp-29940	92	21	(	(	PUNCT
bjp-29940	92	22	1	1	NUM
bjp-29940	92	23	1	1	NUM
bjp-29940	92	24	.	.	NOUN
bjp-29940	92	25	0	0	NUM
bjp-29940	92	26	)	)	PUNCT
bjp-29940	92	27	4	4	NUM
bjp-29940	92	28	(	(	PUNCT
bjp-29940	92	29	4	4	NUM
bjp-29940	92	30	.9	.9	NUM
bjp-29940	92	31	)	)	PUNCT
bjp-29940	93	1	5	5	NUM
bjp-29940	93	2	.	.	SYM
bjp-29940	93	3	8	8	NUM
bjp-29940	93	4	(	(	PUNCT
bjp-29940	93	5	0	0	NUM
bjp-29940	93	6	.8	.8	NUM
bjp-29940	93	7	)	)	PUNCT
bjp-29940	93	8	39	39	NUM
bjp-29940	93	9	(	(	PUNCT
bjp-29940	93	10	4	4	NUM
bjp-29940	93	11	7	7	NUM
bjp-29940	93	12	.	.	NOUN
bjp-29940	93	13	6	6	NUM
bjp-29940	93	14	)	)	PUNCT
bjp-29940	93	15	22	22	NUM
bjp-29940	93	16	(	(	PUNCT
bjp-29940	93	17	2	2	NUM
bjp-29940	93	18	6	6	NUM
bjp-29940	93	19	.	.	PUNCT
bjp-29940	94	1	8)	8)	NUM
bjp-29940	94	2	40	40	NUM
bjp-29940	94	3	(	(	PUNCT
bjp-29940	94	4	4	4	NUM
bjp-29940	94	5	8	8	NUM
bjp-29940	94	6	.	.	PUNCT
bjp-29940	95	1	8)	8)	NUM
bjp-29940	95	2	20	20	NUM
bjp-29940	95	3	(	(	PUNCT
bjp-29940	95	4	2	2	NUM
bjp-29940	95	5	4	4	NUM
bjp-29940	95	6	.	.	NOUN
bjp-29940	95	7	4	4	NUM
bjp-29940	95	8	)	)	PUNCT
bjp-29940	95	9	26	26	NUM
bjp-29940	95	10	(	(	PUNCT
bjp-29940	95	11	3	3	NUM
bjp-29940	95	12	1	1	NUM
bjp-29940	95	13	.	.	NOUN
bjp-29940	95	14	7	7	NUM
bjp-29940	95	15	)	)	SYM
bjp-29940	95	16	1	1	NUM
bjp-29940	95	17	(	(	PUNCT
bjp-29940	95	18	1	1	NUM
bjp-29940	95	19	.2	.2	NUM
bjp-29940	95	20	)	)	PUNCT
bjp-29940	96	1	d	d	SYM
bjp-29940	96	2	46	46	NUM
bjp-29940	96	3	(	(	PUNCT
bjp-29940	96	4	5	5	NUM
bjp-29940	96	5	6	6	NUM
bjp-29940	96	6	.	.	NOUN
bjp-29940	96	7	1	1	NUM
bjp-29940	96	8	)	)	PUNCT
bjp-29940	96	9	1	1	NUM
bjp-29940	96	10	(	(	PUNCT
bjp-29940	96	11	1	1	NUM
bjp-29940	96	12	.2	.2	NUM
bjp-29940	96	13	)	)	PUNCT
bjp-29940	96	14	5	5	NUM
bjp-29940	96	15	(	(	PUNCT
bjp-29940	96	16	6	6	NUM
bjp-29940	96	17	.1	.1	NUM
bjp-29940	96	18	)	)	PUNCT
bjp-29940	96	19	3	3	NUM
bjp-29940	96	20	(	(	PUNCT
bjp-29940	96	21	3	3	NUM
bjp-29940	96	22	.7	.7	NUM
bjp-29940	96	23	)	)	PUNCT
bjp-29940	96	24	18	18	NUM
bjp-29940	96	25	(	(	PUNCT
bjp-29940	96	26	2	2	NUM
bjp-29940	96	27	2	2	NUM
bjp-29940	96	28	.	.	NOUN
bjp-29940	96	29	0	0	NUM
bjp-29940	96	30	)	)	PUNCT
bjp-29940	97	1	p	p	PROPN
bjp-29940	97	2	la	la	PROPN
bjp-29940	97	3	ce	ce	PROPN
bjp-29940	97	4	b	b	PROPN
bjp-29940	97	5	o	o	PROPN
bjp-29940	98	1	+	+	CCONJ
bjp-29940	98	2	p	p	ADJ
bjp-29940	98	3	eg	eg	NOUN
bjp-29940	98	4	in	in	ADP
bjp-29940	98	5	te	te	PROPN
bjp-29940	98	6	rf	rf	VERB
bjp-29940	98	7	er	er	INTJ
bjp-29940	98	8	o	o	X
bjp-29940	98	9	n	n	CCONJ
bjp-29940	98	10	-a	-a	PUNCT
bjp-29940	98	11	lf	lf	ADP
bjp-29940	98	12	a	a	PRON
bjp-29940	98	13	/	/	SYM
bjp-29940	98	14	ri	ri	PROPN
bjp-29940	98	15	b	b	PROPN
bjp-29940	98	16	av	av	PROPN
bjp-29940	98	17	ir	ir	PROPN
bjp-29940	98	18	in	in	ADP
bjp-29940	98	19	42	42	NUM
bjp-29940	98	20	50	50	NUM
bjp-29940	98	21	.0	.0	NUM
bjp-29940	98	22	(	(	PUNCT
bjp-29940	98	23	3	3	NUM
bjp-29940	98	24	26	26	NUM
bjp-29940	98	25	1	1	NUM
bjp-29940	98	26	)	)	PUNCT
bjp-29940	98	27	29	29	NUM
bjp-29940	98	28	(	(	PUNCT
bjp-29940	98	29	6	6	NUM
bjp-29940	98	30	9	9	NUM
bjp-29940	98	31	.	.	NOUN
bjp-29940	98	32	0	0	NUM
bjp-29940	98	33	)	)	PUNCT
bjp-29940	98	34	4	4	NUM
bjp-29940	98	35	(	(	PUNCT
bjp-29940	98	36	9	9	NUM
bjp-29940	98	37	.5	.5	NUM
bjp-29940	98	38	)	)	PUNCT
bjp-29940	98	39	0	0	NUM
bjp-29940	99	1	5	5	NUM
bjp-29940	99	2	.	.	X
bjp-29940	99	3	73	73	NUM
bjp-29940	99	4	(	(	PUNCT
bjp-29940	99	5	0	0	NUM
bjp-29940	99	6	.6	.6	NUM
bjp-29940	99	7	)	)	PUNCT
bjp-29940	99	8	16	16	NUM
bjp-29940	99	9	(	(	PUNCT
bjp-29940	99	10	3	3	NUM
bjp-29940	99	11	8	8	NUM
bjp-29940	99	12	.	.	NOUN
bjp-29940	99	13	1	1	NUM
bjp-29940	99	14	)	)	PUNCT
bjp-29940	99	15	9	9	NUM
bjp-29940	99	16	(	(	PUNCT
bjp-29940	99	17	2	2	NUM
bjp-29940	99	18	1	1	NUM
bjp-29940	99	19	.	.	NOUN
bjp-29940	99	20	4	4	NUM
bjp-29940	99	21	)	)	PUNCT
bjp-29940	99	22	27	27	NUM
bjp-29940	99	23	(	(	PUNCT
bjp-29940	99	24	6	6	NUM
bjp-29940	99	25	4	4	NUM
bjp-29940	99	26	.	.	NOUN
bjp-29940	99	27	3	3	NUM
bjp-29940	99	28	)	)	PUNCT
bjp-29940	99	29	6	6	NUM
bjp-29940	99	30	(	(	PUNCT
bjp-29940	99	31	1	1	NUM
bjp-29940	99	32	4	4	NUM
bjp-29940	99	33	.	.	NOUN
bjp-29940	99	34	3	3	NUM
bjp-29940	99	35	)	)	PUNCT
bjp-29940	99	36	0	0	NUM
bjp-29940	100	1	16	16	NUM
bjp-29940	100	2	(	(	PUNCT
bjp-29940	100	3	3	3	NUM
bjp-29940	100	4	8	8	NUM
bjp-29940	100	5	.	.	NOUN
bjp-29940	100	6	1	1	NUM
bjp-29940	100	7	)	)	PUNCT
bjp-29940	100	8	24	24	NUM
bjp-29940	100	9	(	(	PUNCT
bjp-29940	100	10	5	5	NUM
bjp-29940	100	11	7	7	NUM
bjp-29940	100	12	.	.	NOUN
bjp-29940	100	13	1	1	NUM
bjp-29940	100	14	)	)	PUNCT
bjp-29940	100	15	0	0	NUM
bjp-29940	100	16	1	1	NUM
bjp-29940	100	17	(	(	PUNCT
bjp-29940	100	18	2	2	NUM
bjp-29940	100	19	.4	.4	NUM
bjp-29940	100	20	)	)	PUNCT
bjp-29940	100	21	1	1	NUM
bjp-29940	100	22	(	(	PUNCT
bjp-29940	100	23	2	2	NUM
bjp-29940	100	24	.4	.4	NUM
bjp-29940	100	25	)	)	PUNCT
bjp-29940	100	26	5	5	NUM
bjp-29940	100	27	(	(	PUNCT
bjp-29940	100	28	1	1	NUM
bjp-29940	100	29	1	1	NUM
bjp-29940	100	30	.	.	NOUN
bjp-29940	100	31	9	9	NUM
bjp-29940	100	32	)	)	PUNCT
bjp-29940	101	1	h	h	NOUN
bjp-29940	101	2	ez	ez	NOUN
bjp-29940	101	3	o	o	PROPN
bjp-29940	101	4	d	d	X
bjp-29940	101	5	e	e	X
bjp-29940	101	6	et	et	PROPN
bjp-29940	101	7	a	a	DET
bjp-29940	101	8	l.	l.	PROPN
bjp-29940	101	9	20	20	NUM
bjp-29940	101	10	14	14	NUM
bjp-29940	101	11	d	d	NUM
bjp-29940	101	12	ac	ac	PROPN
bjp-29940	101	13	la	la	PROPN
bjp-29940	101	14	ta	ta	PROPN
bjp-29940	101	15	sv	sv	PROPN
bjp-29940	101	16	ir	ir	PROPN
bjp-29940	101	17	2	2	NUM
bjp-29940	101	18	0	0	NUM
bjp-29940	101	19	m	m	VERB
bjp-29940	101	20	g	g	NOUN
bjp-29940	101	21	+	+	CCONJ
bjp-29940	101	22	p	p	NOUN
bjp-29940	101	23	eg	eg	NOUN
bjp-29940	101	24	in	in	ADP
bjp-29940	101	25	te	te	PROPN
bjp-29940	101	26	rf	rf	VERB
bjp-29940	102	1	er	er	INTJ
bjp-29940	102	2	o	o	X
bjp-29940	102	3	n	n	INTJ
bjp-29940	102	4	al	al	PROPN
bjp-29940	102	5	fa	fa	PROPN
bjp-29940	102	6	/	/	SYM
bjp-29940	102	7	ri	ri	PROPN
bjp-29940	103	1	b	b	PROPN
bjp-29940	103	2	av	av	PROPN
bjp-29940	103	3	ir	ir	PROPN
bjp-29940	103	4	in	in	ADP
bjp-29940	103	5	15	15	NUM
bjp-29940	103	6	9	9	NUM
bjp-29940	103	7	51	51	NUM
bjp-29940	103	8	(	(	PUNCT
bjp-29940	103	9	2	2	NUM
bjp-29940	103	10	2	2	NUM
bjp-29940	103	11	–	–	PUNCT
bjp-29940	103	12	7	7	NUM
bjp-29940	103	13	0	0	NUM
bjp-29940	103	14	)	)	PUNCT
bjp-29940	103	15	10	10	NUM
bjp-29940	103	16	7	7	NUM
bjp-29940	103	17	(	(	PUNCT
bjp-29940	103	18	6	6	NUM
bjp-29940	103	19	7	7	NUM
bjp-29940	103	20	.	.	NOUN
bjp-29940	103	21	3	3	NUM
bjp-29940	103	22	)	)	PUNCT
bjp-29940	103	23	13	13	NUM
bjp-29940	103	24	(	(	PUNCT
bjp-29940	103	25	8	8	NUM
bjp-29940	103	26	.2	.2	NUM
bjp-29940	103	27	)	)	PUNCT
bjp-29940	103	28	6	6	NUM
bjp-29940	103	29	.	.	X
bjp-29940	104	1	5	5	NUM
bjp-29940	104	2	*	*	SYM
bjp-29940	104	3	13	13	NUM
bjp-29940	104	4	3	3	NUM
bjp-29940	104	5	(	(	PUNCT
bjp-29940	104	6	8	8	NUM
bjp-29940	104	7	3	3	NUM
bjp-29940	104	8	.	.	NOUN
bjp-29940	104	9	6	6	NUM
bjp-29940	104	10	)	)	PUNCT
bjp-29940	104	11	53	53	NUM
bjp-29940	104	12	(	(	PUNCT
bjp-29940	104	13	3	3	NUM
bjp-29940	104	14	3	3	NUM
bjp-29940	104	15	.	.	NOUN
bjp-29940	104	16	3	3	NUM
bjp-29940	104	17	)	)	PUNCT
bjp-29940	104	18	82	82	NUM
bjp-29940	104	19	(	(	PUNCT
bjp-29940	104	20	5	5	NUM
bjp-29940	104	21	1	1	NUM
bjp-29940	104	22	.	.	NOUN
bjp-29940	104	23	6	6	NUM
bjp-29940	104	24	)	)	PUNCT
bjp-29940	104	25	17	17	NUM
bjp-29940	104	26	(	(	PUNCT
bjp-29940	104	27	10	10	NUM
bjp-29940	104	28	.7	.7	NUM
bjp-29940	104	29	)	)	PUNCT
bjp-29940	104	30	10	10	NUM
bjp-29940	104	31	6	6	NUM
bjp-29940	104	32	(	(	PUNCT
bjp-29940	104	33	7	7	NUM
bjp-29940	104	34	2	2	NUM
bjp-29940	104	35	.	.	NOUN
bjp-29940	104	36	1	1	NUM
bjp-29940	104	37	)	)	PUNCT
bjp-29940	104	38	41	41	NUM
bjp-29940	104	39	(	(	PUNCT
bjp-29940	104	40	2	2	NUM
bjp-29940	104	41	7	7	NUM
bjp-29940	104	42	.	.	NOUN
bjp-29940	104	43	9	9	NUM
bjp-29940	104	44	)	)	PUNCT
bjp-29940	104	45	12	12	NUM
bjp-29940	104	46	(	(	PUNCT
bjp-29940	104	47	7	7	NUM
bjp-29940	104	48	.5	.5	NUM
bjp-29940	104	49	)	)	PUNCT
bjp-29940	104	50	31	31	NUM
bjp-29940	104	51	(	(	PUNCT
bjp-29940	104	52	1	1	NUM
bjp-29940	104	53	9	9	NUM
bjp-29940	104	54	.	.	NOUN
bjp-29940	104	55	5	5	NUM
bjp-29940	104	56	)	)	PUNCT
bjp-29940	104	57	d	d	AUX
bjp-29940	104	58	ac	ac	PROPN
bjp-29940	104	59	la	la	INTJ
bjp-29940	104	60	ta	ta	PROPN
bjp-29940	104	61	sv	sv	PROPN
bjp-29940	104	62	ir	ir	PROPN
bjp-29940	104	63	6	6	NUM
bjp-29940	104	64	0	0	NUM
bjp-29940	104	65	m	m	VERB
bjp-29940	104	66	g	g	NOUN
bjp-29940	104	67	+	+	CCONJ
bjp-29940	104	68	p	p	NOUN
bjp-29940	104	69	eg	eg	NOUN
bjp-29940	104	70	in	in	ADP
bjp-29940	104	71	te	te	PROPN
bjp-29940	104	72	rf	rf	VERB
bjp-29940	105	1	er	er	INTJ
bjp-29940	105	2	o	o	X
bjp-29940	105	3	n	n	INTJ
bjp-29940	105	4	al	al	PROPN
bjp-29940	105	5	fa	fa	PROPN
bjp-29940	105	6	/	/	SYM
bjp-29940	105	7	ri	ri	PROPN
bjp-29940	106	1	b	b	PROPN
bjp-29940	106	2	av	av	PROPN
bjp-29940	106	3	ir	ir	PROPN
bjp-29940	106	4	in	in	ADP
bjp-29940	106	5	15	15	NUM
bjp-29940	106	6	8	8	NUM
bjp-29940	106	7	50	50	NUM
bjp-29940	106	8	(	(	PUNCT
bjp-29940	106	9	1	1	NUM
bjp-29940	106	10	8	8	NUM
bjp-29940	106	11	–	–	PUNCT
bjp-29940	106	12	6	6	NUM
bjp-29940	106	13	7	7	NUM
bjp-29940	106	14	)	)	PUNCT
bjp-29940	106	15	10	10	NUM
bjp-29940	106	16	3	3	NUM
bjp-29940	106	17	(	(	PUNCT
bjp-29940	106	18	6	6	NUM
bjp-29940	106	19	5	5	NUM
bjp-29940	106	20	.	.	NOUN
bjp-29940	106	21	2	2	NUM
bjp-29940	106	22	)	)	PUNCT
bjp-29940	106	23	8	8	NUM
bjp-29940	106	24	(	(	PUNCT
bjp-29940	106	25	5	5	NUM
bjp-29940	106	26	.1	.1	NUM
bjp-29940	106	27	)	)	PUNCT
bjp-29940	107	1	6	6	NUM
bjp-29940	107	2	.	.	X
bjp-29940	108	1	5	5	NUM
bjp-29940	108	2	*	*	SYM
bjp-29940	108	3	12	12	NUM
bjp-29940	108	4	3	3	NUM
bjp-29940	108	5	(	(	PUNCT
bjp-29940	108	6	77	77	NUM
bjp-29940	108	7	.8	.8	NUM
bjp-29940	108	8	)	)	PUNCT
bjp-29940	108	9	44	44	NUM
bjp-29940	108	10	(	(	PUNCT
bjp-29940	108	11	2	2	NUM
bjp-29940	108	12	7	7	NUM
bjp-29940	108	13	.	.	NUM
bjp-29940	108	14	8)	8)	NUM
bjp-29940	108	15	86	86	NUM
bjp-29940	108	16	(	(	PUNCT
bjp-29940	108	17	5	5	NUM
bjp-29940	108	18	4	4	NUM
bjp-29940	108	19	.	.	NOUN
bjp-29940	108	20	4	4	NUM
bjp-29940	108	21	)	)	PUNCT
bjp-29940	108	22	18	18	NUM
bjp-29940	108	23	(	(	PUNCT
bjp-29940	108	24	1	1	NUM
bjp-29940	108	25	1	1	NUM
bjp-29940	108	26	.	.	NOUN
bjp-29940	108	27	4	4	NUM
bjp-29940	108	28	)	)	PUNCT
bjp-29940	108	29	11	11	NUM
bjp-29940	108	30	3	3	NUM
bjp-29940	108	31	(	(	PUNCT
bjp-29940	108	32	7	7	NUM
bjp-29940	108	33	7	7	NUM
bjp-29940	108	34	.	.	NOUN
bjp-29940	108	35	9	9	NUM
bjp-29940	108	36	)	)	PUNCT
bjp-29940	108	37	31	31	NUM
bjp-29940	108	38	(	(	PUNCT
bjp-29940	108	39	2	2	NUM
bjp-29940	108	40	1	1	NUM
bjp-29940	108	41	.	.	NOUN
bjp-29940	108	42	4	4	NUM
bjp-29940	108	43	)	)	PUNCT
bjp-29940	108	44	13	13	NUM
bjp-29940	108	45	(	(	PUNCT
bjp-29940	108	46	8	8	NUM
bjp-29940	108	47	.2	.2	NUM
bjp-29940	108	48	)	)	PUNCT
bjp-29940	108	49	42	42	NUM
bjp-29940	108	50	(	(	PUNCT
bjp-29940	108	51	2	2	NUM
bjp-29940	108	52	6	6	NUM
bjp-29940	108	53	.	.	NOUN
bjp-29940	108	54	6	6	NUM
bjp-29940	108	55	)	)	PUNCT
bjp-29940	108	56	p	p	PROPN
bjp-29940	108	57	la	la	PROPN
bjp-29940	108	58	ce	ce	PROPN
bjp-29940	108	59	b	b	PROPN
bjp-29940	108	60	o	o	PROPN
bjp-29940	109	1	+	+	CCONJ
bjp-29940	109	2	p	p	ADJ
bjp-29940	109	3	eg	eg	NOUN
bjp-29940	109	4	in	in	ADP
bjp-29940	109	5	te	te	PROPN
bjp-29940	109	6	rf	rf	VERB
bjp-29940	109	7	er	er	INTJ
bjp-29940	109	8	o	o	X
bjp-29940	109	9	n	n	CCONJ
bjp-29940	109	10	-a	-a	PUNCT
bjp-29940	109	11	lf	lf	ADP
bjp-29940	109	12	a	a	DET
bjp-29940	109	13	/	/	SYM
bjp-29940	109	14	ri	ri	PROPN
bjp-29940	109	15	b	b	PROPN
bjp-29940	109	16	av	av	PROPN
bjp-29940	109	17	ir	ir	PROPN
bjp-29940	109	18	in	in	ADP
bjp-29940	109	19	78	78	NUM
bjp-29940	109	20	51	51	NUM
bjp-29940	109	21	(	(	PUNCT
bjp-29940	109	22	2	2	NUM
bjp-29940	109	23	5	5	NUM
bjp-29940	109	24	–	–	PUNCT
bjp-29940	109	25	6	6	NUM
bjp-29940	109	26	6	6	NUM
bjp-29940	109	27	)	)	PUNCT
bjp-29940	109	28	55	55	NUM
bjp-29940	109	29	(	(	PUNCT
bjp-29940	109	30	7	7	NUM
bjp-29940	109	31	0	0	NUM
bjp-29940	109	32	.	.	NOUN
bjp-29940	109	33	2	2	NUM
bjp-29940	109	34	)	)	PUNCT
bjp-29940	109	35	8	8	NUM
bjp-29940	109	36	(	(	PUNCT
bjp-29940	109	37	1	1	NUM
bjp-29940	109	38	0	0	NUM
bjp-29940	109	39	.	.	NOUN
bjp-29940	109	40	3	3	NUM
bjp-29940	109	41	)	)	PUNCT
bjp-29940	109	42	6	6	NUM
bjp-29940	109	43	.	.	NOUN
bjp-29940	110	1	4	4	NUM
bjp-29940	110	2	*	*	SYM
bjp-29940	110	3	61	61	NUM
bjp-29940	110	4	(	(	PUNCT
bjp-29940	110	5	7	7	NUM
bjp-29940	110	6	8	8	NUM
bjp-29940	110	7	.	.	NOUN
bjp-29940	110	8	2	2	NUM
bjp-29940	110	9	)	)	PUNCT
bjp-29940	110	10	23	23	NUM
bjp-29940	110	11	(	(	PUNCT
bjp-29940	110	12	2	2	NUM
bjp-29940	110	13	9	9	NUM
bjp-29940	110	14	.	.	NOUN
bjp-29940	110	15	5	5	NUM
bjp-29940	110	16	)	)	PUNCT
bjp-29940	110	17	38	38	NUM
bjp-29940	110	18	(	(	PUNCT
bjp-29940	110	19	4	4	NUM
bjp-29940	110	20	8	8	NUM
bjp-29940	110	21	.	.	NOUN
bjp-29940	110	22	7	7	NUM
bjp-29940	110	23	)	)	PUNCT
bjp-29940	110	24	11	11	NUM
bjp-29940	110	25	(	(	PUNCT
bjp-29940	110	26	1	1	NUM
bjp-29940	110	27	4	4	NUM
bjp-29940	110	28	.	.	NOUN
bjp-29940	110	29	1	1	NUM
bjp-29940	110	30	)	)	PUNCT
bjp-29940	110	31	56	56	NUM
bjp-29940	110	32	(	(	PUNCT
bjp-29940	110	33	7	7	NUM
bjp-29940	110	34	7	7	NUM
bjp-29940	110	35	.	.	NUM
bjp-29940	110	36	8)	8)	NUM
bjp-29940	110	37	16	16	NUM
bjp-29940	110	38	(	(	PUNCT
bjp-29940	110	39	2	2	NUM
bjp-29940	110	40	2	2	NUM
bjp-29940	110	41	.	.	NOUN
bjp-29940	110	42	2	2	NUM
bjp-29940	110	43	)	)	PUNCT
bjp-29940	110	44	6	6	NUM
bjp-29940	110	45	(	(	PUNCT
bjp-29940	110	46	7	7	NUM
bjp-29940	110	47	.7	.7	NUM
bjp-29940	110	48	)	)	PUNCT
bjp-29940	110	49	23	23	NUM
bjp-29940	111	1	(	(	PUNCT
bjp-29940	111	2	2	2	NUM
bjp-29940	111	3	9	9	NUM
bjp-29940	111	4	.	.	NOUN
bjp-29940	111	5	5	5	NUM
bjp-29940	111	6	)	)	PUNCT
bjp-29940	111	7	bangladesh	bangladesh	NOUN
bjp-29940	111	8	j	j	PROPN
bjp-29940	111	9	pharmacol	pharmacol	PROPN
bjp-29940	111	10	2017	2017	NUM
bjp-29940	111	11	;	;	PUNCT
bjp-29940	111	12	12	12	NUM
bjp-29940	111	13	:	:	SYM
bjp-29940	111	14	12	12	NUM
bjp-29940	111	15	-	-	SYM
bjp-29940	111	16	22	22	NUM
bjp-29940	111	17	15	15	NUM
bjp-29940	111	18	t	t	NOUN
bjp-29940	111	19	a	a	DET
bjp-29940	111	20	b	b	X
bjp-29940	111	21	le	le	X
bjp-29940	112	1	i	i	PRON
bjp-29940	112	2	i	i	PRON
bjp-29940	112	3	a	a	PRON
bjp-29940	112	4	s	s	X
bjp-29940	112	5	u	u	NOUN
bjp-29940	112	6	m	m	NOUN
bjp-29940	112	7	m	m	VERB
bjp-29940	112	8	a	a	DET
bjp-29940	112	9	ry	ry	NOUN
bjp-29940	112	10	o	o	PROPN
bjp-29940	112	11	f	f	PROPN
bjp-29940	112	12	in	in	ADP
bjp-29940	112	13	cl	cl	NOUN
bjp-29940	112	14	u	u	NOUN
bjp-29940	113	1	d	d	NOUN
bjp-29940	113	2	ed	ed	NOUN
bjp-29940	113	3	s	s	PROPN
bjp-29940	113	4	tu	tu	PROPN
bjp-29940	113	5	d	d	X
bjp-29940	113	6	ie	ie	X
bjp-29940	113	7	s	s	PROPN
bjp-29940	113	8	in	in	ADP
bjp-29940	113	9	t	t	PROPN
bjp-29940	113	10	h	h	NOUN
bjp-29940	113	11	e	e	PROPN
bjp-29940	113	12	a	a	PROPN
bjp-29940	113	13	n	n	ADV
bjp-29940	113	14	a	a	DET
bjp-29940	113	15	ly	ly	X
bjp-29940	114	1	si	si	NOUN
bjp-29940	114	2	s	s	X
bjp-29940	114	3	s	s	PROPN
bjp-29940	114	4	tu	tu	PROPN
bjp-29940	114	5	d	d	X
bjp-29940	114	6	y	y	PROPN
bjp-29940	115	1	i	i	NOUN
bjp-29940	115	2	d	d	X
bjp-29940	115	3	s	s	PROPN
bjp-29940	115	4	tu	tu	PROPN
bjp-29940	115	5	d	d	X
bjp-29940	115	6	y	y	PROPN
bjp-29940	115	7	d	d	PROPN
bjp-29940	115	8	es	es	VERB
bjp-29940	115	9	ig	ig	PROPN
bjp-29940	116	1	n	n	PRON
bjp-29940	116	2	p	p	NOUN
bjp-29940	116	3	o	o	X
bjp-29940	116	4	p	p	X
bjp-29940	116	5	u	u	X
bjp-29940	116	6	la	la	X
bjp-29940	116	7	ti	ti	X
bjp-29940	116	8	o	o	NOUN
bjp-29940	116	9	n	n	PROPN
bjp-29940	116	10	s	s	NOUN
bjp-29940	116	11	am	be	AUX
bjp-29940	116	12	p	p	X
bjp-29940	116	13	le	le	X
bjp-29940	116	14	s	s	NOUN
bjp-29940	116	15	iz	iz	INTJ
bjp-29940	116	16	e	e	X
bjp-29940	116	17	f	f	PROPN
bjp-29940	116	18	in	in	ADP
bjp-29940	116	19	d	d	PROPN
bjp-29940	116	20	in	in	ADP
bjp-29940	116	21	g	g	PROPN
bjp-29940	116	22	s	s	PART
bjp-29940	116	23	r	r	NOUN
bjp-29940	116	24	eg	eg	NOUN
bjp-29940	116	25	i	i	PRON
bjp-29940	116	26	m	m	VERB
bjp-29940	116	27	en	en	ADP
bjp-29940	116	28	s	s	PROPN
bjp-29940	116	29	in	in	ADP
bjp-29940	116	30	te	te	ADP
bjp-29940	116	31	rv	rv	PROPN
bjp-29940	116	32	en	en	ADP
bjp-29940	116	33	ti	ti	X
bjp-29940	116	34	o	o	NOUN
bjp-29940	117	1	n	n	ADP
bjp-29940	117	2	c	c	NOUN
bjp-29940	117	3	o	o	NOUN
bjp-29940	117	4	n	n	PRON
bjp-29940	117	5	tr	tr	NOUN
bjp-29940	118	1	o	o	PROPN
bjp-29940	118	2	l	l	NOUN
bjp-29940	118	3	h	h	NOUN
bjp-29940	118	4	ez	ez	NOUN
bjp-29940	118	5	o	o	X
bjp-29940	119	1	d	d	X
bjp-29940	119	2	e	e	X
bjp-29940	119	3	et	et	PROPN
bjp-29940	119	4	a	a	DET
bjp-29940	119	5	l.	l.	PROPN
bjp-29940	119	6	2	2	NUM
bjp-29940	119	7	01	01	NUM
bjp-29940	119	8	4	4	NUM
bjp-29940	119	9	p	p	NOUN
bjp-29940	119	10	h	h	NOUN
bjp-29940	119	11	a	a	DET
bjp-29940	119	12	se	se	PROPN
bjp-29940	119	13	i	i	PROPN
bjp-29940	119	14	ii	ii	PROPN
bjp-29940	119	15	,	,	PUNCT
bjp-29940	119	16	ra	ra	PROPN
bjp-29940	119	17	n	n	ADV
bjp-29940	120	1	d	d	X
bjp-29940	120	2	o	o	X
bjp-29940	120	3	m	m	VERB
bjp-29940	120	4	iz	iz	INTJ
bjp-29940	120	5	ed	ed	NOUN
bjp-29940	120	6	,	,	PUNCT
bjp-29940	121	1	d	d	X
bjp-29940	121	2	o	o	X
bjp-29940	121	3	u	u	PROPN
bjp-29940	121	4	b	b	PROPN
bjp-29940	121	5	le	le	PROPN
bjp-29940	121	6	b	b	PROPN
bjp-29940	121	7	li	li	PROPN
bjp-29940	121	8	n	n	PROPN
bjp-29940	121	9	d	d	PROPN
bjp-29940	121	10	,	,	PUNCT
bjp-29940	121	11	co	co	X
bjp-29940	121	12	n	n	PRON
bjp-29940	121	13	tr	tr	NOUN
bjp-29940	121	14	o	o	PROPN
bjp-29940	122	1	ll	ll	NOUN
bjp-29940	122	2	ed	ed	PROPN
bjp-29940	122	3	t	t	PROPN
bjp-29940	122	4	ri	ri	PROPN
bjp-29940	122	5	a	a	DET
bjp-29940	122	6	l	l	NOUN
bjp-29940	122	7	-p	-p	NOUN
bjp-29940	122	8	a	a	DET
bjp-29940	122	9	ti	ti	X
bjp-29940	122	10	en	en	X
bjp-29940	122	11	ts	ts	ADP
bjp-29940	122	12	a	a	DET
bjp-29940	122	13	g	g	NOUN
bjp-29940	122	14	e	e	PROPN
bjp-29940	122	15	18	18	NUM
bjp-29940	122	16	-7	-7	NOUN
bjp-29940	122	17	0	0	NUM
bjp-29940	123	1	-p	-p	DET
bjp-29940	123	2	a	a	DET
bjp-29940	123	3	ti	ti	X
bjp-29940	123	4	en	en	INTJ
bjp-29940	123	5	ts	ts	ADP
bjp-29940	123	6	i	i	PROPN
bjp-29940	123	7	n	n	PROPN
bjp-29940	123	8	fe	fe	X
bjp-29940	124	1	ct	ct	NUM
bjp-29940	124	2	ed	ed	PROPN
bjp-29940	125	1	w	w	PROPN
bjp-29940	125	2	it	it	PRON
bjp-29940	126	1	h	h	NOUN
bjp-29940	127	1	h	h	NOUN
bjp-29940	127	2	c	c	NOUN
bjp-29940	127	3	v	v	NOUN
bjp-29940	127	4	g	g	PROPN
bjp-29940	127	5	t	t	PROPN
bjp-29940	127	6	1	1	NUM
bjp-29940	127	7	(	(	PUNCT
bjp-29940	127	8	9	9	NUM
bjp-29940	127	9	0	0	NUM
bjp-29940	127	10	%	%	NOUN
bjp-29940	127	11	)	)	PUNCT
bjp-29940	128	1	o	o	NOUN
bjp-29940	128	2	r	r	NOUN
bjp-29940	128	3	g	g	PROPN
bjp-29940	128	4	t	t	PROPN
bjp-29940	128	5	4	4	NUM
bjp-29940	128	6	(	(	PUNCT
bjp-29940	128	7	1	1	NUM
bjp-29940	128	8	0	0	NUM
bjp-29940	128	9	%	%	NOUN
bjp-29940	128	10	)	)	PUNCT
bjp-29940	129	1	w	w	PROPN
bjp-29940	129	2	ith	ith	PROPN
bjp-29940	129	3	v	v	INTJ
bjp-29940	129	4	ir	ir	PROPN
bjp-29940	129	5	al	al	PROPN
bjp-29940	129	6	lo	lo	PROPN
bjp-29940	129	7	ad	ad	NOUN
bjp-29940	129	8	≥	≥	NUM
bjp-29940	129	9	10	10	NUM
bjp-29940	129	10	0	0	NUM
bjp-29940	129	11	00	00	NUM
bjp-29940	129	12	0	0	NUM
bjp-29940	130	1	iu	iu	ADP
bjp-29940	130	2	/m	/m	PROPN
bjp-29940	130	3	l	l	PROPN
bjp-29940	130	4	-t	-t	PUNCT
bjp-29940	130	5	re	re	ADP
bjp-29940	130	6	a	a	DET
bjp-29940	130	7	tm	tm	PROPN
bjp-29940	130	8	en	en	PROPN
bjp-29940	130	9	t	t	PROPN
bjp-29940	130	10	n	n	AUX
bjp-29940	130	11	ai	ai	VERB
bjp-29940	130	12	v	v	ADP
bjp-29940	130	13	e	e	X
bjp-29940	130	14	-n	-n	X
bjp-29940	130	15	o	o	X
bjp-29940	130	16	h	h	NOUN
bjp-29940	130	17	is	be	AUX
bjp-29940	130	18	to	to	PART
bjp-29940	130	19	ry	ry	VERB
bjp-29940	131	1	o	o	PROPN
bjp-29940	131	2	r	r	NOUN
bjp-29940	131	3	ev	ev	X
bjp-29940	131	4	i	i	PROPN
bjp-29940	131	5	d	d	PROPN
bjp-29940	131	6	en	en	PROPN
bjp-29940	131	7	ce	ce	PROPN
bjp-29940	132	1	o	o	X
bjp-29940	132	2	f	f	PROPN
bjp-29940	132	3	h	h	NOUN
bjp-29940	132	4	ep	ep	PROPN
bjp-29940	132	5	a	a	DET
bjp-29940	132	6	ti	ti	NOUN
bjp-29940	132	7	c	c	NOUN
bjp-29940	132	8	d	d	NOUN
bjp-29940	132	9	ec	ec	PROPN
bjp-29940	133	1	o	o	NOUN
bjp-29940	133	2	m	m	VERB
bjp-29940	133	3	p	p	X
bjp-29940	133	4	en	en	ADP
bjp-29940	133	5	sa	sa	X
bjp-29940	133	6	ti	ti	PROPN
bjp-29940	133	7	o	o	PROPN
bjp-29940	134	1	n	n	CCONJ
bjp-29940	134	2	-n	-n	X
bjp-29940	134	3	o	o	X
bjp-29940	134	4	p	p	X
bjp-29940	134	5	ri	ri	NOUN
bjp-29940	134	6	o	o	NOUN
bjp-29940	134	7	r	r	NOUN
bjp-29940	135	1	ex	ex	NOUN
bjp-29940	136	1	p	p	NOUN
bjp-29940	136	2	o	o	X
bjp-29940	136	3	su	su	PROPN
bjp-29940	136	4	re	re	PROPN
bjp-29940	136	5	t	t	PROPN
bjp-29940	136	6	o	o	PROPN
bjp-29940	136	7	a	a	PRON
bjp-29940	136	8	n	n	NOUN
bjp-29940	136	9	y	y	PROPN
bjp-29940	136	10	a	a	DET
bjp-29940	136	11	g	g	PROPN
bjp-29940	136	12	en	en	ADP
bjp-29940	136	13	t	t	PROPN
bjp-29940	137	1	w	w	NOUN
bjp-29940	137	2	it	it	PRON
bjp-29940	138	1	h	h	NOUN
bjp-29940	138	2	p	p	X
bjp-29940	138	3	o	o	X
bjp-29940	138	4	te	te	ADP
bjp-29940	138	5	n	n	CCONJ
bjp-29940	138	6	ti	ti	NOUN
bjp-29940	138	7	al	al	PROPN
bjp-29940	138	8	a	a	PROPN
bjp-29940	138	9	n	n	NUM
bjp-29940	138	10	ti	ti	NOUN
bjp-29940	138	11	-h	-h	SYM
bjp-29940	138	12	c	c	NOUN
bjp-29940	138	13	v	v	ADP
bjp-29940	138	14	a	a	DET
bjp-29940	138	15	ct	ct	NOUN
bjp-29940	138	16	iv	iv	NUM
bjp-29940	138	17	it	it	PRON
bjp-29940	138	18	y	y	INTJ
bjp-29940	138	19	,	,	PUNCT
bjp-29940	139	1	-n	-n	X
bjp-29940	139	2	o	o	X
bjp-29940	139	3	c	c	X
bjp-29940	139	4	o	o	X
bjp-29940	139	5	in	in	ADP
bjp-29940	139	6	fe	fe	X
bjp-29940	139	7	ct	ct	PROPN
bjp-29940	139	8	io	io	PROPN
bjp-29940	140	1	n	n	PROPN
bjp-29940	141	1	w	w	VERB
bjp-29940	142	1	it	it	PRON
bjp-29940	143	1	h	h	NOUN
bjp-29940	144	1	h	h	NOUN
bjp-29940	145	1	b	b	NOUN
bjp-29940	145	2	v	v	NUM
bjp-29940	145	3	o	o	NOUN
bjp-29940	145	4	r	r	NOUN
bjp-29940	145	5	h	h	NOUN
bjp-29940	146	1	iv	iv	INTJ
bjp-29940	146	2	,	,	PUNCT
bjp-29940	146	3	o	o	NOUN
bjp-29940	146	4	r	r	NOUN
bjp-29940	146	5	ev	ev	X
bjp-29940	146	6	i	i	PROPN
bjp-29940	146	7	d	d	PROPN
bjp-29940	146	8	en	en	PROPN
bjp-29940	146	9	ce	ce	PROPN
bjp-29940	147	1	o	o	PROPN
bjp-29940	147	2	f	f	PROPN
bjp-29940	147	3	ch	ch	PROPN
bjp-29940	147	4	ro	ro	PROPN
bjp-29940	148	1	n	n	PROPN
bjp-29940	148	2	ic	ic	PROPN
bjp-29940	148	3	l	l	NOUN
bjp-29940	148	4	iv	iv	NUM
bjp-29940	149	1	er	er	INTJ
bjp-29940	149	2	d	d	NOUN
bjp-29940	149	3	is	be	AUX
bjp-29940	149	4	ea	ea	X
bjp-29940	149	5	se	se	X
bjp-29940	149	6	o	o	PROPN
bjp-29940	150	1	th	th	INTJ
bjp-29940	150	2	er	er	INTJ
bjp-29940	150	3	t	t	PROPN
bjp-29940	150	4	h	h	NOUN
bjp-29940	150	5	a	a	PRON
bjp-29940	150	6	n	n	NOUN
bjp-29940	150	7	h	h	NOUN
bjp-29940	150	8	c	c	NOUN
bjp-29940	150	9	v	v	NOUN
bjp-29940	150	10	.	.	PUNCT
bjp-29940	151	1	n	n	NOUN
bjp-29940	152	1	=	=	NOUN
bjp-29940	152	2	35	35	NUM
bjp-29940	152	3	9	9	NUM
bjp-29940	152	4	g	g	NOUN
bjp-29940	152	5	t	t	NOUN
bjp-29940	152	6	1	1	NUM
bjp-29940	152	7	=	=	SYM
bjp-29940	152	8	3	3	NUM
bjp-29940	152	9	6	6	NUM
bjp-29940	152	10	5	5	NUM
bjp-29940	152	11	g	g	NOUN
bjp-29940	152	12	t	t	PROPN
bjp-29940	152	13	4	4	NUM
bjp-29940	152	14	=	=	SYM
bjp-29940	152	15	3	3	NUM
bjp-29940	152	16	0	0	NUM
bjp-29940	152	17	-1	-1	SYM
bjp-29940	152	18	59	59	NUM
bjp-29940	153	1	i	i	PRON
bjp-29940	153	2	n	n	VERB
bjp-29940	153	3	i	i	PRON
bjp-29940	153	4	n	n	VERB
bjp-29940	153	5	te	te	VERB
bjp-29940	153	6	rv	rv	X
bjp-29940	153	7	en	en	ADP
bjp-29940	153	8	ti	ti	X
bjp-29940	153	9	o	o	PROPN
bjp-29940	153	10	n	n	PROPN
bjp-29940	153	11	(	(	PUNCT
bjp-29940	153	12	2	2	NUM
bjp-29940	153	13	0	0	NUM
bjp-29940	153	14	m	m	NOUN
bjp-29940	153	15	g	g	NOUN
bjp-29940	153	16	)	)	PUNCT
bjp-29940	153	17	-1	-1	PUNCT
bjp-29940	153	18	58	58	NUM
bjp-29940	154	1	i	i	PRON
bjp-29940	154	2	n	n	VERB
bjp-29940	154	3	i	i	PRON
bjp-29940	154	4	n	n	VERB
bjp-29940	154	5	te	te	VERB
bjp-29940	154	6	rv	rv	X
bjp-29940	154	7	en	en	ADP
bjp-29940	154	8	ti	ti	X
bjp-29940	154	9	o	o	PROPN
bjp-29940	154	10	n	n	PROPN
bjp-29940	154	11	(	(	PUNCT
bjp-29940	154	12	6	6	NUM
bjp-29940	154	13	0	0	NUM
bjp-29940	154	14	m	m	NOUN
bjp-29940	154	15	g	g	NOUN
bjp-29940	154	16	)	)	PUNCT
bjp-29940	154	17	7	7	NUM
bjp-29940	154	18	8	8	NUM
bjp-29940	154	19	in	in	ADP
bjp-29940	154	20	c	c	NOUN
bjp-29940	154	21	o	o	NOUN
bjp-29940	154	22	n	n	PRON
bjp-29940	154	23	tr	tr	NOUN
bjp-29940	154	24	o	o	NOUN
bjp-29940	154	25	l	l	PROPN
bjp-29940	155	1	d	d	NOUN
bjp-29940	155	2	a	a	DET
bjp-29940	155	3	cl	cl	NOUN
bjp-29940	155	4	a	a	DET
bjp-29940	155	5	ta	ta	X
bjp-29940	155	6	sv	sv	PROPN
bjp-29940	155	7	ir	ir	PROPN
bjp-29940	156	1	(	(	PUNCT
bjp-29940	156	2	2	2	NUM
bjp-29940	156	3	0	0	NUM
bjp-29940	156	4	m	m	NOUN
bjp-29940	156	5	g	g	NOUN
bjp-29940	156	6	o	o	NOUN
bjp-29940	156	7	r	r	NOUN
bjp-29940	156	8	60	60	NUM
bjp-29940	156	9	m	m	NOUN
bjp-29940	156	10	g	g	NOUN
bjp-29940	156	11	)	)	PUNCT
bjp-29940	157	1	+	+	CCONJ
bjp-29940	157	2	p	p	ADJ
bjp-29940	157	3	eg	eg	NOUN
bjp-29940	157	4	in	in	ADP
bjp-29940	157	5	te	te	PROPN
bjp-29940	157	6	rf	rf	VERB
bjp-29940	158	1	er	er	INTJ
bjp-29940	158	2	o	o	X
bjp-29940	158	3	n	n	CCONJ
bjp-29940	158	4	-a	-a	PUNCT
bjp-29940	158	5	lf	lf	ADP
bjp-29940	158	6	a	a	PRON
bjp-29940	158	7	/	/	SYM
bjp-29940	158	8	ri	ri	PROPN
bjp-29940	158	9	b	b	PROPN
bjp-29940	159	1	a	a	DET
bjp-29940	159	2	v	v	X
bjp-29940	159	3	ir	ir	NOUN
bjp-29940	159	4	in	in	ADP
bjp-29940	159	5	p	p	PROPN
bjp-29940	159	6	la	la	PROPN
bjp-29940	159	7	ce	ce	PROPN
bjp-29940	159	8	b	b	PROPN
bjp-29940	159	9	o	o	PROPN
bjp-29940	160	1	+	+	CCONJ
bjp-29940	160	2	p	p	NOUN
bjp-29940	160	3	eg	eg	NOUN
bjp-29940	160	4	if	if	SCONJ
bjp-29940	160	5	n	n	X
bjp-29940	160	6	-a	-a	X
bjp-29940	160	7	lf	lf	ADP
bjp-29940	160	8	a	a	PRON
bjp-29940	160	9	-2	-2	NOUN
bjp-29940	160	10	a/	a/	NOUN
bjp-29940	160	11	r	r	PROPN
bjp-29940	160	12	b	b	PROPN
bjp-29940	160	13	v	v	ADP
bjp-29940	160	14	t	t	NOUN
bjp-29940	160	15	h	h	NOUN
bjp-29940	160	16	e	e	PROPN
bjp-29940	160	17	st	st	PROPN
bjp-29940	160	18	u	u	PROPN
bjp-29940	160	19	d	d	PROPN
bjp-29940	160	20	y	y	PROPN
bjp-29940	160	21	s	s	PROPN
bjp-29940	160	22	h	h	NOUN
bjp-29940	160	23	o	o	X
bjp-29940	160	24	w	w	PROPN
bjp-29940	160	25	s	s	PROPN
bjp-29940	160	26	th	th	X
bjp-29940	160	27	a	a	DET
bjp-29940	160	28	t	t	NOUN
bjp-29940	160	29	d	d	NOUN
bjp-29940	160	30	a	a	DET
bjp-29940	160	31	cl	cl	NOUN
bjp-29940	160	32	a	a	DET
bjp-29940	160	33	ta	ta	X
bjp-29940	160	34	sv	sv	PROPN
bjp-29940	160	35	ir	ir	PROPN
bjp-29940	160	36	/	/	SYM
bjp-29940	160	37	p	p	X
bjp-29940	160	38	eg	eg	NOUN
bjp-29940	160	39	in	in	ADP
bjp-29940	160	40	te	te	PROPN
bjp-29940	160	41	rf	rf	VERB
bjp-29940	160	42	er	er	INTJ
bjp-29940	160	43	o	o	X
bjp-29940	160	44	n	n	CCONJ
bjp-29940	160	45	-a	-a	PUNCT
bjp-29940	160	46	lf	lf	ADP
bjp-29940	160	47	a	a	PRON
bjp-29940	160	48	/	/	SYM
bjp-29940	160	49	ri	ri	PROPN
bjp-29940	160	50	b	b	PROPN
bjp-29940	160	51	a	a	PRON
bjp-29940	160	52	v	v	X
bjp-29940	160	53	ir	ir	NOUN
bjp-29940	160	54	in	in	ADP
bjp-29940	160	55	i	i	PROPN
bjp-29940	160	56	s	s	PROPN
bjp-29940	160	57	su	su	PROPN
bjp-29940	161	1	p	p	X
bjp-29940	161	2	er	er	INTJ
bjp-29940	161	3	io	io	X
bjp-29940	161	4	r	r	NOUN
bjp-29940	161	5	to	to	ADP
bjp-29940	161	6	p	p	NOUN
bjp-29940	161	7	eg	eg	NOUN
bjp-29940	161	8	in	in	ADP
bjp-29940	161	9	te	te	PROPN
bjp-29940	161	10	rf	rf	VERB
bjp-29940	161	11	er	er	INTJ
bjp-29940	161	12	o	o	X
bjp-29940	161	13	n	n	CCONJ
bjp-29940	161	14	-a	-a	PUNCT
bjp-29940	161	15	lf	lf	ADP
bjp-29940	161	16	a	a	PRON
bjp-29940	161	17	/	/	SYM
bjp-29940	161	18	ri	ri	PROPN
bjp-29940	161	19	b	b	PROPN
bjp-29940	161	20	a	a	PRON
bjp-29940	161	21	v	v	X
bjp-29940	161	22	ir	ir	NOUN
bjp-29940	161	23	in	in	ADP
bjp-29940	161	24	a	a	DET
bjp-29940	161	25	lo	lo	NOUN
bjp-29940	161	26	n	n	ADP
bjp-29940	162	1	e	e	PROPN
bjp-29940	162	2	h	h	PROPN
bjp-29940	162	3	ez	ez	PROPN
bjp-29940	162	4	o	o	PROPN
bjp-29940	163	1	d	d	X
bjp-29940	163	2	e	e	X
bjp-29940	163	3	et	et	PROPN
bjp-29940	163	4	a	a	DET
bjp-29940	163	5	l.	l.	PROPN
bjp-29940	163	6	2	2	NUM
bjp-29940	163	7	01	01	NUM
bjp-29940	163	8	5	5	NUM
bjp-29940	163	9	p	p	NOUN
bjp-29940	163	10	h	h	NOUN
bjp-29940	163	11	a	a	PRON
bjp-29940	163	12	se	se	PROPN
bjp-29940	163	13	i	i	PROPN
bjp-29940	163	14	ii	ii	PROPN
bjp-29940	163	15	,	,	PUNCT
bjp-29940	163	16	ra	ra	PROPN
bjp-29940	164	1	n	n	ADV
bjp-29940	165	1	d	d	X
bjp-29940	165	2	o	o	X
bjp-29940	165	3	m	m	VERB
bjp-29940	165	4	iz	iz	INTJ
bjp-29940	165	5	ed	ed	NOUN
bjp-29940	165	6	,	,	PUNCT
bjp-29940	166	1	d	d	X
bjp-29940	166	2	o	o	X
bjp-29940	166	3	u	u	PROPN
bjp-29940	166	4	b	b	PROPN
bjp-29940	166	5	le	le	PROPN
bjp-29940	166	6	b	b	PROPN
bjp-29940	166	7	li	li	PROPN
bjp-29940	166	8	n	n	PROPN
bjp-29940	166	9	d	d	PROPN
bjp-29940	166	10	,	,	PUNCT
bjp-29940	166	11	co	co	X
bjp-29940	166	12	n	n	PRON
bjp-29940	166	13	tr	tr	NOUN
bjp-29940	166	14	o	o	PROPN
bjp-29940	167	1	ll	ll	AUX
bjp-29940	167	2	ed	ed	PROPN
bjp-29940	167	3	t	t	PROPN
bjp-29940	167	4	ri	ri	PROPN
bjp-29940	167	5	a	a	DET
bjp-29940	167	6	l	l	NOUN
bjp-29940	167	7	-p	-p	PUNCT
bjp-29940	167	8	at	at	ADP
bjp-29940	167	9	ie	ie	ADV
bjp-29940	167	10	nt	not	PART
bjp-29940	167	11	s	s	VERB
bjp-29940	167	12	a	a	DET
bjp-29940	167	13	ge	ge	PROPN
bjp-29940	167	14	d	d	X
bjp-29940	167	15	≥	≥	NUM
bjp-29940	167	16	18	18	NUM
bjp-29940	167	17	-in	-in	NUM
bjp-29940	167	18	fe	fe	PROPN
bjp-29940	167	19	ct	ct	PROPN
bjp-29940	167	20	ed	ed	PROPN
bjp-29940	167	21	w	w	PROPN
bjp-29940	167	22	ith	ith	PROPN
bjp-29940	167	23	h	h	PROPN
bjp-29940	167	24	c	c	NOUN
bjp-29940	167	25	v	v	ADP
bjp-29940	167	26	g	g	PROPN
bjp-29940	167	27	en	en	PROPN
bjp-29940	167	28	ot	ot	NOUN
bjp-29940	167	29	yp	yp	PROPN
bjp-29940	167	30	e	e	PROPN
bjp-29940	167	31	4	4	NUM
bjp-29940	167	32	w	w	PROPN
bjp-29940	167	33	ith	ith	PROPN
bjp-29940	167	34	v	v	ADP
bjp-29940	167	35	ira	ira	PROPN
bjp-29940	167	36	l	l	PROPN
bjp-29940	167	37	l	l	NOUN
bjp-29940	167	38	oa	oa	X
bjp-29940	167	39	d	d	X
bjp-29940	167	40	≥	≥	NUM
bjp-29940	167	41	1	1	NUM
bjp-29940	167	42	0	0	NUM
bjp-29940	167	43	.	.	PUNCT
bjp-29940	167	44	00	00	NUM
bjp-29940	167	45	0	0	NUM
bjp-29940	168	1	i	i	PRON
bjp-29940	168	2	u	u	NOUN
bjp-29940	168	3	/	/	SYM
bjp-29940	168	4	m	m	VERB
bjp-29940	168	5	l	l	NOUN
bjp-29940	168	6	-n	-n	X
bjp-29940	168	7	ai	ai	VERB
bjp-29940	168	8	v	v	ADP
bjp-29940	168	9	e	e	NOUN
bjp-29940	168	10	to	to	ADP
bjp-29940	168	11	i	i	PRON
bjp-29940	168	12	n	n	VERB
bjp-29940	168	13	te	te	INTJ
bjp-29940	168	14	rf	rf	VERB
bjp-29940	168	15	er	er	INTJ
bjp-29940	168	16	o	o	NOUN
bjp-29940	168	17	n	n	CCONJ
bjp-29940	168	18	-b	-b	PUNCT
bjp-29940	169	1	a	a	DET
bjp-29940	169	2	se	se	PROPN
bjp-29940	169	3	d	d	NOUN
bjp-29940	169	4	r	r	NOUN
bjp-29940	169	5	eg	eg	NOUN
bjp-29940	169	6	i	i	PRON
bjp-29940	169	7	m	m	VERB
bjp-29940	169	8	en	en	ADP
bjp-29940	169	9	s	s	NOUN
bjp-29940	169	10	o	o	NOUN
bjp-29940	169	11	r	r	NOUN
bjp-29940	169	12	d	d	NOUN
bjp-29940	169	13	a	a	DET
bjp-29940	169	14	a	a	DET
bjp-29940	169	15	s	s	NOUN
bjp-29940	169	16	-w	-w	PUNCT
bjp-29940	169	17	it	it	PRON
bjp-29940	169	18	h	h	VERB
bjp-29940	170	1	c	c	NOUN
bjp-29940	170	2	o	o	NOUN
bjp-29940	171	1	m	m	VERB
bjp-29940	171	2	p	p	X
bjp-29940	171	3	en	en	ADP
bjp-29940	171	4	sa	sa	X
bjp-29940	172	1	te	te	PROPN
bjp-29940	173	1	d	d	PROPN
bjp-29940	173	2	c	c	PROPN
bjp-29940	173	3	ir	ir	PROPN
bjp-29940	173	4	rh	rh	NOUN
bjp-29940	173	5	o	o	NOUN
bjp-29940	173	6	si	si	X
bjp-29940	173	7	s	s	X
bjp-29940	173	8	-n	-n	X
bjp-29940	173	9	o	o	X
bjp-29940	173	10	c	c	X
bjp-29940	173	11	o	o	X
bjp-29940	173	12	-i	-i	PUNCT
bjp-29940	173	13	n	n	NUM
bjp-29940	173	14	fe	fe	X
bjp-29940	173	15	ct	ct	NUM
bjp-29940	173	16	io	io	PROPN
bjp-29940	173	17	n	n	PROPN
bjp-29940	173	18	s	s	PROPN
bjp-29940	173	19	w	w	NOUN
bjp-29940	173	20	it	it	PRON
bjp-29940	174	1	h	h	NOUN
bjp-29940	174	2	h	h	NOUN
bjp-29940	175	1	b	b	NOUN
bjp-29940	175	2	v	v	NUM
bjp-29940	175	3	o	o	NOUN
bjp-29940	175	4	r	r	NOUN
bjp-29940	175	5	h	h	NOUN
bjp-29940	176	1	iv	iv	INTJ
bjp-29940	176	2	,	,	PUNCT
bjp-29940	176	3	o	o	NOUN
bjp-29940	176	4	r	r	NOUN
bjp-29940	176	5	a	a	PROPN
bjp-29940	176	6	n	n	NOUN
bjp-29940	176	7	y	y	PROPN
bjp-29940	176	8	m	m	PROPN
bjp-29940	176	9	a	a	DET
bjp-29940	176	10	li	li	PROPN
bjp-29940	176	11	g	g	PROPN
bjp-29940	176	12	n	n	PROPN
bjp-29940	176	13	a	a	DET
bjp-29940	176	14	n	n	X
bjp-29940	176	15	cy	cy	NOUN
bjp-29940	176	16	.	.	PUNCT
bjp-29940	177	1	n	n	NOUN
bjp-29940	178	1	=	=	NOUN
bjp-29940	178	2	12	12	NUM
bjp-29940	178	3	4	4	NUM
bjp-29940	178	4	-8	-8	NUM
bjp-29940	178	5	2	2	NUM
bjp-29940	179	1	i	i	PRON
bjp-29940	180	1	n	n	VERB
bjp-29940	181	1	i	i	PRON
bjp-29940	181	2	n	n	VERB
bjp-29940	181	3	te	te	VERB
bjp-29940	181	4	rv	rv	X
bjp-29940	181	5	en	en	ADP
bjp-29940	181	6	ti	ti	X
bjp-29940	181	7	o	o	PROPN
bjp-29940	182	1	n	n	CCONJ
bjp-29940	182	2	g	g	NOUN
bjp-29940	182	3	ro	ro	X
bjp-29940	182	4	u	u	PROPN
bjp-29940	182	5	p	p	PROPN
bjp-29940	182	6	.	.	PUNCT
bjp-29940	183	1	-4	-4	INTJ
bjp-29940	183	2	2	2	NUM
bjp-29940	184	1	i	i	NOUN
bjp-29940	184	2	n	n	CCONJ
bjp-29940	184	3	p	p	PROPN
bjp-29940	184	4	la	la	PROPN
bjp-29940	184	5	ce	ce	PROPN
bjp-29940	184	6	b	b	PROPN
bjp-29940	184	7	o	o	X
bjp-29940	184	8	g	g	PROPN
bjp-29940	184	9	ro	ro	X
bjp-29940	184	10	u	u	PROPN
bjp-29940	184	11	p	p	PROPN
bjp-29940	184	12	.	.	PUNCT
bjp-29940	185	1	d	d	X
bjp-29940	185	2	a	a	DET
bjp-29940	185	3	cl	cl	NOUN
bjp-29940	185	4	a	a	DET
bjp-29940	185	5	ta	ta	X
bjp-29940	185	6	sv	sv	PROPN
bjp-29940	185	7	ir	ir	PROPN
bjp-29940	186	1	(	(	PUNCT
bjp-29940	186	2	6	6	NUM
bjp-29940	186	3	0	0	NUM
bjp-29940	186	4	m	m	NOUN
bjp-29940	186	5	g	g	NOUN
bjp-29940	186	6	)	)	PUNCT
bjp-29940	187	1	+	+	CCONJ
bjp-29940	187	2	p	p	ADJ
bjp-29940	187	3	eg	eg	NOUN
bjp-29940	187	4	in	in	ADP
bjp-29940	187	5	te	te	PROPN
bjp-29940	187	6	rf	rf	VERB
bjp-29940	188	1	er	er	INTJ
bjp-29940	188	2	o	o	X
bjp-29940	188	3	n	n	CCONJ
bjp-29940	188	4	a	a	DET
bjp-29940	188	5	lf	lf	ADP
bjp-29940	188	6	a	a	DET
bjp-29940	188	7	/	/	SYM
bjp-29940	188	8	ri	ri	PROPN
bjp-29940	188	9	b	b	PROPN
bjp-29940	188	10	av	av	PROPN
bjp-29940	188	11	ir	ir	PROPN
bjp-29940	188	12	in	in	ADP
bjp-29940	188	13	p	p	PROPN
bjp-29940	188	14	la	la	PROPN
bjp-29940	188	15	ce	ce	PROPN
bjp-29940	189	1	b	b	PROPN
bjp-29940	189	2	o	o	PROPN
bjp-29940	190	1	+	+	CCONJ
bjp-29940	190	2	p	p	ADJ
bjp-29940	190	3	eg	eg	NOUN
bjp-29940	190	4	in	in	ADP
bjp-29940	190	5	f	f	PROPN
bjp-29940	190	6	/	/	SYM
bjp-29940	191	1	r	r	PROPN
bjp-29940	191	2	b	b	PROPN
bjp-29940	191	3	v	v	ADP
bjp-29940	191	4	t	t	NOUN
bjp-29940	191	5	h	h	NOUN
bjp-29940	191	6	e	e	PROPN
bjp-29940	191	7	st	st	PROPN
bjp-29940	191	8	u	u	PROPN
bjp-29940	191	9	d	d	PROPN
bjp-29940	191	10	y	y	PROPN
bjp-29940	191	11	s	s	PROPN
bjp-29940	191	12	h	h	NOUN
bjp-29940	191	13	o	o	X
bjp-29940	191	14	w	w	PROPN
bjp-29940	191	15	s	s	PROPN
bjp-29940	191	16	th	th	X
bjp-29940	191	17	a	a	DET
bjp-29940	191	18	t	t	NOUN
bjp-29940	191	19	d	d	NOUN
bjp-29940	191	20	a	a	DET
bjp-29940	191	21	cl	cl	NOUN
bjp-29940	191	22	a	a	DET
bjp-29940	191	23	ta	ta	X
bjp-29940	191	24	sv	sv	PROPN
bjp-29940	191	25	ir	ir	PROPN
bjp-29940	191	26	/	/	SYM
bjp-29940	191	27	p	p	X
bjp-29940	191	28	eg	eg	NOUN
bjp-29940	191	29	in	in	ADP
bjp-29940	191	30	te	te	PROPN
bjp-29940	191	31	rf	rf	VERB
bjp-29940	191	32	er	er	INTJ
bjp-29940	191	33	o	o	X
bjp-29940	191	34	n	n	CCONJ
bjp-29940	191	35	-a	-a	PUNCT
bjp-29940	191	36	lf	lf	ADP
bjp-29940	191	37	a	a	PRON
bjp-29940	191	38	/	/	SYM
bjp-29940	191	39	ri	ri	PROPN
bjp-29940	191	40	b	b	PROPN
bjp-29940	191	41	a	a	PRON
bjp-29940	191	42	v	v	X
bjp-29940	191	43	ir	ir	NOUN
bjp-29940	191	44	in	in	ADP
bjp-29940	191	45	i	i	PROPN
bjp-29940	191	46	s	s	PROPN
bjp-29940	191	47	su	su	PROPN
bjp-29940	191	48	p	p	X
bjp-29940	191	49	er	er	INTJ
bjp-29940	191	50	io	io	X
bjp-29940	191	51	r	r	NOUN
bjp-29940	191	52	to	to	ADP
bjp-29940	191	53	p	p	NOUN
bjp-29940	191	54	eg	eg	NOUN
bjp-29940	191	55	in	in	ADP
bjp-29940	191	56	te	te	PROPN
bjp-29940	191	57	rf	rf	VERB
bjp-29940	191	58	er	er	INTJ
bjp-29940	191	59	o	o	X
bjp-29940	191	60	n	n	CCONJ
bjp-29940	191	61	-a	-a	PUNCT
bjp-29940	191	62	lf	lf	ADP
bjp-29940	191	63	a	a	PRON
bjp-29940	191	64	/	/	SYM
bjp-29940	191	65	ri	ri	PROPN
bjp-29940	191	66	b	b	PROPN
bjp-29940	191	67	a	a	PRON
bjp-29940	191	68	v	v	X
bjp-29940	191	69	ir	ir	NOUN
bjp-29940	191	70	in	in	ADP
bjp-29940	191	71	a	a	DET
bjp-29940	191	72	lo	lo	PROPN
bjp-29940	191	73	n	n	NOUN
bjp-29940	191	74	e	e	PROPN
bjp-29940	191	75	16	16	NUM
bjp-29940	191	76	bangladesh	bangladesh	PROPN
bjp-29940	191	77	j	j	PROPN
bjp-29940	191	78	pharmacol	pharmacol	PROPN
bjp-29940	191	79	2017	2017	NUM
bjp-29940	191	80	;	;	PUNCT
bjp-29940	191	81	12	12	NUM
bjp-29940	191	82	:	:	SYM
bjp-29940	191	83	12	12	NUM
bjp-29940	191	84	-	-	SYM
bjp-29940	191	85	22	22	NUM
bjp-29940	191	86	(	(	PUNCT
bjp-29940	191	87	rr=1.7	rr=1.7	NOUN
bjp-29940	191	88	%	%	NOUN
bjp-29940	191	89	ci	ci	NOUN
bjp-29940	192	1	[	[	X
bjp-29940	192	2	1.3	1.3	NUM
bjp-29940	192	3	to	to	PART
bjp-29940	192	4	2.2	2.2	NUM
bjp-29940	192	5	]	]	PUNCT
bjp-29940	192	6	,	,	PUNCT
bjp-29940	192	7	p=0.0001	p=0.0001	PROPN
bjp-29940	192	8	)	)	PUNCT
bjp-29940	192	9	.	.	PUNCT
bjp-29940	193	1	pooled	pool	VERB
bjp-29940	193	2	studies	study	NOUN
bjp-29940	193	3	were	be	AUX
bjp-29940	193	4	homogenous	homogenous	ADJ
bjp-29940	193	5	(	(	PUNCT
bjp-29940	193	6	p	p	X
bjp-29940	193	7	=	=	NOUN
bjp-29940	193	8	0.31	0.31	NUM
bjp-29940	193	9	;	;	PUNCT
bjp-29940	193	10	i²	i²	NOUN
bjp-29940	193	11	=	=	PROPN
bjp-29940	193	12	3.9	3.9	NUM
bjp-29940	193	13	%	%	NOUN
bjp-29940	193	14	)	)	PUNCT
bjp-29940	193	15	.	.	PUNCT
bjp-29940	194	1	daclatasvir	daclatasvir	PROPN
bjp-29940	194	2	dose	dose	VERB
bjp-29940	194	3	60	60	NUM
bjp-29940	194	4	mg	mg	NOUN
bjp-29940	194	5	vs	vs	ADP
bjp-29940	194	6	20	20	NUM
bjp-29940	194	7	mg	mg	NOUN
bjp-29940	194	8	for	for	ADP
bjp-29940	194	9	all	all	DET
bjp-29940	194	10	efficacy	efficacy	NOUN
bjp-29940	194	11	outcomes	outcome	NOUN
bjp-29940	194	12	,	,	PUNCT
bjp-29940	194	13	data	datum	NOUN
bjp-29940	194	14	were	be	AUX
bjp-29940	194	15	presented	present	VERB
bjp-29940	194	16	in	in	ADP
bjp-29940	194	17	two	two	NUM
bjp-29940	194	18	subgroups	subgroup	NOUN
bjp-29940	194	19	according	accord	VERB
bjp-29940	194	20	to	to	ADP
bjp-29940	194	21	the	the	DET
bjp-29940	194	22	dose	dose	NOUN
bjp-29940	194	23	of	of	ADP
bjp-29940	194	24	daclatasvir	daclatasvir	PROPN
bjp-29940	194	25	(	(	PUNCT
bjp-29940	194	26	60	60	NUM
bjp-29940	194	27	mg	mg	NOUN
bjp-29940	194	28	vs	vs	ADP
bjp-29940	194	29	20	20	NUM
bjp-29940	194	30	mg	mg	NUM
bjp-29940	194	31	)	)	PUNCT
bjp-29940	194	32	.	.	PUNCT
bjp-29940	195	1	there	there	PRON
bjp-29940	195	2	was	be	VERB
bjp-29940	195	3	no	no	DET
bjp-29940	195	4	statistically	statistically	ADV
bjp-29940	195	5	significant	significant	ADJ
bjp-29940	195	6	difference	difference	NOUN
bjp-29940	195	7	between	between	ADP
bjp-29940	195	8	the	the	DET
bjp-29940	195	9	two	two	NUM
bjp-29940	195	10	doses	dose	NOUN
bjp-29940	195	11	in	in	ADP
bjp-29940	195	12	all	all	DET
bjp-29940	195	13	efficacy	efficacy	NOUN
bjp-29940	195	14	outcomes	outcome	NOUN
bjp-29940	195	15	(	(	PUNCT
bjp-29940	195	16	test	test	NOUN
bjp-29940	195	17	for	for	ADP
bjp-29940	195	18	subgroup	subgroup	ADJ
bjp-29940	195	19	analysis	analysis	NOUN
bjp-29940	195	20	:	:	PUNCT
bjp-29940	195	21	p>0.05	p>0.05	NOUN
bjp-29940	195	22	)	)	PUNCT
bjp-29940	195	23	.	.	PUNCT
bjp-29940	196	1	discussion	discussion	NOUN
bjp-29940	196	2	summary	summary	NOUN
bjp-29940	196	3	of	of	ADP
bjp-29940	196	4	evidence	evidence	NOUN
bjp-29940	196	5	this	this	DET
bjp-29940	196	6	study	study	NOUN
bjp-29940	196	7	provides	provide	VERB
bjp-29940	196	8	class	class	NOUN
bjp-29940	196	9	one	one	NUM
bjp-29940	196	10	evidence	evidence	NOUN
bjp-29940	196	11	that	that	PRON
bjp-29940	196	12	daclatasvir	daclatasvir	PROPN
bjp-29940	196	13	plus	plus	CCONJ
bjp-29940	196	14	peg	peg	NOUN
bjp-29940	196	15	-	-	PUNCT
bjp-29940	196	16	ifn	ifn	NOUN
bjp-29940	196	17	/	/	SYM
bjp-29940	196	18	rbv	rbv	NOUN
bjp-29940	196	19	regimen	regimen	NOUN
bjp-29940	196	20	achieves	achieve	VERB
bjp-29940	196	21	moderate	moderate	ADJ
bjp-29940	196	22	efficacy	efficacy	NOUN
bjp-29940	196	23	in	in	ADP
bjp-29940	196	24	treatment	treatment	NOUN
bjp-29940	196	25	of	of	ADP
bjp-29940	196	26	chronic	chronic	ADJ
bjp-29940	196	27	hcv	hcv	NOUN
bjp-29940	196	28	infection	infection	NOUN
bjp-29940	196	29	genotype	genotype	NOUN
bjp-29940	196	30	4	4	NUM
bjp-29940	196	31	.	.	PUNCT
bjp-29940	197	1	the	the	DET
bjp-29940	197	2	overall	overall	ADJ
bjp-29940	197	3	effect	effect	NOUN
bjp-29940	197	4	size	size	NOUN
bjp-29940	197	5	of	of	ADP
bjp-29940	197	6	svr	svr	PROPN
bjp-29940	197	7	,	,	PUNCT
bjp-29940	197	8	rvr	rvr	NOUN
bjp-29940	197	9	,	,	PUNCT
bjp-29940	197	10	ervr	ervr	NOUN
bjp-29940	197	11	,	,	PUNCT
bjp-29940	197	12	cevr	cevr	PROPN
bjp-29940	197	13	,	,	PUNCT
bjp-29940	197	14	and	and	CCONJ
bjp-29940	197	15	eotr	eotr	NOUN
bjp-29940	197	16	rates	rate	NOUN
bjp-29940	197	17	was	be	AUX
bjp-29940	197	18	higher	high	ADJ
bjp-29940	197	19	in	in	ADP
bjp-29940	197	20	the	the	DET
bjp-29940	197	21	daclatasvir	daclatasvir	PROPN
bjp-29940	197	22	plus	plus	CCONJ
bjp-29940	197	23	peg	peg	NOUN
bjp-29940	197	24	-	-	PUNCT
bjp-29940	197	25	ifn	ifn	NOUN
bjp-29940	197	26	/	/	SYM
bjp-29940	197	27	rbv	rbv	NOUN
bjp-29940	197	28	compared	compare	VERB
bjp-29940	197	29	to	to	ADP
bjp-29940	197	30	the	the	DET
bjp-29940	197	31	placebo	placebo	NOUN
bjp-29940	197	32	plus	plus	CCONJ
bjp-29940	197	33	peg	peg	NOUN
bjp-29940	197	34	-	-	PUNCT
bjp-29940	197	35	ifn	ifn	NOUN
bjp-29940	197	36	/	/	SYM
bjp-29940	197	37	rbv	rbv	PROPN
bjp-29940	197	38	group	group	NOUN
bjp-29940	197	39	.	.	PUNCT
bjp-29940	198	1	daclatasvir	daclatasvir	PROPN
bjp-29940	198	2	dose	dose	VERB
bjp-29940	198	3	20	20	NUM
bjp-29940	198	4	mg	mg	NOUN
bjp-29940	198	5	vs	vs	ADP
bjp-29940	198	6	60	60	NUM
bjp-29940	198	7	mg	mg	NUM
bjp-29940	198	8	two	two	NUM
bjp-29940	198	9	doses	dose	NOUN
bjp-29940	198	10	of	of	ADP
bjp-29940	198	11	daclatasvir	daclatasvir	NOUN
bjp-29940	198	12	(	(	PUNCT
bjp-29940	198	13	20	20	NUM
bjp-29940	198	14	and	and	CCONJ
bjp-29940	198	15	60	60	NUM
bjp-29940	198	16	mg	mg	NUM
bjp-29940	198	17	)	)	PUNCT
bjp-29940	198	18	were	be	AUX
bjp-29940	198	19	investigated	investigate	VERB
bjp-29940	198	20	in	in	ADP
bjp-29940	198	21	included	include	VERB
bjp-29940	198	22	clinical	clinical	ADJ
bjp-29940	198	23	trials	trial	NOUN
bjp-29940	198	24	and	and	CCONJ
bjp-29940	198	25	were	be	AUX
bjp-29940	198	26	pooled	pool	VERB
bjp-29940	198	27	in	in	ADP
bjp-29940	198	28	our	our	PRON
bjp-29940	198	29	analysis	analysis	NOUN
bjp-29940	198	30	.	.	PUNCT
bjp-29940	199	1	our	our	PRON
bjp-29940	199	2	results	result	NOUN
bjp-29940	199	3	showed	show	VERB
bjp-29940	199	4	that	that	SCONJ
bjp-29940	199	5	both	both	DET
bjp-29940	199	6	doses	dose	NOUN
bjp-29940	199	7	achieved	achieve	VERB
bjp-29940	199	8	comparable	comparable	ADJ
bjp-29940	199	9	svr	svr	NOUN
bjp-29940	199	10	rates	rate	NOUN
bjp-29940	199	11	at	at	ADP
bjp-29940	199	12	12	12	NUM
bjp-29940	199	13	and	and	CCONJ
bjp-29940	199	14	24	24	NUM
bjp-29940	199	15	weeks	week	NOUN
bjp-29940	199	16	(	(	PUNCT
bjp-29940	199	17	hézode	hézode	PROPN
bjp-29940	199	18	et	et	PROPN
bjp-29940	199	19	al	al	PROPN
bjp-29940	199	20	.	.	PROPN
bjp-29940	199	21	,	,	PUNCT
bjp-29940	199	22	2014	2014	NUM
bjp-29940	199	23	)	)	PUNCT
bjp-29940	199	24	.	.	PUNCT
bjp-29940	200	1	however	however	ADV
bjp-29940	200	2	,	,	PUNCT
bjp-29940	200	3	it	it	PRON
bjp-29940	200	4	is	be	AUX
bjp-29940	200	5	expected	expect	VERB
bjp-29940	200	6	that	that	SCONJ
bjp-29940	200	7	the	the	DET
bjp-29940	200	8	60	60	NUM
bjp-29940	200	9	mg	mg	NOUN
bjp-29940	200	10	dose	dose	NOUN
bjp-29940	200	11	might	might	AUX
bjp-29940	200	12	provide	provide	VERB
bjp-29940	200	13	higher	high	ADJ
bjp-29940	200	14	svr	svr	PROPN
bjp-29940	200	15	rates	rate	NOUN
bjp-29940	200	16	in	in	ADP
bjp-29940	200	17	patients	patient	NOUN
bjp-29940	200	18	with	with	ADP
bjp-29940	200	19	insufficient	insufficient	ADJ
bjp-29940	200	20	response	response	NOUN
bjp-29940	200	21	to	to	ADP
bjp-29940	200	22	other	other	ADJ
bjp-29940	200	23	regimens	regimen	NOUN
bjp-29940	200	24	such	such	ADJ
bjp-29940	200	25	as	as	ADP
bjp-29940	200	26	patients	patient	NOUN
bjp-29940	200	27	with	with	ADP
bjp-29940	200	28	cirrhosis	cirrhosis	NOUN
bjp-29940	200	29	,	,	PUNCT
bjp-29940	200	30	those	those	PRON
bjp-29940	200	31	with	with	ADP
bjp-29940	200	32	an	an	DET
bjp-29940	200	33	initially	initially	ADV
bjp-29940	200	34	high	high	ADJ
bjp-29940	200	35	viral	viral	ADJ
bjp-29940	200	36	load	load	NOUN
bjp-29940	200	37	,	,	PUNCT
bjp-29940	200	38	and	and	CCONJ
bjp-29940	200	39	resistant	resistant	ADJ
bjp-29940	200	40	polymorphism	polymorphism	NOUN
bjp-29940	200	41	substitutions	substitution	NOUN
bjp-29940	200	42	(	(	PUNCT
bjp-29940	200	43	chan	chan	PROPN
bjp-29940	200	44	et	et	PROPN
bjp-29940	200	45	al	al	PROPN
bjp-29940	200	46	.	.	PROPN
bjp-29940	200	47	,	,	PUNCT
bjp-29940	200	48	2012	2012	NUM
bjp-29940	200	49	)	)	PUNCT
bjp-29940	200	50	.	.	PUNCT
bjp-29940	201	1	comparison	comparison	NOUN
bjp-29940	201	2	to	to	ADP
bjp-29940	201	3	other	other	ADJ
bjp-29940	201	4	regimens	regimen	NOUN
bjp-29940	201	5	although	although	SCONJ
bjp-29940	201	6	daclatasvir	daclatasvir	PROPN
bjp-29940	201	7	plus	plus	CCONJ
bjp-29940	201	8	peg	peg	NOUN
bjp-29940	201	9	-	-	PUNCT
bjp-29940	201	10	ifn	ifn	NOUN
bjp-29940	201	11	/	/	SYM
bjp-29940	201	12	rbv	rbv	NOUN
bjp-29940	201	13	regimen	regimen	NOUN
bjp-29940	201	14	achieved	achieve	VERB
bjp-29940	201	15	higher	high	ADJ
bjp-29940	201	16	svr	svr	PROPN
bjp-29940	201	17	rates	rate	NOUN
bjp-29940	201	18	than	than	ADP
bjp-29940	201	19	the	the	DET
bjp-29940	201	20	dual	dual	ADJ
bjp-29940	201	21	regimen	regiman	NOUN
bjp-29940	201	22	,	,	PUNCT
bjp-29940	201	23	it	it	PRON
bjp-29940	201	24	showed	show	VERB
bjp-29940	201	25	moderate	moderate	ADJ
bjp-29940	201	26	svr	svr	PROPN
bjp-29940	201	27	rates	rate	NOUN
bjp-29940	201	28	of	of	ADP
bjp-29940	201	29	76	76	NUM
bjp-29940	201	30	%	%	NOUN
bjp-29940	201	31	after	after	ADP
bjp-29940	201	32	12	12	NUM
bjp-29940	201	33	weeks	week	NOUN
bjp-29940	201	34	and	and	CCONJ
bjp-29940	201	35	79	79	NUM
bjp-29940	201	36	%	%	NOUN
bjp-29940	201	37	after	after	ADP
bjp-29940	201	38	24	24	NUM
bjp-29940	201	39	weeks	week	NOUN
bjp-29940	201	40	.	.	PUNCT
bjp-29940	202	1	in	in	ADP
bjp-29940	202	2	a	a	DET
bjp-29940	202	3	previous	previous	ADJ
bjp-29940	202	4	study	study	NOUN
bjp-29940	202	5	,	,	PUNCT
bjp-29940	202	6	genotype	genotype	NOUN
bjp-29940	202	7	4	4	NUM
bjp-29940	202	8	patients	patient	NOUN
bjp-29940	202	9	treated	treat	VERB
bjp-29940	202	10	with	with	ADP
bjp-29940	202	11	a	a	DET
bjp-29940	202	12	combination	combination	NOUN
bjp-29940	202	13	of	of	ADP
bjp-29940	202	14	sofosbuvir	sofosbuvir	NOUN
bjp-29940	202	15	and	and	CCONJ
bjp-29940	202	16	figure	figure	VERB
bjp-29940	202	17	2	2	NUM
bjp-29940	202	18	:	:	PUNCT
bjp-29940	202	19	forest	forest	NOUN
bjp-29940	202	20	plots	plot	NOUN
bjp-29940	202	21	comparing	compare	VERB
bjp-29940	202	22	the	the	DET
bjp-29940	202	23	dual	dual	ADJ
bjp-29940	202	24	and	and	CCONJ
bjp-29940	202	25	triple	triple	ADJ
bjp-29940	202	26	regimens	regimen	NOUN
bjp-29940	202	27	in	in	ADP
bjp-29940	202	28	terms	term	NOUN
bjp-29940	202	29	of	of	ADP
bjp-29940	202	30	svr	svr	PROPN
bjp-29940	202	31	at	at	ADP
bjp-29940	202	32	24	24	NUM
bjp-29940	202	33	weeks	week	NOUN
bjp-29940	202	34	(	(	PUNCT
bjp-29940	202	35	a	a	NOUN
bjp-29940	202	36	)	)	PUNCT
bjp-29940	202	37	and	and	CCONJ
bjp-29940	202	38	24	24	NUM
bjp-29940	202	39	weeks	week	NOUN
bjp-29940	202	40	(	(	PUNCT
bjp-29940	202	41	b	b	NOUN
bjp-29940	202	42	)	)	PUNCT
bjp-29940	202	43	a	a	DET
bjp-29940	202	44	b	b	PROPN
bjp-29940	202	45	bangladesh	bangladesh	NOUN
bjp-29940	202	46	j	j	PROPN
bjp-29940	202	47	pharmacol	pharmacol	PROPN
bjp-29940	202	48	2017	2017	NUM
bjp-29940	202	49	;	;	PUNCT
bjp-29940	202	50	12	12	NUM
bjp-29940	202	51	:	:	SYM
bjp-29940	202	52	12	12	NUM
bjp-29940	202	53	-	-	SYM
bjp-29940	202	54	22	22	NUM
bjp-29940	202	55	17	17	NUM
bjp-29940	202	56	peg	peg	NOUN
bjp-29940	202	57	-	-	PUNCT
bjp-29940	202	58	ifn	ifn	NOUN
bjp-29940	202	59	/	/	SYM
bjp-29940	202	60	rbv	rbv	NOUN
bjp-29940	202	61	achieved	achieve	VERB
bjp-29940	202	62	a	a	DET
bjp-29940	202	63	svr	svr	PROPN
bjp-29940	202	64	rate	rate	NOUN
bjp-29940	202	65	of	of	ADP
bjp-29940	202	66	96	96	NUM
bjp-29940	202	67	%	%	NOUN
bjp-29940	202	68	.	.	PUNCT
bjp-29940	203	1	in	in	ADP
bjp-29940	203	2	another	another	DET
bjp-29940	203	3	study	study	NOUN
bjp-29940	203	4	,	,	PUNCT
bjp-29940	203	5	genotype	genotype	NOUN
bjp-29940	203	6	4	4	NUM
bjp-29940	203	7	patients	patient	NOUN
bjp-29940	203	8	treated	treat	VERB
bjp-29940	203	9	with	with	ADP
bjp-29940	203	10	simeprevir	simeprevir	NOUN
bjp-29940	203	11	plus	plus	CCONJ
bjp-29940	203	12	peg	peg	NOUN
bjp-29940	203	13	-	-	PUNCT
bjp-29940	203	14	ifn	ifn	NOUN
bjp-29940	203	15	/	/	SYM
bjp-29940	203	16	rbv	rbv	NOUN
bjp-29940	203	17	achieved	achieve	VERB
bjp-29940	203	18	a	a	DET
bjp-29940	203	19	svr	svr	PROPN
bjp-29940	203	20	rate	rate	NOUN
bjp-29940	203	21	of	of	ADP
bjp-29940	203	22	83	83	NUM
bjp-29940	203	23	%	%	NOUN
bjp-29940	203	24	(	(	PUNCT
bjp-29940	203	25	lawitz	lawitz	PROPN
bjp-29940	203	26	et	et	PROPN
bjp-29940	203	27	al	al	PROPN
bjp-29940	203	28	.	.	PROPN
bjp-29940	203	29	,	,	PUNCT
bjp-29940	203	30	2013	2013	NUM
bjp-29940	203	31	;	;	PUNCT
bjp-29940	203	32	moreno	moreno	PROPN
bjp-29940	203	33	et	et	PROPN
bjp-29940	203	34	al	al	PROPN
bjp-29940	203	35	.	.	PROPN
bjp-29940	203	36	,	,	PUNCT
bjp-29940	203	37	2014	2014	NUM
bjp-29940	203	38	)	)	PUNCT
bjp-29940	203	39	.	.	PUNCT
bjp-29940	204	1	in	in	ADP
bjp-29940	204	2	comparison	comparison	NOUN
bjp-29940	204	3	to	to	ADP
bjp-29940	204	4	these	these	DET
bjp-29940	204	5	regimens	regimen	NOUN
bjp-29940	204	6	,	,	PUNCT
bjp-29940	204	7	the	the	DET
bjp-29940	204	8	daclatasvir	daclatasvir	PROPN
bjp-29940	204	9	plus	plus	CCONJ
bjp-29940	204	10	peg	peg	NOUN
bjp-29940	204	11	-	-	PUNCT
bjp-29940	204	12	ifn	ifn	NOUN
bjp-29940	204	13	/	/	SYM
bjp-29940	204	14	rbv	rbv	NOUN
bjp-29940	204	15	regimen	regimen	NOUN
bjp-29940	204	16	is	be	AUX
bjp-29940	204	17	not	not	PART
bjp-29940	204	18	strongly	strongly	ADV
bjp-29940	204	19	recommended	recommend	VERB
bjp-29940	204	20	for	for	ADP
bjp-29940	204	21	treatment	treatment	NOUN
bjp-29940	204	22	of	of	ADP
bjp-29940	204	23	hcv	hcv	NOUN
bjp-29940	204	24	genotype	genotype	NOUN
bjp-29940	204	25	4	4	NUM
bjp-29940	204	26	patients	patient	NOUN
bjp-29940	204	27	.	.	PUNCT
bjp-29940	205	1	however	however	ADV
bjp-29940	205	2	,	,	PUNCT
bjp-29940	205	3	the	the	DET
bjp-29940	205	4	evidence	evidence	NOUN
bjp-29940	205	5	is	be	AUX
bjp-29940	205	6	insufficient	insufficient	ADJ
bjp-29940	205	7	and	and	CCONJ
bjp-29940	205	8	further	further	ADJ
bjp-29940	205	9	trials	trial	NOUN
bjp-29940	205	10	are	be	AUX
bjp-29940	205	11	required	require	VERB
bjp-29940	205	12	to	to	PART
bjp-29940	205	13	investigate	investigate	VERB
bjp-29940	205	14	the	the	DET
bjp-29940	205	15	efficacy	efficacy	NOUN
bjp-29940	205	16	of	of	ADP
bjp-29940	205	17	this	this	DET
bjp-29940	205	18	regimen	regimen	NOUN
bjp-29940	205	19	in	in	ADP
bjp-29940	205	20	hcv	hcv	PROPN
bjp-29940	205	21	genotype	genotype	NOUN
bjp-29940	205	22	4	4	NUM
bjp-29940	205	23	patients	patient	NOUN
bjp-29940	205	24	.	.	PUNCT
bjp-29940	206	1	recent	recent	ADJ
bjp-29940	206	2	data	datum	NOUN
bjp-29940	206	3	in	in	ADP
bjp-29940	206	4	the	the	DET
bjp-29940	206	5	literature	literature	NOUN
bjp-29940	206	6	suggests	suggest	VERB
bjp-29940	206	7	that	that	SCONJ
bjp-29940	206	8	most	most	ADJ
bjp-29940	206	9	oral	oral	ADJ
bjp-29940	206	10	combinations	combination	NOUN
bjp-29940	206	11	of	of	ADP
bjp-29940	206	12	direct	direct	ADJ
bjp-29940	206	13	antiviral	antiviral	ADJ
bjp-29940	206	14	agents	agent	NOUN
bjp-29940	206	15	provide	provide	VERB
bjp-29940	206	16	high	high	ADJ
bjp-29940	206	17	svr	svr	NOUN
bjp-29940	206	18	rates	rate	NOUN
bjp-29940	206	19	with	with	ADP
bjp-29940	206	20	shorter	short	ADJ
bjp-29940	206	21	treatment	treatment	NOUN
bjp-29940	206	22	duration	duration	NOUN
bjp-29940	206	23	,	,	PUNCT
bjp-29940	206	24	excellent	excellent	ADJ
bjp-29940	206	25	tolerability	tolerability	NOUN
bjp-29940	206	26	,	,	PUNCT
bjp-29940	206	27	and	and	CCONJ
bjp-29940	206	28	low	low	ADJ
bjp-29940	206	29	rates	rate	NOUN
bjp-29940	206	30	of	of	ADP
bjp-29940	206	31	virological	virological	ADJ
bjp-29940	206	32	relapse	relapse	NOUN
bjp-29940	206	33	.	.	PUNCT
bjp-29940	207	1	fortunately	fortunately	ADV
bjp-29940	207	2	,	,	PUNCT
bjp-29940	207	3	most	most	ADJ
bjp-29940	207	4	of	of	ADP
bjp-29940	207	5	these	these	DET
bjp-29940	207	6	combinations	combination	NOUN
bjp-29940	207	7	allow	allow	VERB
bjp-29940	207	8	for	for	ADP
bjp-29940	207	9	an	an	DET
bjp-29940	207	10	interferon	interferon	ADJ
bjp-29940	207	11	-	-	PUNCT
bjp-29940	207	12	free	free	ADJ
bjp-29940	207	13	treatment	treatment	NOUN
bjp-29940	207	14	regimen	regiman	NOUN
bjp-29940	207	15	and	and	CCONJ
bjp-29940	207	16	therefore	therefore	ADV
bjp-29940	207	17	,	,	PUNCT
bjp-29940	207	18	less	less	ADJ
bjp-29940	207	19	complications	complication	NOUN
bjp-29940	207	20	(	(	PUNCT
bjp-29940	207	21	everson	everson	PROPN
bjp-29940	207	22	et	et	PROPN
bjp-29940	207	23	al	al	PROPN
bjp-29940	207	24	.	.	PROPN
bjp-29940	207	25	,	,	PUNCT
bjp-29940	207	26	2014	2014	NUM
bjp-29940	207	27	;	;	PUNCT
bjp-29940	207	28	hassanein	hassanein	PROPN
bjp-29940	207	29	et	et	PROPN
bjp-29940	207	30	al	al	PROPN
bjp-29940	207	31	.	.	PROPN
bjp-29940	207	32	,	,	PUNCT
bjp-29940	207	33	2014	2014	NUM
bjp-29940	207	34	;	;	PUNCT
bjp-29940	207	35	kumada	kumada	PROPN
bjp-29940	207	36	et	et	PROPN
bjp-29940	207	37	al	al	PROPN
bjp-29940	207	38	.	.	PROPN
bjp-29940	207	39	,	,	PUNCT
bjp-29940	207	40	2014	2014	NUM
bjp-29940	207	41	;	;	PUNCT
bjp-29940	208	1	suzuki	suzuki	PROPN
bjp-29940	208	2	et	et	PROPN
bjp-29940	208	3	al	al	PROPN
bjp-29940	208	4	.	.	PROPN
bjp-29940	208	5	,	,	PUNCT
bjp-29940	208	6	2013	2013	NUM
bjp-29940	208	7	)	)	PUNCT
bjp-29940	208	8	.	.	PUNCT
bjp-29940	209	1	combining	combine	VERB
bjp-29940	209	2	daclatasvir	daclatasvir	NOUN
bjp-29940	209	3	with	with	ADP
bjp-29940	209	4	other	other	ADJ
bjp-29940	209	5	direct	direct	ADJ
bjp-29940	209	6	antiviral	antiviral	ADJ
bjp-29940	209	7	agents	agent	NOUN
bjp-29940	209	8	such	such	ADJ
bjp-29940	209	9	as	as	ADP
bjp-29940	209	10	asunaprevir	asunaprevir	PROPN
bjp-29940	209	11	,	,	PUNCT
bjp-29940	209	12	sofosbuvir	sofosbuvir	PROPN
bjp-29940	209	13	or	or	CCONJ
bjp-29940	209	14	bms-791325	bms-791325	NOUN
bjp-29940	209	15	have	have	AUX
bjp-29940	209	16	shown	show	VERB
bjp-29940	209	17	a	a	DET
bjp-29940	209	18	high	high	ADJ
bjp-29940	209	19	svr	svr	NOUN
bjp-29940	209	20	-	-	PUNCT
bjp-29940	209	21	up	up	NOUN
bjp-29940	209	22	to	to	ADP
bjp-29940	209	23	100%-in	100%-in	NUM
bjp-29940	209	24	treatment	treatment	NOUN
bjp-29940	209	25	naïve	naïve	ADJ
bjp-29940	209	26	genotype	genotype	NOUN
bjp-29940	209	27	1	1	NUM
bjp-29940	209	28	and	and	CCONJ
bjp-29940	209	29	2	2	NUM
bjp-29940	209	30	patients	patient	NOUN
bjp-29940	209	31	(	(	PUNCT
bjp-29940	209	32	everson	everson	NOUN
bjp-29940	209	33	et	et	PROPN
bjp-29940	209	34	al	al	PROPN
bjp-29940	209	35	.	.	PROPN
bjp-29940	209	36	,	,	PUNCT
bjp-29940	209	37	2014	2014	NUM
bjp-29940	209	38	;	;	PUNCT
bjp-29940	209	39	sulkowski	sulkowski	PROPN
bjp-29940	209	40	et	et	PROPN
bjp-29940	209	41	al	al	PROPN
bjp-29940	209	42	.	.	PROPN
bjp-29940	209	43	,	,	PUNCT
bjp-29940	209	44	2014	2014	NUM
bjp-29940	209	45	)	)	PUNCT
bjp-29940	209	46	.	.	PUNCT
bjp-29940	210	1	a	a	DET
bjp-29940	210	2	recent	recent	ADJ
bjp-29940	210	3	meta	meta	ADJ
bjp-29940	210	4	-	-	PUNCT
bjp-29940	210	5	analysis	analysis	NOUN
bjp-29940	210	6	has	have	AUX
bjp-29940	210	7	shown	show	VERB
bjp-29940	210	8	that	that	SCONJ
bjp-29940	210	9	combining	combine	VERB
bjp-29940	210	10	daclatasvir	daclatasvir	NOUN
bjp-29940	210	11	and	and	CCONJ
bjp-29940	210	12	sofosbuvir	sofosbuvir	PROPN
bjp-29940	210	13	achieved	achieve	VERB
bjp-29940	210	14	a	a	DET
bjp-29940	210	15	svr	svr	PROPN
bjp-29940	210	16	rate	rate	NOUN
bjp-29940	210	17	of	of	ADP
bjp-29940	210	18	88.8	88.8	NUM
bjp-29940	210	19	%	%	NOUN
bjp-29940	210	20	at	at	ADP
bjp-29940	210	21	12	12	NUM
bjp-29940	210	22	weeks	week	NOUN
bjp-29940	210	23	in	in	ADP
bjp-29940	210	24	patients	patient	NOUN
bjp-29940	210	25	infected	infect	VERB
bjp-29940	210	26	with	with	ADP
bjp-29940	210	27	genotype	genotype	NOUN
bjp-29940	210	28	3	3	NUM
bjp-29940	210	29	hcv	hcv	NOUN
bjp-29940	210	30	(	(	PUNCT
bjp-29940	210	31	swallow	swallow	NOUN
bjp-29940	210	32	et	et	PROPN
bjp-29940	210	33	al	al	PROPN
bjp-29940	210	34	.	.	PROPN
bjp-29940	210	35	,	,	PUNCT
bjp-29940	210	36	2015	2015	NUM
bjp-29940	210	37	)	)	PUNCT
bjp-29940	210	38	.	.	PUNCT
bjp-29940	211	1	sofosbuvir	sofosbuvir	PROPN
bjp-29940	211	2	plus	plus	CCONJ
bjp-29940	211	3	daclatasvir	daclatasvir	PROPN
bjp-29940	211	4	combination	combination	NOUN
bjp-29940	211	5	has	have	AUX
bjp-29940	211	6	been	be	AUX
bjp-29940	211	7	recently	recently	ADV
bjp-29940	211	8	approved	approve	VERB
bjp-29940	211	9	in	in	ADP
bjp-29940	211	10	the	the	DET
bjp-29940	211	11	us	us	PROPN
bjp-29940	211	12	and	and	CCONJ
bjp-29940	211	13	eu	eu	PROPN
bjp-29940	211	14	for	for	ADP
bjp-29940	211	15	treatment	treatment	NOUN
bjp-29940	211	16	of	of	ADP
bjp-29940	211	17	genotype	genotype	NOUN
bjp-29940	211	18	3	3	NUM
bjp-29940	211	19	(	(	PUNCT
bjp-29940	211	20	pawlotsky	pawlotsky	PROPN
bjp-29940	211	21	et	et	PROPN
bjp-29940	211	22	al	al	PROPN
bjp-29940	211	23	.	.	PROPN
bjp-29940	211	24	,	,	PUNCT
bjp-29940	211	25	2015	2015	NUM
bjp-29940	211	26	)	)	PUNCT
bjp-29940	211	27	.	.	PUNCT
bjp-29940	212	1	combining	combine	VERB
bjp-29940	212	2	daclatasvir	daclatasvir	NOUN
bjp-29940	212	3	with	with	ADP
bjp-29940	212	4	asunaprevir	asunaprevir	PROPN
bjp-29940	212	5	plus	plus	CCONJ
bjp-29940	212	6	peg	peg	NOUN
bjp-29940	212	7	-	-	PUNCT
bjp-29940	212	8	ifn	ifn	NOUN
bjp-29940	212	9	/	/	SYM
bjp-29940	212	10	rbv	rbv	NOUN
bjp-29940	212	11	achieved	achieve	VERB
bjp-29940	212	12	a	a	DET
bjp-29940	212	13	svr	svr	NOUN
bjp-29940	212	14	of	of	ADP
bjp-29940	212	15	100	100	NUM
bjp-29940	212	16	%	%	NOUN
bjp-29940	212	17	ingenotype	ingenotype	NOUN
bjp-29940	212	18	1	1	NUM
bjp-29940	212	19	and	and	CCONJ
bjp-29940	212	20	4	4	NUM
bjp-29940	212	21	non	non	NOUN
bjp-29940	212	22	-	-	NOUN
bjp-29940	212	23	responders	responder	NOUN
bjp-29940	212	24	(	(	PUNCT
bjp-29940	212	25	jensen	jensen	PROPN
bjp-29940	212	26	et	et	PROPN
bjp-29940	212	27	al	al	PROPN
bjp-29940	212	28	.	.	PROPN
bjp-29940	212	29	,	,	PUNCT
bjp-29940	212	30	2015	2015	NUM
bjp-29940	212	31	)	)	PUNCT
bjp-29940	212	32	.	.	PUNCT
bjp-29940	213	1	because	because	SCONJ
bjp-29940	213	2	late	late	ADJ
bjp-29940	213	3	relapse	relapse	NOUN
bjp-29940	213	4	is	be	AUX
bjp-29940	213	5	extremely	extremely	ADV
bjp-29940	213	6	low	low	ADJ
bjp-29940	213	7	,	,	PUNCT
bjp-29940	213	8	successful	successful	ADJ
bjp-29940	213	9	treatment	treatment	NOUN
bjp-29940	213	10	is	be	AUX
bjp-29940	213	11	usually	usually	ADV
bjp-29940	213	12	measured	measure	VERB
bjp-29940	213	13	by	by	ADP
bjp-29940	213	14	achieving	achieve	VERB
bjp-29940	213	15	a	a	DET
bjp-29940	213	16	svr	svr	NOUN
bjp-29940	213	17	at	at	ADP
bjp-29940	213	18	any	any	DET
bjp-29940	213	19	point	point	NOUN
bjp-29940	213	20	of	of	ADP
bjp-29940	213	21	treatment	treatment	NOUN
bjp-29940	213	22	(	(	PUNCT
bjp-29940	213	23	smith	smith	NOUN
bjp-29940	213	24	-	-	PUNCT
bjp-29940	213	25	palmer	palmer	PROPN
bjp-29940	213	26	et	et	PROPN
bjp-29940	213	27	al	al	PROPN
bjp-29940	213	28	.	.	PROPN
bjp-29940	213	29	,	,	PUNCT
bjp-29940	213	30	2015	2015	NUM
bjp-29940	213	31	)	)	PUNCT
bjp-29940	213	32	.	.	PUNCT
bjp-29940	214	1	longterm	longterm	PROPN
bjp-29940	214	2	follow	follow	NOUN
bjp-29940	214	3	-	-	PUNCT
bjp-29940	214	4	up	up	ADP
bjp-29940	214	5	studies	study	NOUN
bjp-29940	214	6	have	have	AUX
bjp-29940	214	7	shown	show	VERB
bjp-29940	214	8	that	that	SCONJ
bjp-29940	214	9	achieving	achieve	VERB
bjp-29940	214	10	a	a	DET
bjp-29940	214	11	svr	svr	PROPN
bjp-29940	214	12	is	be	AUX
bjp-29940	214	13	associated	associate	VERB
bjp-29940	214	14	with	with	ADP
bjp-29940	214	15	lower	low	ADJ
bjp-29940	214	16	mortality	mortality	NOUN
bjp-29940	214	17	rates	rate	NOUN
bjp-29940	214	18	and	and	CCONJ
bjp-29940	214	19	treatment	treatment	NOUN
bjp-29940	214	20	costs	cost	NOUN
bjp-29940	214	21	with	with	ADP
bjp-29940	214	22	improvement	improvement	NOUN
bjp-29940	214	23	of	of	ADP
bjp-29940	214	24	health	health	NOUN
bjp-29940	214	25	related	relate	VERB
bjp-29940	214	26	quality	quality	NOUN
bjp-29940	214	27	of	of	ADP
bjp-29940	214	28	life	life	NOUN
bjp-29940	214	29	(	(	PUNCT
bjp-29940	214	30	jafferbhoy	jafferbhoy	PROPN
bjp-29940	214	31	et	et	PROPN
bjp-29940	214	32	al	al	PROPN
bjp-29940	214	33	.	.	PROPN
bjp-29940	214	34	,	,	PUNCT
bjp-29940	214	35	2010	2010	NUM
bjp-29940	214	36	;	;	PUNCT
bjp-29940	214	37	larrey	larrey	PROPN
bjp-29940	214	38	et	et	PROPN
bjp-29940	214	39	al	al	PROPN
bjp-29940	214	40	.	.	PROPN
bjp-29940	214	41	,	,	PUNCT
bjp-29940	214	42	2014	2014	NUM
bjp-29940	214	43	)	)	PUNCT
bjp-29940	214	44	.	.	PUNCT
bjp-29940	215	1	moreover	moreover	ADV
bjp-29940	215	2	,	,	PUNCT
bjp-29940	215	3	lowering	lower	VERB
bjp-29940	215	4	the	the	DET
bjp-29940	215	5	incidence	incidence	NOUN
bjp-29940	215	6	of	of	ADP
bjp-29940	215	7	treatment	treatment	NOUN
bjp-29940	215	8	emergent	emergent	ADJ
bjp-29940	215	9	adverse	adverse	ADJ
bjp-29940	215	10	events	event	NOUN
bjp-29940	215	11	and	and	CCONJ
bjp-29940	215	12	shortening	shortening	NOUN
bjp-29940	215	13	of	of	ADP
bjp-29940	215	14	the	the	DET
bjp-29940	215	15	treatment	treatment	NOUN
bjp-29940	215	16	course	course	NOUN
bjp-29940	215	17	observed	observe	VERB
bjp-29940	215	18	within	within	ADP
bjp-29940	215	19	the	the	DET
bjp-29940	215	20	daclatasvir	daclatasvir	PROPN
bjp-29940	215	21	group	group	NOUN
bjp-29940	215	22	in	in	ADP
bjp-29940	215	23	this	this	DET
bjp-29940	215	24	study	study	NOUN
bjp-29940	215	25	positively	positively	ADV
bjp-29940	215	26	influenced	influence	VERB
bjp-29940	215	27	the	the	DET
bjp-29940	215	28	patients	patient	NOUN
bjp-29940	215	29	'	'	PART
bjp-29940	215	30	adherence	adherence	NOUN
bjp-29940	215	31	to	to	ADP
bjp-29940	215	32	treatment	treatment	NOUN
bjp-29940	215	33	.	.	PUNCT
bjp-29940	216	1	although	although	SCONJ
bjp-29940	216	2	cirrhotic	cirrhotic	ADJ
bjp-29940	216	3	patients	patient	NOUN
bjp-29940	216	4	were	be	AUX
bjp-29940	216	5	not	not	PART
bjp-29940	216	6	well	well	ADV
bjp-29940	216	7	represented	represent	VERB
bjp-29940	216	8	in	in	ADP
bjp-29940	216	9	both	both	DET
bjp-29940	216	10	included	include	VERB
bjp-29940	216	11	studies	study	NOUN
bjp-29940	216	12	,	,	PUNCT
bjp-29940	216	13	hezode	hezode	PROPN
bjp-29940	216	14	et	et	PROPN
bjp-29940	216	15	al	al	PROPN
bjp-29940	216	16	.	.	PROPN
bjp-29940	217	1	(	(	PUNCT
bjp-29940	217	2	2014	2014	NUM
bjp-29940	217	3	)	)	PUNCT
bjp-29940	217	4	reported	report	VERB
bjp-29940	217	5	that	that	SCONJ
bjp-29940	217	6	cirrhotic	cirrhotic	ADJ
bjp-29940	217	7	patients	patient	NOUN
bjp-29940	217	8	treated	treat	VERB
bjp-29940	217	9	with	with	ADP
bjp-29940	217	10	20	20	NUM
bjp-29940	217	11	and	and	CCONJ
bjp-29940	217	12	60	60	NUM
bjp-29940	217	13	mg	mg	NOUN
bjp-29940	217	14	of	of	ADP
bjp-29940	217	15	daclatasvir	daclatasvir	NOUN
bjp-29940	217	16	achieved	achieve	VERB
bjp-29940	217	17	svr	svr	PROPN
bjp-29940	217	18	rates	rate	NOUN
bjp-29940	217	19	of	of	ADP
bjp-29940	217	20	62	62	NUM
bjp-29940	217	21	and	and	CCONJ
bjp-29940	217	22	63	63	NUM
bjp-29940	217	23	%	%	NOUN
bjp-29940	217	24	respectively	respectively	ADV
bjp-29940	217	25	,	,	PUNCT
bjp-29940	217	26	in	in	ADP
bjp-29940	217	27	contrast	contrast	NOUN
bjp-29940	217	28	to	to	ADP
bjp-29940	217	29	38	38	NUM
bjp-29940	217	30	%	%	NOUN
bjp-29940	217	31	achieved	achieve	VERB
bjp-29940	217	32	by	by	ADP
bjp-29940	217	33	patients	patient	NOUN
bjp-29940	217	34	treated	treat	VERB
bjp-29940	217	35	with	with	ADP
bjp-29940	217	36	peg	peg	NOUN
bjp-29940	217	37	-	-	PUNCT
bjp-29940	217	38	ifn	ifn	NOUN
bjp-29940	217	39	/	/	SYM
bjp-29940	217	40	rbv	rbv	NOUN
bjp-29940	217	41	alone	alone	ADV
bjp-29940	217	42	(	(	PUNCT
bjp-29940	217	43	hézode	hézode	PROPN
bjp-29940	217	44	et	et	PROPN
bjp-29940	217	45	al	al	PROPN
bjp-29940	217	46	.	.	PROPN
bjp-29940	217	47	,	,	PUNCT
bjp-29940	217	48	2014	2014	NUM
bjp-29940	217	49	)	)	PUNCT
bjp-29940	217	50	.	.	PUNCT
bjp-29940	218	1	further	further	ADJ
bjp-29940	218	2	evaluation	evaluation	NOUN
bjp-29940	218	3	of	of	ADP
bjp-29940	218	4	the	the	DET
bjp-29940	218	5	efficacy	efficacy	NOUN
bjp-29940	218	6	of	of	ADP
bjp-29940	218	7	this	this	DET
bjp-29940	218	8	regimen	regimen	NOUN
bjp-29940	218	9	in	in	ADP
bjp-29940	218	10	cirrhotic	cirrhotic	ADJ
bjp-29940	218	11	population	population	NOUN
bjp-29940	218	12	is	be	AUX
bjp-29940	218	13	needed	need	VERB
bjp-29940	218	14	.	.	PUNCT
bjp-29940	219	1	different	different	ADJ
bjp-29940	219	2	genotypic	genotypic	NOUN
bjp-29940	219	3	subtypes	subtype	NOUN
bjp-29940	219	4	may	may	AUX
bjp-29940	219	5	have	have	VERB
bjp-29940	219	6	different	different	ADJ
bjp-29940	219	7	response	response	NOUN
bjp-29940	219	8	rates	rate	NOUN
bjp-29940	219	9	to	to	ADP
bjp-29940	219	10	daclatasvir	daclatasvir	PROPN
bjp-29940	219	11	treatment	treatment	PROPN
bjp-29940	219	12	.	.	PUNCT
bjp-29940	220	1	genotype	genotype	NOUN
bjp-29940	220	2	4a	4a	NOUN
bjp-29940	220	3	and	and	CCONJ
bjp-29940	220	4	4d	4d	NUM
bjp-29940	220	5	are	be	AUX
bjp-29940	220	6	the	the	DET
bjp-29940	220	7	most	most	ADV
bjp-29940	220	8	prevalent	prevalent	ADJ
bjp-29940	220	9	phenotypes	phenotype	NOUN
bjp-29940	220	10	,	,	PUNCT
bjp-29940	220	11	especially	especially	ADV
bjp-29940	220	12	in	in	ADP
bjp-29940	220	13	egypt	egypt	PROPN
bjp-29940	220	14	,	,	PUNCT
bjp-29940	220	15	europe	europe	PROPN
bjp-29940	220	16	,	,	PUNCT
bjp-29940	220	17	and	and	CCONJ
bjp-29940	220	18	saudi	saudi	PROPN
bjp-29940	220	19	arabia	arabia	PROPN
bjp-29940	220	20	(	(	PUNCT
bjp-29940	220	21	al	al	PROPN
bjp-29940	220	22	ashgar	ashgar	PROPN
bjp-29940	220	23	et	et	PROPN
bjp-29940	220	24	al	al	PROPN
bjp-29940	220	25	.	.	PROPN
bjp-29940	220	26	,	,	PUNCT
bjp-29940	220	27	2013	2013	NUM
bjp-29940	220	28	)	)	PUNCT
bjp-29940	220	29	.	.	PUNCT
bjp-29940	221	1	figure	figure	VERB
bjp-29940	221	2	3	3	NUM
bjp-29940	221	3	:	:	PUNCT
bjp-29940	221	4	forest	forest	NOUN
bjp-29940	221	5	plots	plot	NOUN
bjp-29940	221	6	comparing	compare	VERB
bjp-29940	221	7	the	the	DET
bjp-29940	221	8	dual	dual	ADJ
bjp-29940	221	9	and	and	CCONJ
bjp-29940	221	10	triple	triple	ADJ
bjp-29940	221	11	regimens	regimen	NOUN
bjp-29940	221	12	in	in	ADP
bjp-29940	221	13	terms	term	NOUN
bjp-29940	221	14	of	of	ADP
bjp-29940	221	15	relapse	relapse	NOUN
bjp-29940	221	16	rate	rate	NOUN
bjp-29940	221	17	(	(	PUNCT
bjp-29940	221	18	a	a	NOUN
bjp-29940	221	19	)	)	PUNCT
bjp-29940	221	20	and	and	CCONJ
bjp-29940	221	21	rapid	rapid	ADJ
bjp-29940	221	22	virologic	virologic	ADJ
bjp-29940	221	23	response	response	NOUN
bjp-29940	221	24	rate	rate	NOUN
bjp-29940	221	25	(	(	PUNCT
bjp-29940	221	26	b	b	NOUN
bjp-29940	221	27	)	)	PUNCT
bjp-29940	221	28	18	18	NUM
bjp-29940	221	29	bangladesh	bangladesh	NOUN
bjp-29940	221	30	j	j	PROPN
bjp-29940	221	31	pharmacol	pharmacol	PROPN
bjp-29940	221	32	2017	2017	NUM
bjp-29940	221	33	;	;	PUNCT
bjp-29940	221	34	12	12	NUM
bjp-29940	221	35	:	:	SYM
bjp-29940	221	36	12	12	NUM
bjp-29940	221	37	-	-	SYM
bjp-29940	221	38	22	22	NUM
bjp-29940	221	39	both	both	DET
bjp-29940	221	40	subtypes	subtype	NOUN
bjp-29940	221	41	were	be	AUX
bjp-29940	221	42	well	well	ADV
bjp-29940	221	43	represented	represent	VERB
bjp-29940	221	44	in	in	ADP
bjp-29940	221	45	the	the	DET
bjp-29940	221	46	included	include	VERB
bjp-29940	221	47	study	study	NOUN
bjp-29940	221	48	by	by	ADP
bjp-29940	221	49	hezode	hezode	PROPN
bjp-29940	221	50	et	et	PROPN
bjp-29940	221	51	al	al	PROPN
bjp-29940	221	52	.	.	PROPN
bjp-29940	222	1	(	(	PUNCT
bjp-29940	222	2	2015	2015	NUM
bjp-29940	222	3	)	)	PUNCT
bjp-29940	222	4	,	,	PUNCT
bjp-29940	222	5	which	which	PRON
bjp-29940	222	6	showed	show	VERB
bjp-29940	222	7	that	that	SCONJ
bjp-29940	222	8	the	the	DET
bjp-29940	222	9	triple	triple	ADJ
bjp-29940	222	10	regimen	regiman	NOUN
bjp-29940	222	11	achieved	achieve	VERB
bjp-29940	222	12	higher	high	ADJ
bjp-29940	222	13	svr	svr	PROPN
bjp-29940	222	14	rates	rate	NOUN
bjp-29940	222	15	in	in	ADP
bjp-29940	222	16	genotype	genotype	NOUN
bjp-29940	222	17	1b	1b	NUM
bjp-29940	222	18	and	and	CCONJ
bjp-29940	222	19	4	4	NUM
bjp-29940	222	20	,	,	PUNCT
bjp-29940	222	21	compared	compare	VERB
bjp-29940	222	22	to	to	ADP
bjp-29940	222	23	genotype	genotype	NOUN
bjp-29940	222	24	1a	1a	NOUN
bjp-29940	222	25	(	(	PUNCT
bjp-29940	222	26	hézode	hézode	NOUN
bjp-29940	222	27	et	et	PROPN
bjp-29940	222	28	al	al	PROPN
bjp-29940	222	29	.	.	PROPN
bjp-29940	222	30	,	,	PUNCT
bjp-29940	222	31	2015	2015	NUM
bjp-29940	222	32	)	)	PUNCT
bjp-29940	222	33	.	.	PUNCT
bjp-29940	223	1	further	further	ADJ
bjp-29940	223	2	evaluation	evaluation	NOUN
bjp-29940	223	3	of	of	ADP
bjp-29940	223	4	the	the	DET
bjp-29940	223	5	impact	impact	NOUN
bjp-29940	223	6	of	of	ADP
bjp-29940	223	7	different	different	ADJ
bjp-29940	223	8	genotypic	genotypic	NOUN
bjp-29940	223	9	subtypes	subtype	NOUN
bjp-29940	223	10	on	on	ADP
bjp-29940	223	11	virological	virological	ADJ
bjp-29940	223	12	response	response	NOUN
bjp-29940	223	13	rates	rate	NOUN
bjp-29940	223	14	to	to	ADP
bjp-29940	223	15	the	the	DET
bjp-29940	223	16	daclatasvir	daclatasvir	PROPN
bjp-29940	223	17	-	-	PUNCT
bjp-29940	223	18	containing	contain	VERB
bjp-29940	223	19	regimen	regimen	NOUN
bjp-29940	223	20	is	be	AUX
bjp-29940	223	21	required	require	VERB
bjp-29940	223	22	in	in	ADP
bjp-29940	223	23	larger	large	ADJ
bjp-29940	223	24	clinical	clinical	ADJ
bjp-29940	223	25	trials	trial	NOUN
bjp-29940	223	26	.	.	PUNCT
bjp-29940	224	1	few	few	ADJ
bjp-29940	224	2	reports	report	NOUN
bjp-29940	224	3	described	describe	VERB
bjp-29940	224	4	that	that	SCONJ
bjp-29940	224	5	ns5a	ns5a	ADJ
bjp-29940	224	6	genetic	genetic	ADJ
bjp-29940	224	7	polymorphisms	polymorphism	NOUN
bjp-29940	224	8	can	can	AUX
bjp-29940	224	9	influence	influence	VERB
bjp-29940	224	10	virological	virological	ADJ
bjp-29940	224	11	response	response	NOUN
bjp-29940	224	12	to	to	ADP
bjp-29940	224	13	daclatasvir	daclatasvir	PROPN
bjp-29940	224	14	in	in	ADP
bjp-29940	224	15	hcv	hcv	PROPN
bjp-29940	224	16	genotype	genotype	NOUN
bjp-29940	224	17	4	4	NUM
bjp-29940	224	18	patients	patient	NOUN
bjp-29940	224	19	(	(	PUNCT
bjp-29940	224	20	fridell	fridell	ADV
bjp-29940	224	21	et	et	PROPN
bjp-29940	224	22	al	al	PROPN
bjp-29940	224	23	.	.	PROPN
bjp-29940	224	24	,	,	PUNCT
bjp-29940	224	25	2011	2011	NUM
bjp-29940	224	26	;	;	PUNCT
bjp-29940	224	27	gao	gao	PROPN
bjp-29940	224	28	et	et	PROPN
bjp-29940	224	29	al	al	PROPN
bjp-29940	224	30	.	.	PROPN
bjp-29940	224	31	,	,	PUNCT
bjp-29940	224	32	2010	2010	NUM
bjp-29940	224	33	;	;	PUNCT
bjp-29940	224	34	hézode	hézode	PROPN
bjp-29940	224	35	et	et	PROPN
bjp-29940	224	36	al	al	PROPN
bjp-29940	224	37	.	.	PROPN
bjp-29940	224	38	,	,	PUNCT
bjp-29940	224	39	2014	2014	NUM
bjp-29940	224	40	;	;	PUNCT
bjp-29940	224	41	zhou	zhou	PROPN
bjp-29940	224	42	et	et	PROPN
bjp-29940	224	43	al	al	PROPN
bjp-29940	224	44	.	.	PROPN
bjp-29940	224	45	,	,	PUNCT
bjp-29940	224	46	2016	2016	NUM
bjp-29940	224	47	)	)	PUNCT
bjp-29940	224	48	.	.	PUNCT
bjp-29940	225	1	one	one	NUM
bjp-29940	225	2	hundred	hundred	NUM
bjp-29940	225	3	thirty	thirty	NUM
bjp-29940	225	4	four	four	NUM
bjp-29940	225	5	out	out	ADP
bjp-29940	225	6	of	of	ADP
bjp-29940	225	7	229	229	NUM
bjp-29940	225	8	hcv	hcv	PROPN
bjp-29940	225	9	genotype	genotype	NOUN
bjp-29940	225	10	4	4	NUM
bjp-29940	225	11	patients	patient	NOUN
bjp-29940	225	12	had	have	VERB
bjp-29940	225	13	ns5a	ns5a	ADJ
bjp-29940	225	14	polymorphisms	polymorphism	NOUN
bjp-29940	225	15	(	(	PUNCT
bjp-29940	225	16	zhou	zhou	X
bjp-29940	225	17	et	et	PROPN
bjp-29940	225	18	al	al	PROPN
bjp-29940	225	19	.	.	PROPN
bjp-29940	225	20	,	,	PUNCT
bjp-29940	225	21	2016	2016	NUM
bjp-29940	225	22	)	)	PUNCT
bjp-29940	225	23	.	.	PUNCT
bjp-29940	226	1	they	they	PRON
bjp-29940	226	2	found	find	VERB
bjp-29940	226	3	that	that	SCONJ
bjp-29940	226	4	the	the	DET
bjp-29940	226	5	most	most	ADV
bjp-29940	226	6	common	common	ADJ
bjp-29940	226	7	ns5a	ns5a	ADJ
bjp-29940	226	8	polymorphism	polymorphism	NOUN
bjp-29940	226	9	was	be	AUX
bjp-29940	226	10	l30r	l30r	ADJ
bjp-29940	226	11	substitution	substitution	NOUN
bjp-29940	226	12	,	,	PUNCT
bjp-29940	226	13	which	which	PRON
bjp-29940	226	14	is	be	AUX
bjp-29940	226	15	estimated	estimate	VERB
bjp-29940	226	16	to	to	PART
bjp-29940	226	17	decrease	decrease	VERB
bjp-29940	226	18	the	the	DET
bjp-29940	226	19	response	response	NOUN
bjp-29940	226	20	to	to	ADP
bjp-29940	226	21	daclatasvir	daclatasvir	NOUN
bjp-29940	226	22	by	by	ADP
bjp-29940	226	23	10	10	NUM
bjp-29940	226	24	folds	fold	NOUN
bjp-29940	226	25	,	,	PUNCT
bjp-29940	226	26	compared	compare	VERB
bjp-29940	226	27	to	to	ADP
bjp-29940	226	28	patients	patient	NOUN
bjp-29940	226	29	without	without	ADP
bjp-29940	226	30	this	this	DET
bjp-29940	226	31	polymorphism	polymorphism	NOUN
bjp-29940	226	32	(	(	PUNCT
bjp-29940	226	33	zhou	zhou	PROPN
bjp-29940	226	34	et	et	PROPN
bjp-29940	226	35	al	al	PROPN
bjp-29940	226	36	.	.	PROPN
bjp-29940	226	37	,	,	PUNCT
bjp-29940	226	38	2016	2016	NUM
bjp-29940	226	39	)	)	PUNCT
bjp-29940	226	40	.	.	PUNCT
bjp-29940	227	1	hezode	hezode	PROPN
bjp-29940	227	2	et	et	PROPN
bjp-29940	227	3	al	al	PROPN
bjp-29940	227	4	.	.	PROPN
bjp-29940	228	1	(	(	PUNCT
bjp-29940	228	2	2014	2014	NUM
bjp-29940	228	3	)	)	PUNCT
bjp-29940	228	4	reported	report	VERB
bjp-29940	228	5	that	that	SCONJ
bjp-29940	228	6	patients	patient	NOUN
bjp-29940	228	7	with	with	ADP
bjp-29940	228	8	cc	cc	PROPN
bjp-29940	228	9	il28b	il28b	NOUN
bjp-29940	228	10	genotype	genotype	NOUN
bjp-29940	228	11	had	have	VERB
bjp-29940	228	12	a	a	DET
bjp-29940	228	13	higher	high	ADJ
bjp-29940	228	14	chance	chance	NOUN
bjp-29940	228	15	of	of	ADP
bjp-29940	228	16	achieving	achieve	VERB
bjp-29940	228	17	svr	svr	PROPN
bjp-29940	228	18	,	,	PUNCT
bjp-29940	228	19	compared	compare	VERB
bjp-29940	228	20	to	to	ADP
bjp-29940	228	21	those	those	PRON
bjp-29940	228	22	with	with	ADP
bjp-29940	228	23	a	a	DET
bjp-29940	228	24	non	non	ADJ
bjp-29940	228	25	-	-	ADJ
bjp-29940	228	26	cc	cc	ADJ
bjp-29940	228	27	genotype	genotype	NOUN
bjp-29940	228	28	,	,	PUNCT
bjp-29940	228	29	regardless	regardless	ADV
bjp-29940	228	30	of	of	ADP
bjp-29940	228	31	therapy	therapy	NOUN
bjp-29940	228	32	(	(	PUNCT
bjp-29940	228	33	hézode	hézode	PROPN
bjp-29940	228	34	et	et	PROPN
bjp-29940	228	35	al	al	PROPN
bjp-29940	228	36	.	.	PROPN
bjp-29940	228	37	,	,	PUNCT
bjp-29940	228	38	2014	2014	NUM
bjp-29940	228	39	)	)	PUNCT
bjp-29940	228	40	.	.	PUNCT
bjp-29940	229	1	also	also	ADV
bjp-29940	229	2	,	,	PUNCT
bjp-29940	229	3	as	as	SCONJ
bjp-29940	229	4	shown	show	VERB
bjp-29940	229	5	by	by	ADP
bjp-29940	229	6	in	in	ADP
bjp-29940	229	7	vivo	vivo	NOUN
bjp-29940	229	8	and	and	CCONJ
bjp-29940	229	9	in	in	ADP
bjp-29940	229	10	vitro	vitro	X
bjp-29940	229	11	studies	study	NOUN
bjp-29940	229	12	,	,	PUNCT
bjp-29940	229	13	the	the	DET
bjp-29940	229	14	combination	combination	NOUN
bjp-29940	229	15	of	of	ADP
bjp-29940	229	16	l30	l30	ADJ
bjp-29940	229	17	polymorphism	polymorphism	NOUN
bjp-29940	229	18	and	and	CCONJ
bjp-29940	229	19	il28b	il28b	NOUN
bjp-29940	229	20	non	non	ADJ
bjp-29940	229	21	-	-	ADJ
bjp-29940	229	22	cc	cc	ADJ
bjp-29940	229	23	genotype	genotype	NOUN
bjp-29940	229	24	can	can	AUX
bjp-29940	229	25	significantly	significantly	ADV
bjp-29940	229	26	increase	increase	VERB
bjp-29940	229	27	daclatasvir	daclatasvir	PROPN
bjp-29940	229	28	resistance	resistance	NOUN
bjp-29940	229	29	(	(	PUNCT
bjp-29940	229	30	wang	wang	PROPN
bjp-29940	229	31	et	et	PROPN
bjp-29940	229	32	al	al	PROPN
bjp-29940	229	33	.	.	PROPN
bjp-29940	229	34	,	,	PUNCT
bjp-29940	229	35	2012	2012	NUM
bjp-29940	229	36	;	;	PUNCT
bjp-29940	229	37	wang	wang	PROPN
bjp-29940	229	38	et	et	PROPN
bjp-29940	229	39	al	al	PROPN
bjp-29940	229	40	.	.	PROPN
bjp-29940	229	41	,	,	PUNCT
bjp-29940	229	42	2014	2014	NUM
bjp-29940	229	43	)	)	PUNCT
bjp-29940	229	44	.	.	PUNCT
bjp-29940	230	1	although	although	SCONJ
bjp-29940	230	2	safety	safety	NOUN
bjp-29940	230	3	outcomes	outcome	NOUN
bjp-29940	230	4	of	of	ADP
bjp-29940	230	5	daclatasvir	daclatasvir	NOUN
bjp-29940	230	6	were	be	AUX
bjp-29940	230	7	not	not	PART
bjp-29940	230	8	eligible	eligible	ADJ
bjp-29940	230	9	for	for	ADP
bjp-29940	230	10	quantitative	quantitative	ADJ
bjp-29940	230	11	analysis	analysis	NOUN
bjp-29940	230	12	,	,	PUNCT
bjp-29940	230	13	both	both	PRON
bjp-29940	230	14	included	include	VERB
bjp-29940	230	15	studies	study	NOUN
bjp-29940	230	16	reported	report	VERB
bjp-29940	230	17	that	that	SCONJ
bjp-29940	230	18	adding	add	VERB
bjp-29940	230	19	daclatasvir	daclatasvir	NOUN
bjp-29940	230	20	to	to	PART
bjp-29940	230	21	peg	peg	NOUN
bjp-29940	230	22	-	-	PUNCT
bjp-29940	230	23	ifn	ifn	NOUN
bjp-29940	230	24	/	/	SYM
bjp-29940	230	25	rbv	rbv	NOUN
bjp-29940	230	26	did	do	AUX
bjp-29940	230	27	not	not	PART
bjp-29940	230	28	increase	increase	VERB
bjp-29940	230	29	the	the	DET
bjp-29940	230	30	rate	rate	NOUN
bjp-29940	230	31	of	of	ADP
bjp-29940	230	32	adverse	adverse	ADJ
bjp-29940	230	33	events	event	NOUN
bjp-29940	230	34	,	,	PUNCT
bjp-29940	230	35	compared	compare	VERB
bjp-29940	230	36	to	to	ADP
bjp-29940	230	37	the	the	DET
bjp-29940	230	38	dual	dual	ADJ
bjp-29940	230	39	regimen	regiman	NOUN
bjp-29940	230	40	.	.	PUNCT
bjp-29940	231	1	the	the	DET
bjp-29940	231	2	most	most	ADV
bjp-29940	231	3	frequently	frequently	ADV
bjp-29940	231	4	reported	report	VERB
bjp-29940	231	5	adverse	adverse	ADJ
bjp-29940	231	6	events	event	NOUN
bjp-29940	231	7	in	in	ADP
bjp-29940	231	8	both	both	DET
bjp-29940	231	9	regimens	regimen	NOUN
bjp-29940	231	10	were	be	AUX
bjp-29940	231	11	headache	headache	NOUN
bjp-29940	231	12	,	,	PUNCT
bjp-29940	231	13	fatigue	fatigue	NOUN
bjp-29940	231	14	and	and	CCONJ
bjp-29940	231	15	nausea	nausea	NOUN
bjp-29940	231	16	(	(	PUNCT
bjp-29940	231	17	hézode	hézode	PROPN
bjp-29940	231	18	et	et	PROPN
bjp-29940	231	19	al	al	PROPN
bjp-29940	231	20	.	.	PROPN
bjp-29940	231	21	,	,	PUNCT
bjp-29940	231	22	2014	2014	NUM
bjp-29940	231	23	;	;	PUNCT
bjp-29940	231	24	hézode	hézode	PROPN
bjp-29940	231	25	et	et	PROPN
bjp-29940	231	26	al	al	PROPN
bjp-29940	231	27	.	.	PROPN
bjp-29940	231	28	,	,	PUNCT
bjp-29940	231	29	2015	2015	NUM
bjp-29940	231	30	)	)	PUNCT
bjp-29940	231	31	.	.	PUNCT
bjp-29940	232	1	overall	overall	ADJ
bjp-29940	232	2	completeness	completeness	NOUN
bjp-29940	232	3	of	of	ADP
bjp-29940	232	4	evidence	evidence	NOUN
bjp-29940	232	5	of	of	ADP
bjp-29940	232	6	the	the	DET
bjp-29940	232	7	154	154	NUM
bjp-29940	232	8	patients	patient	NOUN
bjp-29940	232	9	included	include	VERB
bjp-29940	232	10	in	in	ADP
bjp-29940	232	11	this	this	DET
bjp-29940	232	12	analysis	analysis	NOUN
bjp-29940	232	13	,	,	PUNCT
bjp-29940	232	14	there	there	PRON
bjp-29940	232	15	were	be	VERB
bjp-29940	232	16	39	39	NUM
bjp-29940	232	17	discontinuations	discontinuation	NOUN
bjp-29940	232	18	(	(	PUNCT
bjp-29940	232	19	25.3	25.3	NUM
bjp-29940	232	20	%	%	NOUN
bjp-29940	232	21	)	)	PUNCT
bjp-29940	232	22	in	in	ADP
bjp-29940	232	23	the	the	DET
bjp-29940	232	24	two	two	NUM
bjp-29940	232	25	included	include	VERB
bjp-29940	232	26	trials	trial	NOUN
bjp-29940	232	27	(	(	PUNCT
bjp-29940	232	28	daclatasvir	daclatasvir	PROPN
bjp-29940	232	29	23/106	23/106	NUM
bjp-29940	232	30	and	and	CCONJ
bjp-29940	232	31	placebo	placebo	NOUN
bjp-29940	232	32	16/48	16/48	NUM
bjp-29940	232	33	)	)	PUNCT
bjp-29940	232	34	.	.	PUNCT
bjp-29940	233	1	however	however	ADV
bjp-29940	233	2	,	,	PUNCT
bjp-29940	233	3	we	we	PRON
bjp-29940	233	4	believe	believe	VERB
bjp-29940	233	5	this	this	PRON
bjp-29940	233	6	is	be	AUX
bjp-29940	233	7	unlikely	unlikely	ADJ
bjp-29940	233	8	to	to	PART
bjp-29940	233	9	affect	affect	VERB
bjp-29940	233	10	the	the	DET
bjp-29940	233	11	analysis	analysis	NOUN
bjp-29940	233	12	outcomes	outcome	NOUN
bjp-29940	233	13	because	because	SCONJ
bjp-29940	233	14	the	the	DET
bjp-29940	233	15	investigators	investigator	NOUN
bjp-29940	233	16	of	of	ADP
bjp-29940	233	17	both	both	DET
bjp-29940	233	18	studies	study	NOUN
bjp-29940	233	19	analyzed	analyze	VERB
bjp-29940	233	20	their	their	PRON
bjp-29940	233	21	data	datum	NOUN
bjp-29940	233	22	in	in	ADP
bjp-29940	233	23	an	an	DET
bjp-29940	233	24	intention	intention	NOUN
bjp-29940	233	25	to	to	PART
bjp-29940	233	26	treat	treat	VERB
bjp-29940	233	27	approach	approach	NOUN
bjp-29940	233	28	by	by	ADP
bjp-29940	233	29	considering	consider	VERB
bjp-29940	233	30	all	all	DET
bjp-29940	233	31	patients	patient	NOUN
bjp-29940	233	32	allocated	allocate	VERB
bjp-29940	233	33	to	to	PART
bjp-29940	233	34	study	study	VERB
bjp-29940	233	35	arms	arm	NOUN
bjp-29940	233	36	,	,	PUNCT
bjp-29940	233	37	regardless	regardless	ADV
bjp-29940	233	38	of	of	ADP
bjp-29940	233	39	any	any	DET
bjp-29940	233	40	discontinuation	discontinuation	NOUN
bjp-29940	233	41	following	follow	VERB
bjp-29940	233	42	randomization	randomization	NOUN
bjp-29940	233	43	strength	strength	NOUN
bjp-29940	233	44	points	point	VERB
bjp-29940	233	45	both	both	DET
bjp-29940	233	46	studies	study	NOUN
bjp-29940	233	47	included	include	VERB
bjp-29940	233	48	in	in	ADP
bjp-29940	233	49	this	this	DET
bjp-29940	233	50	analysis	analysis	NOUN
bjp-29940	233	51	were	be	AUX
bjp-29940	233	52	of	of	ADP
bjp-29940	233	53	low	low	ADJ
bjp-29940	233	54	risk	risk	NOUN
bjp-29940	233	55	of	of	ADP
bjp-29940	233	56	bias	bias	NOUN
bjp-29940	233	57	as	as	SCONJ
bjp-29940	233	58	indicated	indicate	VERB
bjp-29940	233	59	by	by	ADP
bjp-29940	233	60	cochrane	cochrane	NOUN
bjp-29940	233	61	risk	risk	NOUN
bjp-29940	233	62	of	of	ADP
bjp-29940	233	63	bias	bias	NOUN
bjp-29940	233	64	assessment	assessment	NOUN
bjp-29940	233	65	tool	tool	NOUN
bjp-29940	233	66	.	.	PUNCT
bjp-29940	234	1	we	we	PRON
bjp-29940	234	2	followed	follow	VERB
bjp-29940	234	3	the	the	DET
bjp-29940	234	4	prisma	prisma	NOUN
bjp-29940	234	5	statement	statement	NOUN
bjp-29940	234	6	guidelines	guideline	NOUN
bjp-29940	234	7	during	during	ADP
bjp-29940	234	8	preparation	preparation	NOUN
bjp-29940	234	9	and	and	CCONJ
bjp-29940	234	10	reporting	reporting	NOUN
bjp-29940	234	11	of	of	ADP
bjp-29940	234	12	this	this	DET
bjp-29940	234	13	meta	meta	ADJ
bjp-29940	234	14	-	-	PUNCT
bjp-29940	234	15	analysis	analysis	NOUN
bjp-29940	234	16	and	and	CCONJ
bjp-29940	234	17	conducted	conduct	VERB
bjp-29940	234	18	all	all	DET
bjp-29940	234	19	steps	step	NOUN
bjp-29940	234	20	in	in	ADP
bjp-29940	234	21	accordance	accordance	NOUN
bjp-29940	234	22	to	to	ADP
bjp-29940	234	23	cochrane	cochrane	PROPN
bjp-29940	234	24	handbook	handbook	NOUN
bjp-29940	234	25	of	of	ADP
bjp-29940	234	26	systematic	systematic	ADJ
bjp-29940	234	27	reviews	review	NOUN
bjp-29940	234	28	of	of	ADP
bjp-29940	234	29	interventions	intervention	NOUN
bjp-29940	234	30	.	.	PUNCT
bjp-29940	235	1	we	we	PRON
bjp-29940	235	2	also	also	ADV
bjp-29940	235	3	conducted	conduct	VERB
bjp-29940	235	4	a	a	DET
bjp-29940	235	5	subgroup	subgroup	NOUN
bjp-29940	235	6	analysis	analysis	NOUN
bjp-29940	235	7	to	to	PART
bjp-29940	235	8	evaluate	evaluate	VERB
bjp-29940	235	9	the	the	DET
bjp-29940	235	10	effect	effect	NOUN
bjp-29940	235	11	of	of	ADP
bjp-29940	235	12	daclatasvir	daclatasvir	PROPN
bjp-29940	235	13	dose	dose	VERB
bjp-29940	235	14	on	on	ADP
bjp-29940	235	15	the	the	DET
bjp-29940	235	16	patients	patient	NOUN
bjp-29940	235	17	'	'	PART
bjp-29940	235	18	response	response	NOUN
bjp-29940	235	19	.	.	PUNCT
bjp-29940	236	1	figure	figure	VERB
bjp-29940	236	2	4	4	NUM
bjp-29940	236	3	:	:	PUNCT
bjp-29940	236	4	forest	forest	NOUN
bjp-29940	236	5	plots	plot	NOUN
bjp-29940	236	6	comparing	compare	VERB
bjp-29940	236	7	the	the	DET
bjp-29940	236	8	dual	dual	ADJ
bjp-29940	236	9	and	and	CCONJ
bjp-29940	236	10	triple	triple	ADJ
bjp-29940	236	11	regimens	regimen	NOUN
bjp-29940	236	12	in	in	ADP
bjp-29940	236	13	terms	term	NOUN
bjp-29940	236	14	of	of	ADP
bjp-29940	236	15	extended	extended	ADJ
bjp-29940	236	16	rapid	rapid	ADJ
bjp-29940	236	17	virologic	virologic	ADJ
bjp-29940	236	18	response	response	NOUN
bjp-29940	236	19	rate	rate	NOUN
bjp-29940	236	20	(	(	PUNCT
bjp-29940	236	21	a	a	NOUN
bjp-29940	236	22	)	)	PUNCT
bjp-29940	236	23	and	and	CCONJ
bjp-29940	236	24	complete	complete	VERB
bjp-29940	236	25	early	early	ADJ
bjp-29940	236	26	virologic	virologic	ADJ
bjp-29940	236	27	response	response	NOUN
bjp-29940	236	28	rate	rate	NOUN
bjp-29940	236	29	(	(	PUNCT
bjp-29940	236	30	b	b	NOUN
bjp-29940	236	31	)	)	PUNCT
bjp-29940	236	32	bangladesh	bangladesh	NOUN
bjp-29940	236	33	j	j	PROPN
bjp-29940	236	34	pharmacol	pharmacol	PROPN
bjp-29940	236	35	2017	2017	NUM
bjp-29940	236	36	;	;	PUNCT
bjp-29940	236	37	12	12	NUM
bjp-29940	236	38	:	:	SYM
bjp-29940	236	39	12	12	NUM
bjp-29940	236	40	-	-	SYM
bjp-29940	236	41	22	22	NUM
bjp-29940	236	42	19	19	NUM
bjp-29940	236	43	limitations	limitation	NOUN
bjp-29940	236	44	the	the	DET
bjp-29940	236	45	relatively	relatively	ADV
bjp-29940	236	46	small	small	ADJ
bjp-29940	236	47	number	number	NOUN
bjp-29940	236	48	of	of	ADP
bjp-29940	236	49	available	available	ADJ
bjp-29940	236	50	studies	study	NOUN
bjp-29940	236	51	discussing	discuss	VERB
bjp-29940	236	52	our	our	PRON
bjp-29940	236	53	objective	objective	ADJ
bjp-29940	236	54	limits	limit	NOUN
bjp-29940	236	55	the	the	DET
bjp-29940	236	56	generalizability	generalizability	NOUN
bjp-29940	236	57	of	of	ADP
bjp-29940	236	58	our	our	PRON
bjp-29940	236	59	findings	finding	NOUN
bjp-29940	236	60	.	.	PUNCT
bjp-29940	237	1	both	both	PRON
bjp-29940	237	2	included	include	VERB
bjp-29940	237	3	studies	study	NOUN
bjp-29940	237	4	enrolled	enrol	VERB
bjp-29940	237	5	only	only	ADV
bjp-29940	237	6	treatment	treatment	NOUN
bjp-29940	237	7	naïve	naïve	ADJ
bjp-29940	237	8	patients	patient	NOUN
bjp-29940	237	9	.	.	PUNCT
bjp-29940	238	1	future	future	ADJ
bjp-29940	238	2	studies	study	NOUN
bjp-29940	238	3	should	should	AUX
bjp-29940	238	4	evaluate	evaluate	VERB
bjp-29940	238	5	the	the	DET
bjp-29940	238	6	efficacy	efficacy	NOUN
bjp-29940	238	7	of	of	ADP
bjp-29940	238	8	the	the	DET
bjp-29940	238	9	same	same	ADJ
bjp-29940	238	10	regimen	regiman	NOUN
bjp-29940	238	11	in	in	ADP
bjp-29940	238	12	partial	partial	ADJ
bjp-29940	238	13	or	or	CCONJ
bjp-29940	238	14	null	null	ADJ
bjp-29940	238	15	responders	responder	NOUN
bjp-29940	238	16	.	.	PUNCT
bjp-29940	239	1	conclusion	conclusion	VERB
bjp-29940	239	2	the	the	DET
bjp-29940	239	3	present	present	ADJ
bjp-29940	239	4	meta	meta	ADJ
bjp-29940	239	5	-	-	PUNCT
bjp-29940	239	6	analysis	analysis	NOUN
bjp-29940	239	7	shows	show	VERB
bjp-29940	239	8	that	that	SCONJ
bjp-29940	239	9	the	the	DET
bjp-29940	239	10	triple	triple	ADJ
bjp-29940	239	11	regimen	regiman	NOUN
bjp-29940	239	12	of	of	ADP
bjp-29940	239	13	daclatasvir	daclatasvir	NOUN
bjp-29940	239	14	plus	plus	CCONJ
bjp-29940	239	15	peg	peg	NOUN
bjp-29940	239	16	-	-	PUNCT
bjp-29940	239	17	ifn	ifn	NOUN
bjp-29940	239	18	/	/	SYM
bjp-29940	239	19	rbv	rbv	NOUN
bjp-29940	239	20	achieved	achieve	VERB
bjp-29940	239	21	higher	high	ADJ
bjp-29940	239	22	response	response	NOUN
bjp-29940	239	23	and	and	CCONJ
bjp-29940	239	24	lower	low	ADJ
bjp-29940	239	25	relapse	relapse	NOUN
bjp-29940	239	26	rates	rate	NOUN
bjp-29940	239	27	than	than	ADP
bjp-29940	239	28	the	the	DET
bjp-29940	239	29	dual	dual	ADJ
bjp-29940	239	30	regimen	regiman	NOUN
bjp-29940	239	31	of	of	ADP
bjp-29940	239	32	peg	peg	NOUN
bjp-29940	239	33	-	-	PUNCT
bjp-29940	239	34	ifn	ifn	NOUN
bjp-29940	239	35	/	/	SYM
bjp-29940	239	36	rbv	rbv	NOUN
bjp-29940	239	37	.	.	PUNCT
bjp-29940	240	1	both	both	DET
bjp-29940	240	2	daclatasvir	daclatasvir	PROPN
bjp-29940	240	3	doses	dose	VERB
bjp-29940	240	4	(	(	PUNCT
bjp-29940	240	5	60	60	NUM
bjp-29940	240	6	mg	mg	NOUN
bjp-29940	240	7	vs	vs	ADP
bjp-29940	240	8	20	20	NUM
bjp-29940	240	9	mg	mg	NOUN
bjp-29940	240	10	)	)	PUNCT
bjp-29940	240	11	achieved	achieve	VERB
bjp-29940	240	12	similarly	similarly	ADV
bjp-29940	240	13	moderate	moderate	ADJ
bjp-29940	240	14	virological	virological	ADJ
bjp-29940	240	15	response	response	NOUN
bjp-29940	240	16	rates	rate	NOUN
bjp-29940	240	17	.	.	PUNCT
bjp-29940	241	1	however	however	ADV
bjp-29940	241	2	,	,	PUNCT
bjp-29940	241	3	the	the	DET
bjp-29940	241	4	current	current	ADJ
bjp-29940	241	5	evidence	evidence	NOUN
bjp-29940	241	6	is	be	AUX
bjp-29940	241	7	not	not	PART
bjp-29940	241	8	sufficient	sufficient	ADJ
bjp-29940	241	9	and	and	CCONJ
bjp-29940	241	10	further	far	ADV
bjp-29940	241	11	randomized	randomize	VERB
bjp-29940	241	12	controlled	control	VERB
bjp-29940	241	13	trials	trial	NOUN
bjp-29940	241	14	are	be	AUX
bjp-29940	241	15	needed	need	VERB
bjp-29940	241	16	.	.	PUNCT
bjp-29940	242	1	conflict	conflict	NOUN
bjp-29940	242	2	of	of	ADP
bjp-29940	242	3	interest	interest	NOUN
bjp-29940	242	4	all	all	DET
bjp-29940	242	5	authors	author	NOUN
bjp-29940	242	6	have	have	AUX
bjp-29940	242	7	completed	complete	VERB
bjp-29940	242	8	the	the	DET
bjp-29940	242	9	icmje	icmje	PROPN
bjp-29940	242	10	uniform	uniform	ADJ
bjp-29940	242	11	disclosure	disclosure	NOUN
bjp-29940	242	12	form	form	NOUN
bjp-29940	242	13	and	and	CCONJ
bjp-29940	242	14	declare	declare	VERB
bjp-29940	242	15	no	no	DET
bjp-29940	242	16	support	support	NOUN
bjp-29940	242	17	from	from	ADP
bjp-29940	242	18	any	any	DET
bjp-29940	242	19	organization	organization	NOUN
bjp-29940	242	20	for	for	ADP
bjp-29940	242	21	the	the	DET
bjp-29940	242	22	submitted	submit	VERB
bjp-29940	242	23	work	work	NOUN
bjp-29940	242	24	.	.	PUNCT
bjp-29940	243	1	references	reference	NOUN
bjp-29940	243	2	al	al	PROPN
bjp-29940	243	3	ashgar	ashgar	PROPN
bjp-29940	243	4	hia	hia	PROPN
bjp-29940	243	5	,	,	PUNCT
bjp-29940	243	6	khan	khan	PROPN
bjp-29940	243	7	mq	mq	PROPN
bjp-29940	243	8	,	,	PUNCT
bjp-29940	243	9	al	al	PROPN
bjp-29940	243	10	-	-	PUNCT
bjp-29940	243	11	ahdal	ahdal	PROPN
bjp-29940	243	12	m	m	PROPN
bjp-29940	243	13	,	,	PUNCT
bjp-29940	243	14	thawadi	thawadi	PROPN
bjp-29940	243	15	sa	sa	PROPN
bjp-29940	243	16	,	,	PUNCT
bjp-29940	243	17	helmy	helmy	ADV
bjp-29940	243	18	as	as	ADP
bjp-29940	243	19	,	,	PUNCT
bjp-29940	243	20	qahtani	qahtani	PROPN
bjp-29940	243	21	aa	aa	PROPN
bjp-29940	243	22	,	,	PUNCT
bjp-29940	243	23	sanai	sanai	PROPN
bjp-29940	243	24	fm	fm	PROPN
bjp-29940	243	25	.	.	PUNCT
bjp-29940	244	1	hepatitis	hepatitis	PROPN
bjp-29940	244	2	c	c	PROPN
bjp-29940	244	3	genotype	genotype	NOUN
bjp-29940	244	4	4	4	NUM
bjp-29940	244	5	:	:	PUNCT
bjp-29940	244	6	genotypic	genotypic	ADJ
bjp-29940	244	7	diversity	diversity	NOUN
bjp-29940	244	8	,	,	PUNCT
bjp-29940	244	9	epidemiological	epidemiological	ADJ
bjp-29940	244	10	profile	profile	NOUN
bjp-29940	244	11	,	,	PUNCT
bjp-29940	244	12	and	and	CCONJ
bjp-29940	244	13	clinical	clinical	ADJ
bjp-29940	244	14	relevance	relevance	NOUN
bjp-29940	244	15	of	of	ADP
bjp-29940	244	16	subtypes	subtype	NOUN
bjp-29940	244	17	in	in	ADP
bjp-29940	244	18	saudi	saudi	PROPN
bjp-29940	244	19	arabia	arabia	PROPN
bjp-29940	244	20	.	.	PUNCT
bjp-29940	245	1	saudi	saudi	PROPN
bjp-29940	245	2	j	j	PROPN
bjp-29940	245	3	gastroenterol	gastroenterol	PROPN
bjp-29940	245	4	.	.	PUNCT
bjp-29940	246	1	2013	2013	NUM
bjp-29940	246	2	;	;	PUNCT
bjp-29940	246	3	19	19	NUM
bjp-29940	246	4	:	:	SYM
bjp-29940	246	5	28	28	NUM
bjp-29940	246	6	.	.	PUNCT
bjp-29940	247	1	armstrong	armstrong	PROPN
bjp-29940	247	2	gl	gl	PROPN
bjp-29940	247	3	,	,	PUNCT
bjp-29940	247	4	wasley	wasley	PROPN
bjp-29940	247	5	a	a	NOUN
bjp-29940	247	6	,	,	PUNCT
bjp-29940	247	7	simard	simard	PROPN
bjp-29940	247	8	ep	ep	PROPN
bjp-29940	247	9	,	,	PUNCT
bjp-29940	247	10	mcquillan	mcquillan	PROPN
bjp-29940	247	11	gm	gm	PROPN
bjp-29940	247	12	,	,	PUNCT
bjp-29940	247	13	kuhnert	kuhnert	PROPN
bjp-29940	247	14	wl	wl	PROPN
bjp-29940	247	15	,	,	PUNCT
bjp-29940	247	16	alter	alter	PROPN
bjp-29940	247	17	mj	mj	PROPN
bjp-29940	247	18	.	.	PUNCT
bjp-29940	248	1	the	the	DET
bjp-29940	248	2	prevalence	prevalence	NOUN
bjp-29940	248	3	of	of	ADP
bjp-29940	248	4	hepatitis	hepatitis	PROPN
bjp-29940	248	5	c	c	PROPN
bjp-29940	248	6	virus	virus	NOUN
bjp-29940	248	7	infection	infection	NOUN
bjp-29940	248	8	in	in	ADP
bjp-29940	248	9	the	the	DET
bjp-29940	248	10	united	united	PROPN
bjp-29940	248	11	states	states	PROPN
bjp-29940	248	12	,	,	PUNCT
bjp-29940	248	13	1999	1999	NUM
bjp-29940	248	14	through	through	ADP
bjp-29940	248	15	2002	2002	NUM
bjp-29940	248	16	.	.	PUNCT
bjp-29940	249	1	ann	ann	PROPN
bjp-29940	249	2	intern	intern	PROPN
bjp-29940	249	3	med	me	VERB
bjp-29940	249	4	.	.	PUNCT
bjp-29940	250	1	2006	2006	NUM
bjp-29940	250	2	;	;	PUNCT
bjp-29940	250	3	144	144	NUM
bjp-29940	250	4	:	:	PUNCT
bjp-29940	250	5	705	705	NUM
bjp-29940	250	6	-	-	SYM
bjp-29940	250	7	14	14	NUM
bjp-29940	250	8	.	.	PUNCT
bjp-29940	251	1	chan	chan	PROPN
bjp-29940	251	2	p	p	X
bjp-29940	251	3	,	,	PUNCT
bjp-29940	251	4	tafoya	tafoya	ADJ
bjp-29940	251	5	e	e	NOUN
bjp-29940	251	6	,	,	PUNCT
bjp-29940	251	7	bifano	bifano	NOUN
bjp-29940	251	8	m	m	NOUN
bjp-29940	251	9	,	,	PUNCT
bjp-29940	251	10	bertz	bertz	PROPN
bjp-29940	251	11	r	r	NOUN
bjp-29940	251	12	,	,	PUNCT
bjp-29940	251	13	yin	yin	NOUN
bjp-29940	251	14	p	p	X
bjp-29940	251	15	,	,	PUNCT
bjp-29940	251	16	hughes	hughes	PROPN
bjp-29940	251	17	e	e	PROPN
bjp-29940	251	18	,	,	PUNCT
bjp-29940	251	19	ahmad	ahmad	PROPN
bjp-29940	251	20	a.	a.	PROPN
bjp-29940	251	21	exposure	exposure	NOUN
bjp-29940	251	22	-	-	PUNCT
bjp-29940	251	23	response	response	NOUN
bjp-29940	251	24	analysis	analysis	NOUN
bjp-29940	251	25	of	of	ADP
bjp-29940	251	26	daclatasvir	daclatasvir	NOUN
bjp-29940	251	27	in	in	ADP
bjp-29940	251	28	patients	patient	NOUN
bjp-29940	251	29	with	with	ADP
bjp-29940	251	30	genotype	genotype	NOUN
bjp-29940	251	31	1	1	NUM
bjp-29940	251	32	chronic	chronic	ADJ
bjp-29940	251	33	hcv	hcv	NOUN
bjp-29940	251	34	infection	infection	NOUN
bjp-29940	251	35	:	:	PUNCT
bjp-29940	251	36	dose	dose	NOUN
bjp-29940	251	37	selection	selection	NOUN
bjp-29940	251	38	for	for	ADP
bjp-29940	251	39	phase	phase	NOUN
bjp-29940	251	40	3	3	NUM
bjp-29940	251	41	clinical	clinical	ADJ
bjp-29940	251	42	trials	trial	NOUN
bjp-29940	251	43	.	.	PUNCT
bjp-29940	252	1	rev	rev	PROPN
bjp-29940	252	2	antivir	antivir	PROPN
bjp-29940	252	3	ther	ther	PROPN
bjp-29940	252	4	infect	infect	VERB
bjp-29940	252	5	dis	dis	PROPN
bjp-29940	252	6	.	.	PUNCT
bjp-29940	253	1	2012	2012	NUM
bjp-29940	253	2	;	;	PUNCT
bjp-29940	253	3	6	6	NUM
bjp-29940	253	4	:	:	SYM
bjp-29940	253	5	14	14	NUM
bjp-29940	253	6	.	.	PUNCT
bjp-29940	254	1	cornberg	cornberg	PROPN
bjp-29940	254	2	m	m	PROPN
bjp-29940	254	3	,	,	PUNCT
bjp-29940	254	4	razavi	razavi	VERB
bjp-29940	254	5	ha	ha	INTJ
bjp-29940	254	6	,	,	PUNCT
bjp-29940	254	7	alberti	alberti	PROPN
bjp-29940	254	8	a	a	PROPN
bjp-29940	254	9	,	,	PUNCT
bjp-29940	254	10	bernasconi	bernasconi	PROPN
bjp-29940	254	11	e	e	PROPN
bjp-29940	254	12	,	,	PUNCT
bjp-29940	254	13	buti	buti	PROPN
bjp-29940	254	14	m	m	PROPN
bjp-29940	254	15	,	,	PUNCT
bjp-29940	254	16	cooper	cooper	PROPN
bjp-29940	254	17	c	c	PROPN
bjp-29940	254	18	,	,	PUNCT
bjp-29940	254	19	forns	forn	NOUN
bjp-29940	254	20	x.	x.	NOUN
bjp-29940	254	21	a	a	DET
bjp-29940	254	22	systematic	systematic	ADJ
bjp-29940	254	23	review	review	NOUN
bjp-29940	254	24	of	of	ADP
bjp-29940	254	25	hepatitis	hepatitis	PROPN
bjp-29940	254	26	c	c	PROPN
bjp-29940	254	27	virus	virus	PROPN
bjp-29940	254	28	epidemiology	epidemiology	NOUN
bjp-29940	254	29	in	in	ADP
bjp-29940	254	30	europe	europe	PROPN
bjp-29940	254	31	,	,	PUNCT
bjp-29940	254	32	canada	canada	PROPN
bjp-29940	254	33	and	and	CCONJ
bjp-29940	254	34	israel	israel	PROPN
bjp-29940	254	35	.	.	PUNCT
bjp-29940	255	1	liver	liver	PROPN
bjp-29940	255	2	int	int	PROPN
bjp-29940	255	3	.	.	PUNCT
bjp-29940	256	1	2011	2011	NUM
bjp-29940	256	2	;	;	PUNCT
bjp-29940	256	3	31	31	NUM
bjp-29940	256	4	:	:	SYM
bjp-29940	256	5	30	30	NUM
bjp-29940	256	6	-	-	SYM
bjp-29940	256	7	60	60	NUM
bjp-29940	256	8	.	.	PUNCT
bjp-29940	257	1	dore	dore	PROPN
bjp-29940	257	2	gj	gj	PROPN
bjp-29940	257	3	,	,	PUNCT
bjp-29940	257	4	lawitz	lawitz	PROPN
bjp-29940	257	5	e	e	NOUN
bjp-29940	257	6	,	,	PUNCT
bjp-29940	257	7	hézode	hézode	PROPN
bjp-29940	257	8	c	c	NOUN
bjp-29940	257	9	,	,	PUNCT
bjp-29940	257	10	shafran	shafran	ADJ
bjp-29940	257	11	sd	sd	NOUN
bjp-29940	257	12	,	,	PUNCT
bjp-29940	257	13	ramji	ramji	VERB
bjp-29940	257	14	a	a	DET
bjp-29940	257	15	,	,	PUNCT
bjp-29940	257	16	tatum	tatum	PROPN
bjp-29940	257	17	ha	ha	INTJ
bjp-29940	257	18	,	,	PUNCT
bjp-29940	257	19	zaltron	zaltron	PROPN
bjp-29940	257	20	s.	s.	PROPN
bjp-29940	257	21	daclatasvir	daclatasvir	PROPN
bjp-29940	257	22	plus	plus	CCONJ
bjp-29940	257	23	peginterferon	peginterferon	PROPN
bjp-29940	257	24	and	and	CCONJ
bjp-29940	257	25	ribavirin	ribavirin	NOUN
bjp-29940	257	26	is	be	AUX
bjp-29940	257	27	non	non	ADJ
bjp-29940	257	28	-	-	ADJ
bjp-29940	257	29	inferior	inferior	ADJ
bjp-29940	257	30	to	to	ADP
bjp-29940	257	31	peginterferon	peginterferon	NOUN
bjp-29940	257	32	and	and	CCONJ
bjp-29940	257	33	ribavirin	ribavirin	NOUN
bjp-29940	257	34	alone	alone	ADV
bjp-29940	257	35	,	,	PUNCT
bjp-29940	257	36	and	and	CCONJ
bjp-29940	257	37	reduces	reduce	VERB
bjp-29940	257	38	the	the	DET
bjp-29940	257	39	duration	duration	NOUN
bjp-29940	257	40	of	of	ADP
bjp-29940	257	41	treatment	treatment	NOUN
bjp-29940	257	42	for	for	ADP
bjp-29940	257	43	hcv	hcv	NOUN
bjp-29940	257	44	genotype	genotype	NOUN
bjp-29940	257	45	2	2	NUM
bjp-29940	257	46	or	or	CCONJ
bjp-29940	257	47	3	3	NUM
bjp-29940	257	48	infection	infection	NOUN
bjp-29940	257	49	.	.	PUNCT
bjp-29940	258	1	gastroenterology	gastroenterology	NOUN
bjp-29940	258	2	2015	2015	NUM
bjp-29940	258	3	;	;	PUNCT
bjp-29940	258	4	148	148	NUM
bjp-29940	258	5	:	:	SYM
bjp-29940	258	6	355	355	NUM
bjp-29940	258	7	-	-	SYM
bjp-29940	258	8	66	66	NUM
bjp-29940	258	9	.	.	PUNCT
bjp-29940	259	1	egger	egger	NOUN
bjp-29940	259	2	m	m	PROPN
bjp-29940	259	3	,	,	PUNCT
bjp-29940	259	4	smith	smith	PROPN
bjp-29940	259	5	gd	gd	PROPN
bjp-29940	259	6	,	,	PUNCT
bjp-29940	259	7	schneider	schneider	PROPN
bjp-29940	259	8	m	m	PROPN
bjp-29940	259	9	,	,	PUNCT
bjp-29940	259	10	minder	minder	PROPN
bjp-29940	259	11	c.	c.	PROPN
bjp-29940	259	12	bias	bias	PROPN
bjp-29940	259	13	in	in	ADP
bjp-29940	259	14	metaanalysis	metaanalysis	NOUN
bjp-29940	259	15	detected	detect	VERB
bjp-29940	259	16	by	by	ADP
bjp-29940	259	17	a	a	DET
bjp-29940	259	18	simple	simple	ADJ
bjp-29940	259	19	,	,	PUNCT
bjp-29940	259	20	graphical	graphical	ADJ
bjp-29940	259	21	test	test	NOUN
bjp-29940	259	22	.	.	PUNCT
bjp-29940	260	1	bmj	bmj	PROPN
bjp-29940	260	2	.	.	PUNCT
bjp-29940	260	3	1997	1997	NUM
bjp-29940	260	4	;	;	PUNCT
bjp-29940	260	5	315	315	NUM
bjp-29940	260	6	:	:	PUNCT
bjp-29940	260	7	629	629	NUM
bjp-29940	260	8	-	-	SYM
bjp-29940	260	9	34	34	NUM
bjp-29940	260	10	.	.	PUNCT
bjp-29940	261	1	everson	everson	PROPN
bjp-29940	261	2	gt	gt	PROPN
bjp-29940	261	3	,	,	PUNCT
bjp-29940	261	4	sims	sim	NOUN
bjp-29940	261	5	kd	kd	PROPN
bjp-29940	261	6	,	,	PUNCT
bjp-29940	261	7	rodriguez	rodriguez	NOUN
bjp-29940	261	8	-	-	PUNCT
bjp-29940	261	9	torres	torres	PROPN
bjp-29940	261	10	m	m	PROPN
bjp-29940	261	11	,	,	PUNCT
bjp-29940	261	12	hézode	hézode	PROPN
bjp-29940	261	13	c	c	NOUN
bjp-29940	261	14	,	,	PUNCT
bjp-29940	261	15	lawitz	lawitz	PROPN
bjp-29940	261	16	e	e	NOUN
bjp-29940	261	17	,	,	PUNCT
bjp-29940	261	18	bourlière	bourlière	PROPN
bjp-29940	261	19	m	m	PROPN
bjp-29940	261	20	,	,	PUNCT
bjp-29940	261	21	tatum	tatum	PROPN
bjp-29940	261	22	h.	h.	PROPN
bjp-29940	261	23	efficacy	efficacy	PROPN
bjp-29940	261	24	of	of	ADP
bjp-29940	261	25	an	an	DET
bjp-29940	261	26	interferon	interferon	ADJ
bjp-29940	261	27	-	-	PUNCT
bjp-29940	261	28	and	and	CCONJ
bjp-29940	261	29	ribavirin	ribavirin	NOUN
bjp-29940	261	30	-	-	PUNCT
bjp-29940	261	31	free	free	ADJ
bjp-29940	261	32	regimen	regiman	NOUN
bjp-29940	261	33	of	of	ADP
bjp-29940	261	34	daclatasvir	daclatasvir	PROPN
bjp-29940	261	35	,	,	PUNCT
bjp-29940	261	36	asunaprevir	asunaprevir	PROPN
bjp-29940	261	37	,	,	PUNCT
bjp-29940	261	38	and	and	CCONJ
bjp-29940	261	39	bms791325	bms791325	NOUN
bjp-29940	261	40	in	in	ADP
bjp-29940	261	41	treatment	treatment	NOUN
bjp-29940	261	42	-	-	PUNCT
bjp-29940	261	43	naive	naive	ADJ
bjp-29940	261	44	patients	patient	NOUN
bjp-29940	261	45	with	with	ADP
bjp-29940	261	46	hcv	hcv	NOUN
bjp-29940	261	47	genotype	genotype	NOUN
bjp-29940	261	48	1	1	NUM
bjp-29940	261	49	infection	infection	NOUN
bjp-29940	261	50	.	.	PUNCT
bjp-29940	262	1	gastroenterology	gastroenterology	NOUN
bjp-29940	262	2	2014	2014	NUM
bjp-29940	262	3	;	;	PUNCT
bjp-29940	262	4	146	146	NUM
bjp-29940	262	5	:	:	SYM
bjp-29940	262	6	420	420	NUM
bjp-29940	262	7	-	-	SYM
bjp-29940	262	8	29	29	NUM
bjp-29940	262	9	.	.	PUNCT
bjp-29940	263	1	fridell	fridell	PROPN
bjp-29940	263	2	ra	ra	PROPN
bjp-29940	263	3	,	,	PUNCT
bjp-29940	263	4	qiu	qiu	PROPN
bjp-29940	263	5	d	d	PROPN
bjp-29940	263	6	,	,	PUNCT
bjp-29940	263	7	valera	valera	PROPN
bjp-29940	263	8	l	l	PROPN
bjp-29940	263	9	,	,	PUNCT
bjp-29940	263	10	wang	wang	PROPN
bjp-29940	263	11	c	c	PROPN
bjp-29940	263	12	,	,	PUNCT
bjp-29940	263	13	rose	rise	VERB
bjp-29940	263	14	re	re	ADP
bjp-29940	263	15	,	,	PUNCT
bjp-29940	263	16	gao	gao	PROPN
bjp-29940	263	17	m.	m.	NOUN
bjp-29940	263	18	distinct	distinct	ADJ
bjp-29940	263	19	functions	function	NOUN
bjp-29940	263	20	of	of	ADP
bjp-29940	263	21	ns5a	ns5a	NOUN
bjp-29940	263	22	in	in	ADP
bjp-29940	263	23	hepatitis	hepatitis	PROPN
bjp-29940	263	24	c	c	PROPN
bjp-29940	263	25	virus	virus	NOUN
bjp-29940	263	26	rna	rna	NOUN
bjp-29940	263	27	replication	replication	NOUN
bjp-29940	263	28	uncovered	uncover	VERB
bjp-29940	263	29	by	by	ADP
bjp-29940	263	30	studies	study	NOUN
bjp-29940	263	31	with	with	ADP
bjp-29940	263	32	the	the	DET
bjp-29940	263	33	ns5a	ns5a	PROPN
bjp-29940	263	34	inhibitor	inhibitor	NOUN
bjp-29940	263	35	bms-790052	bms-790052	NOUN
bjp-29940	263	36	.	.	PUNCT
bjp-29940	264	1	j	j	PROPN
bjp-29940	264	2	virol	virol	NOUN
bjp-29940	264	3	.	.	PUNCT
bjp-29940	265	1	2011	2011	NUM
bjp-29940	265	2	;	;	PUNCT
bjp-29940	265	3	85	85	NUM
bjp-29940	265	4	:	:	PUNCT
bjp-29940	265	5	7312	7312	NUM
bjp-29940	265	6	-	-	SYM
bjp-29940	265	7	20	20	NUM
bjp-29940	265	8	.	.	PUNCT
bjp-29940	266	1	fridell	fridell	PROPN
bjp-29940	266	2	ra	ra	PROPN
bjp-29940	266	3	,	,	PUNCT
bjp-29940	266	4	wang	wang	PROPN
bjp-29940	266	5	c	c	PROPN
bjp-29940	266	6	,	,	PUNCT
bjp-29940	266	7	sun	sun	PROPN
bjp-29940	266	8	j	j	PROPN
bjp-29940	266	9	,	,	PUNCT
bjp-29940	266	10	o’boyle	o’boyle	PROPN
bjp-29940	266	11	dr	dr	PROPN
bjp-29940	266	12	,	,	PUNCT
bjp-29940	266	13	nower	nower	NOUN
bjp-29940	266	14	p	p	PROPN
bjp-29940	266	15	,	,	PUNCT
bjp-29940	266	16	valera	valera	PROPN
bjp-29940	266	17	l	l	PROPN
bjp-29940	266	18	,	,	PUNCT
bjp-29940	266	19	kienzle	kienzle	VERB
bjp-29940	266	20	b.	b.	NOUN
bjp-29940	266	21	genotypic	genotypic	NOUN
bjp-29940	266	22	and	and	CCONJ
bjp-29940	266	23	phenotypic	phenotypic	ADJ
bjp-29940	266	24	analysis	analysis	NOUN
bjp-29940	266	25	of	of	ADP
bjp-29940	266	26	variants	variant	NOUN
bjp-29940	266	27	resistant	resistant	ADJ
bjp-29940	266	28	to	to	ADP
bjp-29940	266	29	hepatitis	hepatitis	PROPN
bjp-29940	266	30	c	c	PROPN
bjp-29940	266	31	virus	virus	NOUN
bjp-29940	266	32	nonstructural	nonstructural	ADJ
bjp-29940	266	33	protein	protein	NOUN
bjp-29940	266	34	5a	5a	NUM
bjp-29940	266	35	replication	replication	NOUN
bjp-29940	266	36	complex	complex	ADJ
bjp-29940	266	37	inhibitor	inhibitor	NOUN
bjp-29940	266	38	bms‐790052	bms‐790052	NOUN
bjp-29940	266	39	in	in	ADP
bjp-29940	266	40	humans	human	NOUN
bjp-29940	266	41	:	:	PUNCT
bjp-29940	266	42	in	in	ADP
bjp-29940	266	43	vitro	vitro	X
bjp-29940	266	44	and	and	CCONJ
bjp-29940	266	45	in	in	ADP
bjp-29940	266	46	vivo	vivo	NOUN
bjp-29940	266	47	correlations	correlation	NOUN
bjp-29940	266	48	.	.	PUNCT
bjp-29940	267	1	hepatology	hepatology	NOUN
bjp-29940	267	2	2011	2011	NUM
bjp-29940	267	3	;	;	PUNCT
bjp-29940	267	4	54	54	NUM
bjp-29940	267	5	:	:	SYM
bjp-29940	267	6	1924	1924	NUM
bjp-29940	267	7	-	-	SYM
bjp-29940	267	8	35	35	NUM
bjp-29940	267	9	.	.	PUNCT
bjp-29940	268	1	gao	gao	PROPN
bjp-29940	268	2	m	m	PROPN
bjp-29940	268	3	,	,	PUNCT
bjp-29940	268	4	nettles	nettle	NOUN
bjp-29940	268	5	re	re	VERB
bjp-29940	268	6	,	,	PUNCT
bjp-29940	268	7	belema	belema	PROPN
bjp-29940	268	8	m	m	PROPN
bjp-29940	268	9	,	,	PUNCT
bjp-29940	268	10	snyder	snyder	PROPN
bjp-29940	268	11	lb	lb	PROPN
bjp-29940	268	12	,	,	PUNCT
bjp-29940	268	13	nguyen	nguyen	PROPN
bjp-29940	268	14	vn	vn	PROPN
bjp-29940	268	15	,	,	PUNCT
bjp-29940	268	16	fridell	fridell	PROPN
bjp-29940	268	17	ra	ra	PROPN
bjp-29940	268	18	,	,	PUNCT
bjp-29940	268	19	serrano	serrano	PROPN
bjp-29940	268	20	mh	mh	PROPN
bjp-29940	268	21	,	,	PUNCT
bjp-29940	268	22	wu	wu	PROPN
bjp-29940	268	23	,	,	PUNCT
bjp-29940	268	24	langley	langley	PROPN
bjp-29940	268	25	dr	dr	PROPN
bjp-29940	268	26	,	,	PUNCT
bjp-29940	268	27	jin	jin	PROPN
bjp-29940	268	28	,	,	PUNCT
bjp-29940	268	29	sun	sun	NOUN
bjp-29940	268	30	h	h	NOUN
bjp-29940	268	31	,	,	PUNCT
bjp-29940	268	32	o’boyleli	o’boyleli	PROPN
bjp-29940	268	33	dr	dr	PROPN
bjp-29940	268	34	,	,	PUNCT
bjp-29940	268	35	lemm	lemm	PROPN
bjp-29940	268	36	ja	ja	PROPN
bjp-29940	268	37	,	,	PUNCT
bjp-29940	268	38	wang	wang	PROPN
bjp-29940	268	39	c	c	PROPN
bjp-29940	268	40	,	,	PUNCT
bjp-29940	268	41	knipe	knipe	PROPN
bjp-29940	268	42	jo	jo	PROPN
bjp-29940	268	43	,	,	PUNCT
bjp-29940	268	44	chien	chien	PROPN
bjp-29940	268	45	c	c	AUX
bjp-29940	268	46	,	,	PUNCT
bjp-29940	268	47	colonno	colonno	PROPN
bjp-29940	268	48	rj	rj	PROPN
bjp-29940	268	49	,	,	PUNCT
bjp-29940	268	50	grasela	grasela	PROPN
bjp-29940	268	51	dm	dm	PROPN
bjp-29940	268	52	,	,	PUNCT
bjp-29940	268	53	meanwell	meanwell	NOUN
bjp-29940	268	54	na	na	NOUN
bjp-29940	268	55	,	,	PUNCT
bjp-29940	268	56	hamann	hamann	PROPN
bjp-29940	268	57	lg	lg	PROPN
bjp-29940	268	58	.	.	PROPN
bjp-29940	268	59	chemical	chemical	PROPN
bjp-29940	268	60	genetics	genetics	PROPN
bjp-29940	268	61	strategy	strategy	NOUN
bjp-29940	268	62	identifies	identify	VERB
bjp-29940	268	63	an	an	DET
bjp-29940	268	64	hcv	hcv	NOUN
bjp-29940	268	65	ns5a	ns5a	ADJ
bjp-29940	268	66	inhibitor	inhibitor	NOUN
bjp-29940	268	67	with	with	ADP
bjp-29940	268	68	a	a	DET
bjp-29940	268	69	potent	potent	ADJ
bjp-29940	268	70	clinical	clinical	ADJ
bjp-29940	268	71	effect	effect	NOUN
bjp-29940	268	72	.	.	PUNCT
bjp-29940	269	1	nature	nature	NOUN
bjp-29940	269	2	2010	2010	NUM
bjp-29940	269	3	;	;	PUNCT
bjp-29940	269	4	465	465	NUM
bjp-29940	269	5	:	:	PUNCT
bjp-29940	269	6	96	96	NUM
bjp-29940	269	7	-	-	SYM
bjp-29940	269	8	100	100	NUM
bjp-29940	269	9	.	.	PUNCT
bjp-29940	270	1	ghany	ghany	ADJ
bjp-29940	270	2	mg	mg	PROPN
bjp-29940	270	3	,	,	PUNCT
bjp-29940	270	4	strader	strader	PROPN
bjp-29940	270	5	db	db	PROPN
bjp-29940	270	6	,	,	PUNCT
bjp-29940	270	7	thomas	thomas	PROPN
bjp-29940	270	8	dl	dl	PROPN
bjp-29940	270	9	,	,	PUNCT
bjp-29940	270	10	seeff	seeff	PROPN
bjp-29940	270	11	lb	lb	NOUN
bjp-29940	270	12	.	.	PUNCT
bjp-29940	270	13	diagnosis	diagnosis	NOUN
bjp-29940	270	14	,	,	PUNCT
bjp-29940	270	15	management	management	NOUN
bjp-29940	270	16	,	,	PUNCT
bjp-29940	270	17	and	and	CCONJ
bjp-29940	270	18	treatment	treatment	NOUN
bjp-29940	270	19	of	of	ADP
bjp-29940	270	20	hepatitis	hepatitis	PROPN
bjp-29940	270	21	c	c	NOUN
bjp-29940	270	22	:	:	PUNCT
bjp-29940	270	23	an	an	DET
bjp-29940	270	24	update	update	NOUN
bjp-29940	270	25	.	.	PUNCT
bjp-29940	271	1	hepatology	hepatology	NOUN
bjp-29940	271	2	2009	2009	NUM
bjp-29940	271	3	;	;	PUNCT
bjp-29940	271	4	49	49	NUM
bjp-29940	271	5	:	:	PUNCT
bjp-29940	271	6	1335	1335	NUM
bjp-29940	271	7	-	-	SYM
bjp-29940	271	8	74	74	NUM
bjp-29940	271	9	.	.	PUNCT
bjp-29940	272	1	hanafiah	hanafiah	PROPN
bjp-29940	272	2	km	km	PROPN
bjp-29940	272	3	,	,	PUNCT
bjp-29940	272	4	groeger	groeger	PROPN
bjp-29940	272	5	j	j	PROPN
bjp-29940	272	6	,	,	PUNCT
bjp-29940	272	7	flaxman	flaxman	NOUN
bjp-29940	272	8	ad	ad	NOUN
bjp-29940	272	9	,	,	PUNCT
bjp-29940	272	10	wiersma	wiersma	PROPN
bjp-29940	272	11	st	st	PROPN
bjp-29940	272	12	.	.	PROPN
bjp-29940	272	13	global	global	ADJ
bjp-29940	272	14	epidemiology	epidemiology	NOUN
bjp-29940	272	15	of	of	ADP
bjp-29940	272	16	hepatitis	hepatitis	PROPN
bjp-29940	272	17	c	c	PROPN
bjp-29940	272	18	virus	virus	NOUN
bjp-29940	272	19	infection	infection	NOUN
bjp-29940	272	20	:	:	PUNCT
bjp-29940	272	21	new	new	ADJ
bjp-29940	272	22	estimates	estimate	NOUN
bjp-29940	272	23	of	of	ADP
bjp-29940	272	24	age	age	NOUN
bjp-29940	272	25	-	-	PUNCT
bjp-29940	272	26	specific	specific	ADJ
bjp-29940	272	27	antibody	antibody	NOUN
bjp-29940	272	28	to	to	ADP
bjp-29940	272	29	hcv	hcv	VERB
bjp-29940	272	30	seroprevalence	seroprevalence	NOUN
bjp-29940	272	31	.	.	PUNCT
bjp-29940	273	1	hepatology	hepatology	NOUN
bjp-29940	273	2	2013	2013	NUM
bjp-29940	273	3	;	;	PUNCT
bjp-29940	273	4	57	57	NUM
bjp-29940	273	5	:	:	SYM
bjp-29940	273	6	1333	1333	NUM
bjp-29940	273	7	-	-	SYM
bjp-29940	273	8	42	42	NUM
bjp-29940	273	9	.	.	PUNCT
bjp-29940	274	1	hassanein	hassanein	PROPN
bjp-29940	274	2	t	t	PROPN
bjp-29940	274	3	,	,	PUNCT
bjp-29940	274	4	sims	sim	NOUN
bjp-29940	274	5	kd	kd	PROPN
bjp-29940	274	6	,	,	PUNCT
bjp-29940	274	7	bennett	bennett	PROPN
bjp-29940	274	8	m	m	PROPN
bjp-29940	274	9	,	,	PUNCT
bjp-29940	274	10	gitlin	gitlin	PROPN
bjp-29940	274	11	n	n	NUM
bjp-29940	274	12	,	,	PUNCT
bjp-29940	274	13	lawitz	lawitz	PROPN
bjp-29940	274	14	e.	e.	PROPN
bjp-29940	275	1	a	a	DET
bjp-29940	275	2	randomized	randomized	ADJ
bjp-29940	275	3	trial	trial	NOUN
bjp-29940	275	4	of	of	ADP
bjp-29940	275	5	daclatasvir	daclatasvir	NOUN
bjp-29940	275	6	in	in	ADP
bjp-29940	275	7	combination	combination	NOUN
bjp-29940	275	8	with	with	ADP
bjp-29940	275	9	asunaprevir	asunaprevir	PROPN
bjp-29940	275	10	and	and	CCONJ
bjp-29940	275	11	beclabuvir	beclabuvir	NOUN
bjp-29940	275	12	in	in	ADP
bjp-29940	275	13	patients	patient	NOUN
bjp-29940	275	14	with	with	ADP
bjp-29940	275	15	chronic	chronic	ADJ
bjp-29940	275	16	hepatitis	hepatitis	PROPN
bjp-29940	275	17	c	c	PROPN
bjp-29940	275	18	virus	virus	NOUN
bjp-29940	275	19	genotype	genotype	NOUN
bjp-29940	275	20	4	4	NUM
bjp-29940	275	21	infection	infection	NOUN
bjp-29940	275	22	.	.	PUNCT
bjp-29940	276	1	j	j	PROPN
bjp-29940	276	2	hepatol	hepatol	ADJ
bjp-29940	276	3	.	.	PUNCT
bjp-29940	277	1	2015	2015	NUM
bjp-29940	277	2	;	;	PUNCT
bjp-29940	277	3	62	62	NUM
bjp-29940	277	4	:	:	SYM
bjp-29940	277	5	1204	1204	NUM
bjp-29940	277	6	-	-	SYM
bjp-29940	277	7	06	06	NUM
bjp-29940	277	8	.	.	PUNCT
bjp-29940	278	1	hézode	hézode	PROPN
bjp-29940	278	2	c	c	PROPN
bjp-29940	278	3	,	,	PUNCT
bjp-29940	278	4	alric	alric	PROPN
bjp-29940	278	5	l	l	PROPN
bjp-29940	278	6	,	,	PUNCT
bjp-29940	278	7	brown	brown	ADJ
bjp-29940	278	8	a	a	PROPN
bjp-29940	278	9	,	,	PUNCT
bjp-29940	278	10	hassanein	hassanein	PROPN
bjp-29940	278	11	t	t	PROPN
bjp-29940	278	12	,	,	PUNCT
bjp-29940	278	13	rizzetto	rizzetto	PROPN
bjp-29940	278	14	m	m	PROPN
bjp-29940	278	15	,	,	PUNCT
bjp-29940	278	16	buti	buti	PROPN
bjp-29940	278	17	m	m	PROPN
bjp-29940	278	18	,	,	PUNCT
bjp-29940	278	19	treitel	treitel	NOUN
bjp-29940	278	20	m.	m.	NOUN
bjp-29940	278	21	randomized	randomize	VERB
bjp-29940	278	22	controlled	control	VERB
bjp-29940	278	23	trial	trial	NOUN
bjp-29940	278	24	of	of	ADP
bjp-29940	278	25	the	the	DET
bjp-29940	278	26	ns5a	ns5a	PROPN
bjp-29940	278	27	inhibitor	inhibitor	NOUN
bjp-29940	278	28	daclatasvir	daclatasvir	NOUN
bjp-29940	278	29	plus	plus	CCONJ
bjp-29940	278	30	peginterferon	peginterferon	NOUN
bjp-29940	278	31	and	and	CCONJ
bjp-29940	278	32	ribavirin	ribavirin	NOUN
bjp-29940	278	33	for	for	ADP
bjp-29940	278	34	hcv	hcv	X
bjp-29940	278	35	genotype-4	genotype-4	PROPN
bjp-29940	278	36	(	(	PUNCT
bjp-29940	278	37	command-4	command-4	NUM
bjp-29940	278	38	)	)	PUNCT
bjp-29940	278	39	.	.	PUNCT
bjp-29940	279	1	antivir	antivir	PROPN
bjp-29940	279	2	ther	ther	ADV
bjp-29940	279	3	.	.	PUNCT
bjp-29940	280	1	2015	2015	NUM
bjp-29940	280	2	;	;	PUNCT
bjp-29940	280	3	4	4	X
bjp-29940	280	4	.	.	X
bjp-29940	280	5	hézode	hézode	PROPN
bjp-29940	280	6	c	c	PROPN
bjp-29940	280	7	,	,	PUNCT
bjp-29940	280	8	hirschfield	hirschfield	NOUN
bjp-29940	280	9	gm	gm	PROPN
bjp-29940	280	10	,	,	PUNCT
bjp-29940	280	11	ghesquiere	ghesquiere	NOUN
bjp-29940	280	12	w	w	PROPN
bjp-29940	280	13	,	,	PUNCT
bjp-29940	280	14	sievert	sievert	NOUN
bjp-29940	280	15	w	w	PROPN
bjp-29940	280	16	,	,	PUNCT
bjp-29940	280	17	rodriguez	rodriguez	NOUN
bjp-29940	280	18	-	-	PUNCT
bjp-29940	280	19	torres	torres	PROPN
bjp-29940	280	20	m	m	PROPN
bjp-29940	280	21	,	,	PUNCT
bjp-29940	280	22	shafran	shafran	ADJ
bjp-29940	280	23	sd	sd	NOUN
bjp-29940	280	24	,	,	PUNCT
bjp-29940	280	25	esmat	esmat	ADJ
bjp-29940	280	26	g	g	NOUN
bjp-29940	280	27	,	,	PUNCT
bjp-29940	280	28	et	et	PROPN
bjp-29940	280	29	al	al	PROPN
bjp-29940	280	30	.	.	PUNCT
bjp-29940	281	1	daclatasvir	daclatasvir	PROPN
bjp-29940	281	2	plus	plus	CCONJ
bjp-29940	281	3	peginterferon	peginterferon	PROPN
bjp-29940	281	4	alfa	alfa	NOUN
bjp-29940	281	5	and	and	CCONJ
bjp-29940	281	6	ribavirin	ribavirin	NOUN
bjp-29940	281	7	for	for	ADP
bjp-29940	281	8	treatment	treatment	NOUN
bjp-29940	281	9	-	-	PUNCT
bjp-29940	281	10	naive	naive	ADJ
bjp-29940	281	11	chronic	chronic	ADJ
bjp-29940	281	12	hepatitis	hepatitis	NOUN
bjp-29940	281	13	c	c	PROPN
bjp-29940	281	14	genotype	genotype	NOUN
bjp-29940	281	15	1	1	NUM
bjp-29940	281	16	or	or	CCONJ
bjp-29940	281	17	4	4	NUM
bjp-29940	281	18	infection	infection	NOUN
bjp-29940	281	19	:	:	PUNCT
bjp-29940	281	20	a	a	DET
bjp-29940	281	21	randomised	randomised	ADJ
bjp-29940	281	22	study	study	NOUN
bjp-29940	281	23	.	.	PUNCT
bjp-29940	282	1	gut	gut	PROPN
bjp-29940	282	2	2014	2014	NUM
bjp-29940	282	3	;	;	PUNCT
bjp-29940	282	4	64	64	NUM
bjp-29940	282	5	:	:	SYM
bjp-29940	282	6	948	948	NUM
bjp-29940	282	7	-	-	SYM
bjp-29940	282	8	56	56	NUM
bjp-29940	282	9	.	.	PUNCT
bjp-29940	283	1	jafferbhoy	jafferbhoy	PROPN
bjp-29940	283	2	h	h	PROPN
bjp-29940	283	3	,	,	PUNCT
bjp-29940	283	4	gashau	gashau	PROPN
bjp-29940	283	5	w	w	PROPN
bjp-29940	283	6	,	,	PUNCT
bjp-29940	283	7	dillon	dillon	PROPN
bjp-29940	283	8	jf	jf	PROPN
bjp-29940	283	9	.	.	PROPN
bjp-29940	283	10	cost	cost	NOUN
bjp-29940	283	11	effectiveness	effectiveness	NOUN
bjp-29940	283	12	and	and	CCONJ
bjp-29940	283	13	quality	quality	NOUN
bjp-29940	283	14	of	of	ADP
bjp-29940	283	15	life	life	NOUN
bjp-29940	283	16	considerations	consideration	NOUN
bjp-29940	283	17	in	in	ADP
bjp-29940	283	18	the	the	DET
bjp-29940	283	19	treatment	treatment	NOUN
bjp-29940	283	20	of	of	ADP
bjp-29940	283	21	hepatitis	hepatitis	NOUN
bjp-29940	283	22	c	c	NOUN
bjp-29940	283	23	infection	infection	NOUN
bjp-29940	283	24	.	.	PUNCT
bjp-29940	284	1	clin	clin	PROPN
bjp-29940	284	2	economics	economics	PROPN
bjp-29940	284	3	outcomes	outcome	NOUN
bjp-29940	284	4	res	re	NOUN
bjp-29940	284	5	.	.	PUNCT
bjp-29940	284	6	2010	2010	NUM
bjp-29940	284	7	;	;	PUNCT
bjp-29940	284	8	2	2	NUM
bjp-29940	284	9	:	:	SYM
bjp-29940	284	10	87	87	NUM
bjp-29940	284	11	.	.	PUNCT
bjp-29940	285	1	jensen	jensen	PROPN
bjp-29940	285	2	d	d	PROPN
bjp-29940	285	3	,	,	PUNCT
bjp-29940	285	4	sherman	sherman	PROPN
bjp-29940	285	5	ke	ke	PROPN
bjp-29940	285	6	,	,	PUNCT
bjp-29940	285	7	hézode	hézode	PROPN
bjp-29940	285	8	c	c	NOUN
bjp-29940	285	9	,	,	PUNCT
bjp-29940	285	10	pol	pol	PROPN
bjp-29940	285	11	s	s	PART
bjp-29940	285	12	,	,	PUNCT
bjp-29940	285	13	ledinghen	ledinghen	ADV
bjp-29940	285	14	v	v	ADP
bjp-29940	285	15	,	,	PUNCT
bjp-29940	285	16	de	de	PROPN
bjp-29940	285	17	tran	tran	PROPN
bjp-29940	285	18	a	a	PROPN
bjp-29940	285	19	,	,	PUNCT
bjp-29940	285	20	hughes	hughes	PROPN
bjp-29940	285	21	e.	e.	PROPN
bjp-29940	285	22	daclatasvir	daclatasvir	PROPN
bjp-29940	285	23	and	and	CCONJ
bjp-29940	285	24	asunaprevir	asunaprevir	PROPN
bjp-29940	285	25	plus	plus	CCONJ
bjp-29940	285	26	peginterferon	peginterferon	PROPN
bjp-29940	285	27	alfa	alfa	NOUN
bjp-29940	285	28	and	and	CCONJ
bjp-29940	285	29	ribavirin	ribavirin	NOUN
bjp-29940	285	30	in	in	ADP
bjp-29940	285	31	hcv	hcv	PROPN
bjp-29940	285	32	.	.	PUNCT
bjp-29940	286	1	j	j	PROPN
bjp-29940	286	2	hepatol	hepatol	ADJ
bjp-29940	286	3	.	.	PUNCT
bjp-29940	287	1	2015	2015	NUM
bjp-29940	287	2	;	;	PUNCT
bjp-29940	287	3	2	2	NUM
bjp-29940	287	4	:	:	SYM
bjp-29940	287	5	18	18	NUM
bjp-29940	287	6	.	.	X
bjp-29940	288	1	kamal	kamal	PROPN
bjp-29940	288	2	sm	sm	PROPN
bjp-29940	288	3	.	.	PUNCT
bjp-29940	289	1	hepatitis	hepatitis	PROPN
bjp-29940	289	2	c	c	PROPN
bjp-29940	289	3	virus	virus	NOUN
bjp-29940	289	4	genotype	genotype	NOUN
bjp-29940	289	5	4	4	NUM
bjp-29940	289	6	therapy	therapy	NOUN
bjp-29940	289	7	:	:	PUNCT
bjp-29940	289	8	progress	progress	NOUN
bjp-29940	289	9	and	and	CCONJ
bjp-29940	289	10	challenges	challenge	NOUN
bjp-29940	289	11	.	.	PUNCT
bjp-29940	290	1	liver	liver	NOUN
bjp-29940	290	2	int	int	NOUN
bjp-29940	290	3	.	.	PUNCT
bjp-29940	291	1	2011	2011	NUM
bjp-29940	291	2	;	;	PUNCT
bjp-29940	291	3	31	31	NUM
bjp-29940	291	4	:	:	PUNCT
bjp-29940	291	5	45	45	NUM
bjp-29940	291	6	-	-	SYM
bjp-29940	291	7	52	52	NUM
bjp-29940	291	8	.	.	PUNCT
bjp-29940	291	9	karoney	karoney	PROPN
bjp-29940	291	10	mj	mj	PROPN
bjp-29940	291	11	,	,	PUNCT
bjp-29940	291	12	siika	siika	PROPN
bjp-29940	291	13	am	be	AUX
bjp-29940	291	14	.	.	PUNCT
bjp-29940	292	1	hepatitis	hepatitis	PROPN
bjp-29940	292	2	c	c	PROPN
bjp-29940	292	3	virus	virus	PROPN
bjp-29940	292	4	(	(	PUNCT
bjp-29940	292	5	hcv	hcv	NOUN
bjp-29940	292	6	)	)	PUNCT
bjp-29940	292	7	infection	infection	NOUN
bjp-29940	292	8	in	in	ADP
bjp-29940	292	9	africa	africa	PROPN
bjp-29940	292	10	:	:	PUNCT
bjp-29940	292	11	a	a	DET
bjp-29940	292	12	review	review	NOUN
bjp-29940	292	13	.	.	PUNCT
bjp-29940	293	1	pan	pan	PROPN
bjp-29940	293	2	afr	afr	PROPN
bjp-29940	293	3	med	med	PROPN
bjp-29940	293	4	j.	j.	PROPN
bjp-29940	293	5	2013	2013	NUM
bjp-29940	293	6	;	;	PUNCT
bjp-29940	293	7	14	14	NUM
bjp-29940	293	8	.	.	PUNCT
bjp-29940	294	1	kumada	kumada	PROPN
bjp-29940	294	2	h	h	PROPN
bjp-29940	294	3	,	,	PUNCT
bjp-29940	294	4	suzuki	suzuki	PROPN
bjp-29940	294	5	y	y	PROPN
bjp-29940	294	6	,	,	PUNCT
bjp-29940	294	7	ikeda	ikeda	PROPN
bjp-29940	294	8	k	k	PROPN
bjp-29940	294	9	,	,	PUNCT
bjp-29940	294	10	toyota	toyota	PROPN
bjp-29940	294	11	j	j	PROPN
bjp-29940	294	12	,	,	PUNCT
bjp-29940	294	13	karino	karino	PROPN
bjp-29940	294	14	y	y	PROPN
bjp-29940	294	15	,	,	PUNCT
bjp-29940	294	16	chayama	chayama	PROPN
bjp-29940	294	17	k	k	NOUN
bjp-29940	294	18	,	,	PUNCT
bjp-29940	294	19	takaguchi	takaguchi	PROPN
bjp-29940	294	20	k.	k.	PROPN
bjp-29940	294	21	daclatasvir	daclatasvir	PROPN
bjp-29940	294	22	plus	plus	CCONJ
bjp-29940	294	23	asunaprevir	asunaprevir	PROPN
bjp-29940	294	24	for	for	ADP
bjp-29940	294	25	chronic	chronic	ADJ
bjp-29940	294	26	hcv	hcv	X
bjp-29940	294	27	genotype	genotype	NOUN
bjp-29940	294	28	1b	1b	NUM
bjp-29940	294	29	infection	infection	NOUN
bjp-29940	294	30	.	.	PUNCT
bjp-29940	295	1	hepatology	hepatology	NOUN
bjp-29940	295	2	2014	2014	NUM
bjp-29940	295	3	;	;	PUNCT
bjp-29940	295	4	59	59	NUM
bjp-29940	295	5	:	:	SYM
bjp-29940	295	6	2083	2083	NUM
bjp-29940	295	7	-	-	SYM
bjp-29940	295	8	91	91	NUM
bjp-29940	295	9	.	.	PUNCT
bjp-29940	296	1	larrey	larrey	PROPN
bjp-29940	296	2	d	d	PROPN
bjp-29940	296	3	,	,	PUNCT
bjp-29940	296	4	ripault	ripault	PROPN
bjp-29940	296	5	mp	mp	PROPN
bjp-29940	296	6	,	,	PUNCT
bjp-29940	296	7	pageaux	pageaux	X
bjp-29940	296	8	gp	gp	VERB
bjp-29940	296	9	.	.	PUNCT
bjp-29940	297	1	patient	patient	ADJ
bjp-29940	297	2	adherence	adherence	NOUN
bjp-29940	297	3	issues	issue	NOUN
bjp-29940	297	4	in	in	ADP
bjp-29940	297	5	the	the	DET
bjp-29940	297	6	treatment	treatment	NOUN
bjp-29940	297	7	of	of	ADP
bjp-29940	297	8	hepatitis	hepatitis	PROPN
bjp-29940	297	9	c.	c.	PROPN
bjp-29940	297	10	patient	patient	PROPN
bjp-29940	297	11	prefer	prefer	VERB
bjp-29940	297	12	adher	adher	ADV
bjp-29940	297	13	.	.	PUNCT
bjp-29940	298	1	2014	2014	NUM
bjp-29940	298	2	;	;	PUNCT
bjp-29940	298	3	8	8	NUM
bjp-29940	298	4	:	:	SYM
bjp-29940	298	5	763	763	NUM
bjp-29940	298	6	.	.	PUNCT
bjp-29940	299	1	lawitz	lawitz	PROPN
bjp-29940	299	2	e	e	PROPN
bjp-29940	299	3	,	,	PUNCT
bjp-29940	299	4	mangia	mangia	PROPN
bjp-29940	299	5	a	a	PRON
bjp-29940	299	6	,	,	PUNCT
bjp-29940	299	7	wyles	wyles	PROPN
bjp-29940	299	8	d	d	PROPN
bjp-29940	299	9	,	,	PUNCT
bjp-29940	299	10	rodriguez	rodriguez	NOUN
bjp-29940	299	11	-	-	PUNCT
bjp-29940	299	12	torres	torres	PROPN
bjp-29940	299	13	m	m	PROPN
bjp-29940	299	14	,	,	PUNCT
bjp-29940	299	15	hassanein	hassanein	PROPN
bjp-29940	299	16	t	t	PROPN
bjp-29940	299	17	,	,	PUNCT
bjp-29940	299	18	gordon	gordon	PROPN
bjp-29940	299	19	sc	sc	PROPN
bjp-29940	299	20	,	,	PUNCT
bjp-29940	299	21	reddy	reddy	PROPN
bjp-29940	299	22	kr	kr	PROPN
bjp-29940	299	23	.	.	PROPN
bjp-29940	299	24	sofosbuvir	sofosbuvir	PROPN
bjp-29940	299	25	for	for	ADP
bjp-29940	299	26	previously	previously	ADV
bjp-29940	299	27	untreated	untreated	ADJ
bjp-29940	299	28	chronic	chronic	ADJ
bjp-29940	299	29	hepatitis	hepatitis	NOUN
bjp-29940	299	30	c	c	NOUN
bjp-29940	299	31	infection	infection	NOUN
bjp-29940	299	32	.	.	PUNCT
bjp-29940	300	1	n	n	PROPN
bjp-29940	300	2	engl	engl	PROPN
bjp-29940	300	3	j	j	PROPN
bjp-29940	300	4	med	med	PROPN
bjp-29940	300	5	.	.	PUNCT
bjp-29940	300	6	2013	2013	NUM
bjp-29940	300	7	;	;	PUNCT
bjp-29940	300	8	368	368	NUM
bjp-29940	300	9	:	:	PUNCT
bjp-29940	300	10	1878	1878	NUM
bjp-29940	300	11	-	-	SYM
bjp-29940	300	12	87	87	NUM
bjp-29940	300	13	.	.	PUNCT
bjp-29940	301	1	lee	lee	PROPN
bjp-29940	301	2	c	c	PROPN
bjp-29940	301	3	,	,	PUNCT
bjp-29940	301	4	ma	ma	PROPN
bjp-29940	301	5	h	h	PROPN
bjp-29940	301	6	,	,	PUNCT
bjp-29940	301	7	hang	hang	PROPN
bjp-29940	301	8	jq	jq	PROPN
bjp-29940	301	9	,	,	PUNCT
bjp-29940	301	10	leveque	leveque	ADJ
bjp-29940	301	11	v	v	NOUN
bjp-29940	301	12	,	,	PUNCT
bjp-29940	301	13	sklan	sklan	ADJ
bjp-29940	301	14	eh	eh	INTJ
bjp-29940	301	15	,	,	PUNCT
bjp-29940	301	16	elazar	elazar	NOUN
bjp-29940	301	17	m	m	PROPN
bjp-29940	301	18	,	,	PUNCT
bjp-29940	301	19	glenn	glenn	PROPN
bjp-29940	301	20	20	20	NUM
bjp-29940	301	21	bangladesh	bangladesh	PROPN
bjp-29940	301	22	j	j	PROPN
bjp-29940	301	23	pharmacol	pharmacol	PROPN
bjp-29940	301	24	2017	2017	NUM
bjp-29940	301	25	;	;	PUNCT
bjp-29940	301	26	12	12	NUM
bjp-29940	301	27	:	:	SYM
bjp-29940	301	28	12	12	NUM
bjp-29940	301	29	-	-	SYM
bjp-29940	301	30	22	22	NUM
bjp-29940	301	31	author	author	NOUN
bjp-29940	301	32	info	info	NOUN
bjp-29940	301	33	abdelrahman	abdelrahman	PROPN
bjp-29940	301	34	ibrahim	ibrahim	PROPN
bjp-29940	301	35	abushouk	abushouk	PROPN
bjp-29940	301	36	(	(	PUNCT
bjp-29940	301	37	principal	principal	ADJ
bjp-29940	301	38	contact	contact	NOUN
bjp-29940	301	39	)	)	PUNCT
bjp-29940	302	1	e	e	NOUN
bjp-29940	302	2	-	-	NOUN
bjp-29940	302	3	mail	mail	NOUN
bjp-29940	302	4	:	:	PUNCT
bjp-29940	302	5	abdelrahman.abushouk@med.asu.edu.eg	abdelrahman.abushouk@med.asu.edu.eg	NUM
bjp-29940	302	6	protein	protein	NOUN
bjp-29940	302	7	.	.	PUNCT
bjp-29940	303	1	virology	virology	NOUN
bjp-29940	303	2	2011	2011	NUM
bjp-29940	303	3	;	;	PUNCT
bjp-29940	303	4	414	414	NUM
bjp-29940	303	5	:	:	PUNCT
bjp-29940	303	6	10	10	NUM
bjp-29940	303	7	-	-	SYM
bjp-29940	303	8	18	18	NUM
bjp-29940	303	9	.	.	PUNCT
bjp-29940	304	1	lindsay	lindsay	PROPN
bjp-29940	304	2	kl	kl	PROPN
bjp-29940	304	3	.	.	PROPN
bjp-29940	304	4	therapy	therapy	NOUN
bjp-29940	304	5	of	of	ADP
bjp-29940	304	6	hepatitis	hepatitis	PROPN
bjp-29940	304	7	c	c	NOUN
bjp-29940	304	8	:	:	PUNCT
bjp-29940	304	9	overview	overview	NOUN
bjp-29940	304	10	.	.	PUNCT
bjp-29940	305	1	hepatology	hepatology	NOUN
bjp-29940	305	2	1997	1997	NUM
bjp-29940	305	3	;	;	PUNCT
bjp-29940	305	4	26	26	NUM
bjp-29940	305	5	.	.	PUNCT
bjp-29940	306	1	moher	moher	PROPN
bjp-29940	306	2	d.	d.	PROPN
bjp-29940	306	3	preferred	prefer	VERB
bjp-29940	306	4	reporting	reporting	NOUN
bjp-29940	306	5	items	item	NOUN
bjp-29940	306	6	for	for	ADP
bjp-29940	306	7	systematic	systematic	ADJ
bjp-29940	306	8	reviews	review	NOUN
bjp-29940	306	9	and	and	CCONJ
bjp-29940	306	10	meta	meta	NOUN
bjp-29940	306	11	-	-	PUNCT
bjp-29940	306	12	analyses	analysis	NOUN
bjp-29940	306	13	:	:	PUNCT
bjp-29940	306	14	the	the	DET
bjp-29940	306	15	prisma	prisma	PROPN
bjp-29940	306	16	statement	statement	NOUN
bjp-29940	306	17	.	.	PUNCT
bjp-29940	307	1	ann	ann	PROPN
bjp-29940	307	2	intern	intern	PROPN
bjp-29940	307	3	med	med	PROPN
bjp-29940	307	4	.	.	PUNCT
bjp-29940	307	5	2009	2009	NUM
bjp-29940	307	6	;	;	PUNCT
bjp-29940	307	7	151	151	NUM
bjp-29940	307	8	:	:	SYM
bjp-29940	307	9	264	264	NUM
bjp-29940	307	10	.	.	PUNCT
bjp-29940	308	1	e1000097	e1000097	PROPN
bjp-29940	308	2	.	.	PUNCT
bjp-29940	309	1	moreno	moreno	PROPN
bjp-29940	309	2	c	c	PROPN
bjp-29940	309	3	,	,	PUNCT
bjp-29940	309	4	hezode	hezode	PROPN
bjp-29940	309	5	c	c	X
bjp-29940	309	6	,	,	PUNCT
bjp-29940	309	7	marcellin	marcellin	PROPN
bjp-29940	309	8	p	p	NOUN
bjp-29940	309	9	,	,	PUNCT
bjp-29940	309	10	bourgeois	bourgeois	PROPN
bjp-29940	309	11	s	s	NOUN
bjp-29940	309	12	,	,	PUNCT
bjp-29940	309	13	francque	francque	PROPN
bjp-29940	309	14	s	s	PROPN
bjp-29940	309	15	,	,	PUNCT
bjp-29940	309	16	samuel	samuel	PROPN
bjp-29940	309	17	d	d	PROPN
bjp-29940	309	18	,	,	PUNCT
bjp-29940	309	19	ouwerkerk	ouwerkerk	PROPN
bjp-29940	309	20	-	-	PUNCT
bjp-29940	309	21	mahadevan	mahadevan	PROPN
bjp-29940	309	22	s.	s.	PROPN
bjp-29940	309	23	p1319	p1319	PROPN
bjp-29940	309	24	once	once	ADV
bjp-29940	309	25	-	-	PUNCT
bjp-29940	309	26	daily	daily	ADJ
bjp-29940	309	27	simeprevir	simeprevir	NOUN
bjp-29940	309	28	(	(	PUNCT
bjp-29940	309	29	tmc435	tmc435	PROPN
bjp-29940	309	30	)	)	PUNCT
bjp-29940	309	31	with	with	ADP
bjp-29940	309	32	peginterferon	peginterferon	NOUN
bjp-29940	309	33	/	/	SYM
bjp-29940	309	34	ribavirin	ribavirin	NOUN
bjp-29940	309	35	in	in	ADP
bjp-29940	309	36	treatment	treatment	NOUN
bjp-29940	309	37	-	-	PUNCT
bjp-29940	309	38	naive	naive	ADJ
bjp-29940	309	39	or	or	CCONJ
bjp-29940	309	40	treatment	treatment	NOUN
bjp-29940	309	41	-	-	PUNCT
bjp-29940	309	42	experienced	experience	VERB
bjp-29940	309	43	chronic	chronic	ADJ
bjp-29940	309	44	hcv	hcv	NOUN
bjp-29940	309	45	genotype	genotype	NOUN
bjp-29940	309	46	4	4	NUM
bjp-29940	309	47	-	-	PUNCT
bjp-29940	309	48	infected	infected	ADJ
bjp-29940	309	49	patients	patient	NOUN
bjp-29940	309	50	:	:	PUNCT
bjp-29940	309	51	final	final	ADJ
bjp-29940	309	52	results	result	NOUN
bjp-29940	309	53	of	of	ADP
bjp-29940	309	54	a	a	DET
bjp-29940	309	55	phase	phase	NOUN
bjp-29940	309	56	iii	iii	NOUN
bjp-29940	309	57	trial	trial	NOUN
bjp-29940	309	58	.	.	PUNCT
bjp-29940	310	1	j	j	PROPN
bjp-29940	310	2	hepatol	hepatol	ADJ
bjp-29940	310	3	.	.	PUNCT
bjp-29940	311	1	2014	2014	NUM
bjp-29940	311	2	;	;	PUNCT
bjp-29940	311	3	60	60	NUM
bjp-29940	311	4	:	:	PUNCT
bjp-29940	312	1	s535	s535	PROPN
bjp-29940	312	2	.	.	PUNCT
bjp-29940	313	1	negro	negro	PROPN
bjp-29940	313	2	f	f	PROPN
bjp-29940	313	3	,	,	PUNCT
bjp-29940	313	4	alberti	alberti	PROPN
bjp-29940	313	5	a.	a.	PROPN
bjp-29940	313	6	the	the	DET
bjp-29940	313	7	global	global	ADJ
bjp-29940	313	8	health	health	NOUN
bjp-29940	313	9	burden	burden	NOUN
bjp-29940	313	10	of	of	ADP
bjp-29940	313	11	hepatitis	hepatitis	PROPN
bjp-29940	313	12	c	c	PROPN
bjp-29940	313	13	virus	virus	NOUN
bjp-29940	313	14	infection	infection	NOUN
bjp-29940	313	15	.	.	PUNCT
bjp-29940	314	1	liver	liver	NOUN
bjp-29940	314	2	int	int	NOUN
bjp-29940	314	3	.	.	PUNCT
bjp-29940	315	1	2011	2011	NUM
bjp-29940	315	2	;	;	PUNCT
bjp-29940	315	3	31	31	NUM
bjp-29940	315	4	:	:	SYM
bjp-29940	315	5	1	1	NUM
bjp-29940	315	6	-	-	SYM
bjp-29940	315	7	3	3	NUM
bjp-29940	315	8	.	.	PUNCT
bjp-29940	315	9	pawlotsky	pawlotsky	PROPN
bjp-29940	315	10	jm	jm	PROPN
bjp-29940	315	11	,	,	PUNCT
bjp-29940	315	12	aghemo	aghemo	NOUN
bjp-29940	315	13	a	a	PRON
bjp-29940	315	14	,	,	PUNCT
bjp-29940	315	15	back	back	PROPN
bjp-29940	315	16	d.	d.	PROPN
bjp-29940	315	17	easl	easl	PROPN
bjp-29940	315	18	recommendations	recommendation	NOUN
bjp-29940	315	19	on	on	ADP
bjp-29940	315	20	treatment	treatment	NOUN
bjp-29940	315	21	of	of	ADP
bjp-29940	315	22	hepatitis	hepatitis	NOUN
bjp-29940	315	23	c	c	PROPN
bjp-29940	315	24	2015	2015	NUM
bjp-29940	315	25	.	.	PUNCT
bjp-29940	316	1	j	j	PROPN
bjp-29940	316	2	hepatol	hepatol	ADJ
bjp-29940	316	3	.	.	PUNCT
bjp-29940	317	1	2015	2015	NUM
bjp-29940	317	2	;	;	PUNCT
bjp-29940	317	3	63	63	NUM
bjp-29940	317	4	,	,	PUNCT
bjp-29940	317	5	199	199	NUM
bjp-29940	317	6	-	-	SYM
bjp-29940	317	7	236	236	NUM
bjp-29940	317	8	.	.	PUNCT
bjp-29940	318	1	qiu	qiu	PROPN
bjp-29940	318	2	d	d	PROPN
bjp-29940	318	3	,	,	PUNCT
bjp-29940	318	4	lemm	lemm	PROPN
bjp-29940	318	5	ja	ja	PROPN
bjp-29940	318	6	,	,	PUNCT
bjp-29940	318	7	o’boyle	o’boyle	PROPN
bjp-29940	318	8	dr	dr	PROPN
bjp-29940	318	9	,	,	PUNCT
bjp-29940	318	10	sun	sun	PROPN
bjp-29940	318	11	jh	jh	PROPN
bjp-29940	318	12	,	,	PUNCT
bjp-29940	318	13	nower	nower	PROPN
bjp-29940	318	14	pt	pt	PROPN
bjp-29940	318	15	,	,	PUNCT
bjp-29940	318	16	nguyen	nguyen	NOUN
bjp-29940	318	17	v	v	NOUN
bjp-29940	318	18	,	,	PUNCT
bjp-29940	318	19	ruediger	ruediger	NOUN
bjp-29940	318	20	e	e	PROPN
bjp-29940	318	21	hamann	hamann	PROPN
bjp-29940	318	22	lg	lg	PROPN
bjp-29940	318	23	,	,	PUNCT
bjp-29940	318	24	snyder	snyder	PROPN
bjp-29940	318	25	lb	lb	PROPN
bjp-29940	318	26	,	,	PUNCT
bjp-29940	318	27	deon	deon	PROPN
bjp-29940	318	28	dh	dh	NOUN
bjp-29940	318	29	,	,	PUNCT
bjp-29940	318	30	ruediger	ruediger	NOUN
bjp-29940	318	31	e	e	NOUN
bjp-29940	318	32	,	,	PUNCT
bjp-29940	318	33	meanwell	meanwell	ADJ
bjp-29940	318	34	na	na	NOUN
bjp-29940	318	35	,	,	PUNCT
bjp-29940	318	36	belema	belema	NOUN
bjp-29940	318	37	m	m	PROPN
bjp-29940	318	38	,	,	PUNCT
bjp-29940	318	39	gao	gao	PROPN
bjp-29940	318	40	m	m	PROPN
bjp-29940	318	41	,	,	PUNCT
bjp-29940	318	42	fridell	fridell	PROPN
bjp-29940	318	43	ra	ra	PROPN
bjp-29940	318	44	.	.	PUNCT
bjp-29940	319	1	the	the	DET
bjp-29940	319	2	effects	effect	NOUN
bjp-29940	319	3	of	of	ADP
bjp-29940	319	4	ns5a	ns5a	ADJ
bjp-29940	319	5	inhibitors	inhibitor	NOUN
bjp-29940	319	6	on	on	ADP
bjp-29940	319	7	ns5a	ns5a	ADJ
bjp-29940	319	8	phosphorylation	phosphorylation	NOUN
bjp-29940	319	9	,	,	PUNCT
bjp-29940	319	10	polyprotein	polyprotein	ADJ
bjp-29940	319	11	processing	processing	NOUN
bjp-29940	319	12	and	and	CCONJ
bjp-29940	319	13	localization	localization	NOUN
bjp-29940	319	14	.	.	PUNCT
bjp-29940	320	1	j	j	PROPN
bjp-29940	320	2	gen	gen	PROPN
bjp-29940	320	3	virol	virol	NOUN
bjp-29940	320	4	.	.	PUNCT
bjp-29940	321	1	2011	2011	NUM
bjp-29940	321	2	;	;	PUNCT
bjp-29940	321	3	92	92	NUM
bjp-29940	321	4	:	:	SYM
bjp-29940	321	5	2502	2502	NUM
bjp-29940	321	6	-	-	SYM
bjp-29940	321	7	11	11	NUM
bjp-29940	321	8	.	.	PUNCT
bjp-29940	322	1	smith	smith	PROPN
bjp-29940	322	2	db	db	PROPN
bjp-29940	322	3	,	,	PUNCT
bjp-29940	322	4	bukh	bukh	PROPN
bjp-29940	322	5	j	j	PROPN
bjp-29940	322	6	,	,	PUNCT
bjp-29940	322	7	kuiken	kuiken	VERB
bjp-29940	322	8	c	c	PROPN
bjp-29940	322	9	,	,	PUNCT
bjp-29940	322	10	muerhoff	muerhoff	ADJ
bjp-29940	322	11	as	as	ADP
bjp-29940	322	12	,	,	PUNCT
bjp-29940	322	13	rice	rice	NOUN
bjp-29940	322	14	cm	cm	PROPN
bjp-29940	322	15	,	,	PUNCT
bjp-29940	322	16	stapleton	stapleton	PROPN
bjp-29940	322	17	jt	jt	PROPN
bjp-29940	322	18	,	,	PUNCT
bjp-29940	322	19	simmonds	simmonds	PROPN
bjp-29940	322	20	p.	p.	PROPN
bjp-29940	322	21	expanded	expand	VERB
bjp-29940	322	22	classification	classification	NOUN
bjp-29940	322	23	of	of	ADP
bjp-29940	322	24	hepatitis	hepatitis	PROPN
bjp-29940	322	25	c	c	PROPN
bjp-29940	322	26	virus	virus	NOUN
bjp-29940	322	27	into	into	ADP
bjp-29940	322	28	7	7	NUM
bjp-29940	322	29	genotypes	genotype	NOUN
bjp-29940	322	30	and	and	CCONJ
bjp-29940	322	31	67	67	NUM
bjp-29940	322	32	subtypes	subtype	NOUN
bjp-29940	322	33	:	:	PUNCT
bjp-29940	322	34	updated	update	VERB
bjp-29940	322	35	criteria	criterion	NOUN
bjp-29940	322	36	and	and	CCONJ
bjp-29940	322	37	genotype	genotype	NOUN
bjp-29940	322	38	assignment	assignment	NOUN
bjp-29940	322	39	web	web	NOUN
bjp-29940	322	40	resource	resource	NOUN
bjp-29940	322	41	.	.	PUNCT
bjp-29940	323	1	hepatology	hepatology	NOUN
bjp-29940	323	2	2014	2014	NUM
bjp-29940	323	3	;	;	PUNCT
bjp-29940	323	4	59	59	NUM
bjp-29940	323	5	:	:	SYM
bjp-29940	323	6	318	318	NUM
bjp-29940	323	7	-27	-27	NUM
bjp-29940	323	8	.	.	PUNCT
bjp-29940	324	1	smith	smith	PROPN
bjp-29940	324	2	-	-	PUNCT
bjp-29940	324	3	palmer	palmer	PROPN
bjp-29940	324	4	j	j	PROPN
bjp-29940	324	5	,	,	PUNCT
bjp-29940	324	6	cerri	cerri	PROPN
bjp-29940	324	7	k	k	PROPN
bjp-29940	324	8	,	,	PUNCT
bjp-29940	324	9	valentine	valentine	PROPN
bjp-29940	324	10	w.	w.	PROPN
bjp-29940	324	11	achieving	achieve	VERB
bjp-29940	324	12	sustained	sustain	VERB
bjp-29940	324	13	virologic	virologic	ADJ
bjp-29940	324	14	response	response	NOUN
bjp-29940	324	15	in	in	ADP
bjp-29940	324	16	hepatitis	hepatitis	PROPN
bjp-29940	324	17	c	c	NOUN
bjp-29940	324	18	:	:	PUNCT
bjp-29940	324	19	a	a	DET
bjp-29940	324	20	systematic	systematic	ADJ
bjp-29940	324	21	review	review	NOUN
bjp-29940	324	22	of	of	ADP
bjp-29940	324	23	the	the	DET
bjp-29940	324	24	clinical	clinical	ADJ
bjp-29940	324	25	,	,	PUNCT
bjp-29940	324	26	economic	economic	ADJ
bjp-29940	324	27	and	and	CCONJ
bjp-29940	324	28	quality	quality	NOUN
bjp-29940	324	29	of	of	ADP
bjp-29940	324	30	life	life	NOUN
bjp-29940	324	31	benefits	benefit	NOUN
bjp-29940	324	32	.	.	PUNCT
bjp-29940	325	1	bmc	bmc	ADJ
bjp-29940	325	2	infect	infect	PROPN
bjp-29940	325	3	dis	dis	PROPN
bjp-29940	325	4	.	.	PROPN
bjp-29940	326	1	2015	2015	NUM
bjp-29940	326	2	;	;	PUNCT
bjp-29940	326	3	15	15	NUM
bjp-29940	326	4	:	:	SYM
bjp-29940	326	5	1	1	NUM
bjp-29940	326	6	.	.	X
bjp-29940	326	7	sulkowski	sulkowski	PROPN
bjp-29940	326	8	ms	ms	PROPN
bjp-29940	326	9	,	,	PUNCT
bjp-29940	326	10	gardiner	gardiner	PROPN
bjp-29940	326	11	df	df	PROPN
bjp-29940	326	12	,	,	PUNCT
bjp-29940	326	13	rodriguez	rodriguez	NOUN
bjp-29940	326	14	-	-	PUNCT
bjp-29940	326	15	torres	torres	PROPN
bjp-29940	326	16	m	m	PROPN
bjp-29940	326	17	,	,	PUNCT
bjp-29940	326	18	reddy	reddy	PROPN
bjp-29940	326	19	kr	kr	PROPN
bjp-29940	326	20	,	,	PUNCT
bjp-29940	326	21	hassanein	hassanein	PROPN
bjp-29940	326	22	t	t	PROPN
bjp-29940	326	23	,	,	PUNCT
bjp-29940	326	24	jacobson	jacobson	PROPN
bjp-29940	326	25	i	i	PROPN
bjp-29940	326	26	,	,	PUNCT
bjp-29940	326	27	grasela	grasela	PROPN
bjp-29940	326	28	dm	dm	PROPN
bjp-29940	326	29	.	.	PUNCT
bjp-29940	326	30	daclatasvir	daclatasvir	PROPN
bjp-29940	326	31	plus	plus	CCONJ
bjp-29940	326	32	sofosbuvir	sofosbuvir	PROPN
bjp-29940	326	33	for	for	ADP
bjp-29940	326	34	previously	previously	ADV
bjp-29940	326	35	treated	treat	VERB
bjp-29940	326	36	or	or	CCONJ
bjp-29940	326	37	untreated	untreated	ADJ
bjp-29940	326	38	chronic	chronic	ADJ
bjp-29940	326	39	hcv	hcv	NOUN
bjp-29940	326	40	infection	infection	NOUN
bjp-29940	326	41	.	.	PUNCT
bjp-29940	327	1	n	n	PROPN
bjp-29940	327	2	engl	engl	PROPN
bjp-29940	327	3	j	j	PROPN
bjp-29940	327	4	med	med	PROPN
bjp-29940	327	5	.	.	PROPN
bjp-29940	327	6	2014	2014	NUM
bjp-29940	327	7	;	;	PUNCT
bjp-29940	327	8	370	370	NUM
bjp-29940	327	9	:	:	PUNCT
bjp-29940	327	10	211	211	NUM
bjp-29940	327	11	-	-	SYM
bjp-29940	327	12	21	21	NUM
bjp-29940	327	13	.	.	PUNCT
bjp-29940	328	1	suzuki	suzuki	PROPN
bjp-29940	328	2	y	y	PROPN
bjp-29940	328	3	,	,	PUNCT
bjp-29940	328	4	ikeda	ikeda	PROPN
bjp-29940	328	5	k	k	PROPN
bjp-29940	328	6	,	,	PUNCT
bjp-29940	328	7	suzuki	suzuki	PROPN
bjp-29940	328	8	f	f	PROPN
bjp-29940	328	9	,	,	PUNCT
bjp-29940	328	10	toyota	toyota	PROPN
bjp-29940	328	11	j	j	PROPN
bjp-29940	328	12	,	,	PUNCT
bjp-29940	328	13	karino	karino	PROPN
bjp-29940	328	14	y	y	PROPN
bjp-29940	328	15	,	,	PUNCT
bjp-29940	328	16	chayama	chayama	PROPN
bjp-29940	328	17	k	k	PROPN
bjp-29940	328	18	,	,	PUNCT
bjp-29940	328	19	hu	hu	PROPN
bjp-29940	328	20	w.	w.	PROPN
bjp-29940	328	21	dual	dual	PROPN
bjp-29940	328	22	oral	oral	ADJ
bjp-29940	328	23	therapy	therapy	NOUN
bjp-29940	328	24	with	with	ADP
bjp-29940	328	25	daclatasvir	daclatasvir	PROPN
bjp-29940	328	26	and	and	CCONJ
bjp-29940	328	27	asunaprevir	asunaprevir	PROPN
bjp-29940	328	28	for	for	ADP
bjp-29940	328	29	patients	patient	NOUN
bjp-29940	328	30	with	with	ADP
bjp-29940	328	31	hcv	hcv	NOUN
bjp-29940	328	32	genotype	genotype	NOUN
bjp-29940	328	33	1b	1b	NUM
bjp-29940	328	34	infection	infection	NOUN
bjp-29940	328	35	and	and	CCONJ
bjp-29940	328	36	limited	limited	ADJ
bjp-29940	328	37	treatment	treatment	NOUN
bjp-29940	328	38	options	option	NOUN
bjp-29940	328	39	.	.	PUNCT
bjp-29940	329	1	j	j	PROPN
bjp-29940	329	2	hepatol	hepatol	ADJ
bjp-29940	329	3	.	.	PUNCT
bjp-29940	330	1	2013	2013	NUM
bjp-29940	330	2	;	;	PUNCT
bjp-29940	330	3	58	58	NUM
bjp-29940	330	4	:	:	PUNCT
bjp-29940	330	5	655	655	NUM
bjp-29940	330	6	-	-	SYM
bjp-29940	330	7	62	62	NUM
bjp-29940	330	8	.	.	PUNCT
bjp-29940	331	1	swallow	swallow	NOUN
bjp-29940	331	2	e	e	NOUN
bjp-29940	331	3	,	,	PUNCT
bjp-29940	331	4	song	song	PROPN
bjp-29940	331	5	j	j	PROPN
bjp-29940	331	6	,	,	PUNCT
bjp-29940	331	7	yuan	yuan	PROPN
bjp-29940	331	8	y	y	PROPN
bjp-29940	331	9	,	,	PUNCT
bjp-29940	331	10	kalsekar	kalsekar	PROPN
bjp-29940	331	11	a	a	PROPN
bjp-29940	331	12	,	,	PUNCT
bjp-29940	331	13	kelley	kelley	PROPN
bjp-29940	331	14	c	c	PROPN
bjp-29940	331	15	,	,	PUNCT
bjp-29940	331	16	mu	mu	PROPN
bjp-29940	331	17	f	f	PROPN
bjp-29940	331	18	,	,	PUNCT
bjp-29940	331	19	signorovitch	signorovitch	VERB
bjp-29940	331	20	j.	j.	PROPN
bjp-29940	331	21	daclatasvir	daclatasvir	PROPN
bjp-29940	332	1	+	+	CCONJ
bjp-29940	332	2	sofosbuvir	sofosbuvir	PROPN
bjp-29940	332	3	versus	versus	ADP
bjp-29940	332	4	standard	standard	NOUN
bjp-29940	332	5	of	of	ADP
bjp-29940	332	6	care	care	NOUN
bjp-29940	332	7	for	for	ADP
bjp-29940	332	8	hepatitis	hepatitis	PROPN
bjp-29940	332	9	c	c	PROPN
bjp-29940	332	10	genotype	genotype	NOUN
bjp-29940	332	11	3	3	NUM
bjp-29940	332	12	:	:	PUNCT
bjp-29940	332	13	a	a	DET
bjp-29940	332	14	matching	matching	NOUN
bjp-29940	332	15	-	-	PUNCT
bjp-29940	332	16	adjusted	adjust	VERB
bjp-29940	332	17	indirect	indirect	ADJ
bjp-29940	332	18	comparison	comparison	NOUN
bjp-29940	332	19	.	.	PUNCT
bjp-29940	333	1	j	j	PROPN
bjp-29940	333	2	comp	comp	PROPN
bjp-29940	333	3	eff	eff	PROPN
bjp-29940	333	4	res	res	PROPN
bjp-29940	333	5	.	.	PROPN
bjp-29940	334	1	2015	2015	NUM
bjp-29940	334	2	.	.	PUNCT
bjp-29940	335	1	terrin	terrin	PROPN
bjp-29940	335	2	n	n	CCONJ
bjp-29940	335	3	,	,	PUNCT
bjp-29940	335	4	schmid	schmid	PROPN
bjp-29940	335	5	ch	ch	PROPN
bjp-29940	335	6	,	,	PUNCT
bjp-29940	335	7	lau	lau	PROPN
bjp-29940	335	8	j	j	PROPN
bjp-29940	335	9	,	,	PUNCT
bjp-29940	335	10	olkin	olkin	PROPN
bjp-29940	335	11	i.	i.	NOUN
bjp-29940	335	12	adjusting	adjust	VERB
bjp-29940	335	13	for	for	ADP
bjp-29940	335	14	publication	publication	NOUN
bjp-29940	335	15	bias	bias	NOUN
bjp-29940	335	16	in	in	ADP
bjp-29940	335	17	the	the	DET
bjp-29940	335	18	presence	presence	NOUN
bjp-29940	335	19	of	of	ADP
bjp-29940	335	20	heterogeneity	heterogeneity	NOUN
bjp-29940	335	21	.	.	PUNCT
bjp-29940	336	1	stats	stat	NOUN
bjp-29940	336	2	med	med	ADJ
bjp-29940	336	3	.	.	PUNCT
bjp-29940	336	4	2003	2003	NUM
bjp-29940	336	5	;	;	PUNCT
bjp-29940	336	6	22	22	NUM
bjp-29940	336	7	:	:	PUNCT
bjp-29940	336	8	2113	2113	NUM
bjp-29940	336	9	-	-	SYM
bjp-29940	336	10	26	26	NUM
bjp-29940	336	11	.	.	PUNCT
bjp-29940	337	1	thompson	thompson	PROPN
bjp-29940	337	2	aj	aj	PROPN
bjp-29940	337	3	,	,	PUNCT
bjp-29940	337	4	muir	muir	PROPN
bjp-29940	337	5	aj	aj	PROPN
bjp-29940	337	6	,	,	PUNCT
bjp-29940	337	7	sulkowski	sulkowski	PROPN
bjp-29940	337	8	ms	ms	PROPN
bjp-29940	337	9	,	,	PUNCT
bjp-29940	337	10	ge	ge	PROPN
bjp-29940	337	11	d	d	PROPN
bjp-29940	337	12	,	,	PUNCT
bjp-29940	337	13	fellay	fellay	PROPN
bjp-29940	337	14	j	j	PROPN
bjp-29940	337	15	,	,	PUNCT
bjp-29940	337	16	shianna	shianna	PROPN
bjp-29940	337	17	kv	kv	PROPN
bjp-29940	337	18	,	,	PUNCT
bjp-29940	337	19	esteban	esteban	PROPN
bjp-29940	337	20	r.	r.	PROPN
bjp-29940	337	21	interleukin-28b	interleukin-28b	PROPN
bjp-29940	337	22	polymorphism	polymorphism	NOUN
bjp-29940	337	23	improves	improve	VERB
bjp-29940	337	24	viral	viral	ADJ
bjp-29940	337	25	kinetics	kinetic	NOUN
bjp-29940	337	26	and	and	CCONJ
bjp-29940	337	27	is	be	AUX
bjp-29940	337	28	the	the	DET
bjp-29940	337	29	strongest	strong	ADJ
bjp-29940	337	30	pretreatment	pretreatment	NOUN
bjp-29940	337	31	predictor	predictor	NOUN
bjp-29940	337	32	of	of	ADP
bjp-29940	337	33	sustained	sustain	VERB
bjp-29940	337	34	virologic	virologic	ADJ
bjp-29940	337	35	response	response	NOUN
bjp-29940	337	36	in	in	ADP
bjp-29940	337	37	genotype	genotype	NOUN
bjp-29940	337	38	1	1	NUM
bjp-29940	337	39	hepatitis	hepatitis	PROPN
bjp-29940	337	40	c	c	PROPN
bjp-29940	337	41	virus	virus	NOUN
bjp-29940	337	42	.	.	PUNCT
bjp-29940	338	1	gastroenterology	gastroenterology	NOUN
bjp-29940	338	2	2010	2010	NUM
bjp-29940	338	3	;	;	PUNCT
bjp-29940	338	4	139	139	NUM
bjp-29940	338	5	:	:	SYM
bjp-29940	338	6	120	120	NUM
bjp-29940	338	7	-	-	SYM
bjp-29940	338	8	29	29	NUM
bjp-29940	338	9	.	.	PUNCT
bjp-29940	339	1	wang	wang	PROPN
bjp-29940	339	2	c	c	PROPN
bjp-29940	339	3	,	,	PUNCT
bjp-29940	339	4	jia	jia	PROPN
bjp-29940	339	5	l	l	PROPN
bjp-29940	339	6	,	,	PUNCT
bjp-29940	339	7	huang	huang	PROPN
bjp-29940	339	8	h	h	PROPN
bjp-29940	339	9	,	,	PUNCT
bjp-29940	339	10	qiu	qiu	PROPN
bjp-29940	339	11	d	d	PROPN
bjp-29940	339	12	,	,	PUNCT
bjp-29940	339	13	valera	valera	PROPN
bjp-29940	339	14	l	l	PROPN
bjp-29940	339	15	,	,	PUNCT
bjp-29940	339	16	huang	huang	PROPN
bjp-29940	339	17	x	x	PROPN
bjp-29940	339	18	,	,	PUNCT
bjp-29940	339	19	gao	gao	PROPN
bjp-29940	339	20	m.	m.	NOUN
bjp-29940	339	21	in	in	ADP
bjp-29940	339	22	vitro	vitro	X
bjp-29940	339	23	activity	activity	NOUN
bjp-29940	339	24	of	of	ADP
bjp-29940	339	25	bms-790052	bms-790052	NOUN
bjp-29940	339	26	on	on	ADP
bjp-29940	339	27	hepatitis	hepatitis	PROPN
bjp-29940	339	28	c	c	PROPN
bjp-29940	339	29	virus	virus	NOUN
bjp-29940	339	30	genotype	genotype	NOUN
bjp-29940	339	31	4	4	NUM
bjp-29940	339	32	ns5a	ns5a	NOUN
bjp-29940	339	33	.	.	PUNCT
bjp-29940	339	34	antimicrob	antimicrob	PROPN
bjp-29940	339	35	agents	agents	PROPN
bjp-29940	339	36	chemother	chemother	PROPN
bjp-29940	339	37	.	.	PUNCT
bjp-29940	340	1	2012	2012	NUM
bjp-29940	340	2	;	;	PUNCT
bjp-29940	340	3	56	56	NUM
bjp-29940	340	4	:	:	SYM
bjp-29940	340	5	1588	1588	NUM
bjp-29940	340	6	-	-	SYM
bjp-29940	340	7	90	90	NUM
bjp-29940	340	8	.	.	PUNCT
bjp-29940	341	1	wang	wang	PROPN
bjp-29940	341	2	c	c	PROPN
bjp-29940	341	3	,	,	PUNCT
bjp-29940	341	4	jia	jia	PROPN
bjp-29940	341	5	l	l	PROPN
bjp-29940	341	6	,	,	PUNCT
bjp-29940	341	7	o’boyle	o’boyle	PROPN
bjp-29940	341	8	dr	dr	PROPN
bjp-29940	341	9	,	,	PUNCT
bjp-29940	341	10	sun	sun	PROPN
bjp-29940	341	11	jh	jh	PROPN
bjp-29940	341	12	,	,	PUNCT
bjp-29940	341	13	rigat	rigat	PROPN
bjp-29940	341	14	k	k	PROPN
bjp-29940	341	15	,	,	PUNCT
bjp-29940	341	16	valera	valera	PROPN
bjp-29940	341	17	l	l	PROPN
bjp-29940	341	18	,	,	PUNCT
bjp-29940	341	19	roberts	roberts	PROPN
bjp-29940	341	20	s.	s.	PROPN
bjp-29940	341	21	comparison	comparison	NOUN
bjp-29940	341	22	of	of	ADP
bjp-29940	341	23	daclatasvir	daclatasvir	PROPN
bjp-29940	341	24	resistance	resistance	NOUN
bjp-29940	341	25	barriers	barrier	NOUN
bjp-29940	341	26	on	on	ADP
bjp-29940	341	27	ns5a	ns5a	PROPN
bjp-29940	341	28	from	from	ADP
bjp-29940	341	29	hepatitis	hepatitis	PROPN
bjp-29940	341	30	c	c	PROPN
bjp-29940	341	31	virus	virus	NOUN
bjp-29940	341	32	genotypes	genotype	NOUN
bjp-29940	341	33	1	1	NUM
bjp-29940	341	34	to	to	PART
bjp-29940	341	35	6	6	NUM
bjp-29940	341	36	:	:	PUNCT
bjp-29940	341	37	implications	implication	NOUN
bjp-29940	341	38	for	for	ADP
bjp-29940	341	39	cross	cross	ADJ
bjp-29940	341	40	-	-	ADJ
bjp-29940	341	41	genotype	genotype	ADJ
bjp-29940	341	42	activity	activity	NOUN
bjp-29940	341	43	.	.	PUNCT
bjp-29940	342	1	antimicrob	antimicrob	PROPN
bjp-29940	342	2	agents	agents	PROPN
bjp-29940	342	3	chemother	chemother	PROPN
bjp-29940	342	4	.	.	PUNCT
bjp-29940	343	1	2014	2014	NUM
bjp-29940	343	2	;	;	PUNCT
bjp-29940	343	3	58	58	NUM
bjp-29940	343	4	:	:	PUNCT
bjp-29940	343	5	5155	5155	NUM
bjp-29940	343	6	-	-	SYM
bjp-29940	343	7	63	63	NUM
bjp-29940	343	8	.	.	PUNCT
bjp-29940	344	1	yu	yu	PROPN
bjp-29940	344	2	j	j	PROPN
bjp-29940	344	3	,	,	PUNCT
bjp-29940	344	4	wang	wang	PROPN
bjp-29940	344	5	g	g	PROPN
bjp-29940	344	6	,	,	PUNCT
bjp-29940	344	7	sun	sun	PROPN
bjp-29940	344	8	l	l	PROPN
bjp-29940	344	9	,	,	PUNCT
bjp-29940	344	10	li	li	PROPN
bjp-29940	344	11	x	x	PROPN
bjp-29940	344	12	,	,	PUNCT
bjp-29940	344	13	li	li	PROPN
bjp-29940	344	14	s.	s.	PROPN
bjp-29940	344	15	predictive	predictive	PROPN
bjp-29940	344	16	value	value	NOUN
bjp-29940	344	17	of	of	ADP
bjp-29940	344	18	rapid	rapid	ADJ
bjp-29940	344	19	virological	virological	ADJ
bjp-29940	344	20	response	response	NOUN
bjp-29940	344	21	and	and	CCONJ
bjp-29940	344	22	early	early	ADJ
bjp-29940	344	23	virological	virological	ADJ
bjp-29940	344	24	response	response	NOUN
bjp-29940	344	25	on	on	ADP
bjp-29940	344	26	sustained	sustained	ADJ
bjp-29940	344	27	virological	virological	ADJ
bjp-29940	344	28	response	response	NOUN
bjp-29940	344	29	in	in	ADP
bjp-29940	344	30	hcv	hcv	NOUN
bjp-29940	344	31	patients	patient	NOUN
bjp-29940	344	32	treated	treat	VERB
bjp-29940	344	33	with	with	ADP
bjp-29940	344	34	pegylated	pegylated	ADJ
bjp-29940	344	35	interferon	interferon	ADJ
bjp-29940	344	36	α‐2a	α‐2a	NOUN
bjp-29940	344	37	and	and	CCONJ
bjp-29940	344	38	ribavirin	ribavirin	NOUN
bjp-29940	344	39	.	.	PUNCT
bjp-29940	345	1	j	j	PROPN
bjp-29940	345	2	gastroenterol	gastroenterol	NOUN
bjp-29940	345	3	hepatol	hepatol	ADJ
bjp-29940	345	4	.	.	PUNCT
bjp-29940	346	1	2007	2007	NUM
bjp-29940	346	2	;	;	PUNCT
bjp-29940	346	3	22	22	NUM
bjp-29940	346	4	:	:	SYM
bjp-29940	346	5	832	832	NUM
bjp-29940	346	6	-	-	SYM
bjp-29940	346	7	36	36	NUM
bjp-29940	346	8	.	.	PUNCT
bjp-29940	347	1	zhou	zhou	PROPN
bjp-29940	347	2	n	n	PROPN
bjp-29940	347	3	,	,	PUNCT
bjp-29940	347	4	hernandez	hernandez	PROPN
bjp-29940	347	5	d	d	PROPN
bjp-29940	347	6	,	,	PUNCT
bjp-29940	347	7	ueland	ueland	PROPN
bjp-29940	347	8	j	j	PROPN
bjp-29940	347	9	,	,	PUNCT
bjp-29940	347	10	yang	yang	PROPN
bjp-29940	347	11	x	x	PROPN
bjp-29940	347	12	,	,	PUNCT
bjp-29940	347	13	yu	yu	PROPN
bjp-29940	347	14	f	f	PROPN
bjp-29940	347	15	,	,	PUNCT
bjp-29940	347	16	sims	sim	NOUN
bjp-29940	347	17	k	k	NOUN
bjp-29940	347	18	,	,	PUNCT
bjp-29940	347	19	mcphee	mcphee	PROPN
bjp-29940	347	20	f.	f.	PROPN
bjp-29940	347	21	ns5a	ns5a	PROPN
bjp-29940	347	22	sequence	sequence	NOUN
bjp-29940	347	23	heterogeneity	heterogeneity	NOUN
bjp-29940	347	24	and	and	CCONJ
bjp-29940	347	25	mechanisms	mechanism	NOUN
bjp-29940	347	26	of	of	ADP
bjp-29940	347	27	daclatasvir	daclatasvir	PROPN
bjp-29940	347	28	resistance	resistance	VERB
bjp-29940	347	29	in	in	ADP
bjp-29940	347	30	hepatitis	hepatitis	PROPN
bjp-29940	347	31	c	c	PROPN
bjp-29940	347	32	virus	virus	NOUN
bjp-29940	347	33	genotype	genotype	NOUN
bjp-29940	347	34	4	4	NUM
bjp-29940	347	35	infection	infection	NOUN
bjp-29940	347	36	.	.	PUNCT
bjp-29940	348	1	j	j	PROPN
bjp-29940	348	2	infect	infect	VERB
bjp-29940	348	3	dis	dis	PROPN
bjp-29940	348	4	.	.	PROPN
bjp-29940	348	5	2016	2016	NUM
bjp-29940	348	6	;	;	PUNCT
bjp-29940	348	7	213	213	NUM
bjp-29940	348	8	:	:	PUNCT
bjp-29940	348	9	206	206	NUM
bjp-29940	348	10	-	-	SYM
bjp-29940	348	11	15	15	NUM
bjp-29940	348	12	.	.	PUNCT
bjp-29940	349	1	bangladesh	bangladesh	PROPN
bjp-29940	349	2	j	j	PROPN
bjp-29940	349	3	pharmacol	pharmacol	PROPN
bjp-29940	349	4	2017	2017	NUM
bjp-29940	349	5	;	;	PUNCT
bjp-29940	349	6	12	12	NUM
bjp-29940	349	7	:	:	SYM
bjp-29940	349	8	12	12	NUM
bjp-29940	349	9	-	-	SYM
bjp-29940	349	10	22	22	NUM
bjp-29940	349	11	21	21	NUM
bjp-29940	349	12	hezode	hezode	NOUN
bjp-29940	349	13	,	,	PUNCT
bjp-29940	349	14	2014	2014	NUM
bjp-29940	349	15	author	author	NOUN
bjp-29940	349	16	judgment	judgment	NOUN
bjp-29940	349	17	(	(	PUNCT
bjp-29940	349	18	quoting	quote	VERB
bjp-29940	349	19	from	from	ADP
bjp-29940	349	20	the	the	DET
bjp-29940	349	21	text	text	NOUN
bjp-29940	349	22	)	)	PUNCT
bjp-29940	349	23	risk	risk	NOUN
bjp-29940	349	24	of	of	ADP
bjp-29940	349	25	bias	bias	NOUN
bjp-29940	349	26	domain	domain	NOUN
bjp-29940	350	1	quote	quote	NOUN
bjp-29940	350	2	:	:	PUNCT
bjp-29940	350	3	"	"	PUNCT
bjp-29940	350	4	phase2b	phase2b	NOUN
bjp-29940	350	5	study	study	NOUN
bjp-29940	350	6	using	use	VERB
bjp-29940	350	7	a	a	DET
bjp-29940	350	8	randomized	randomized	ADJ
bjp-29940	350	9	block	block	NOUN
bjp-29940	350	10	design	design	NOUN
bjp-29940	350	11	stratified	stratify	VERB
bjp-29940	350	12	&	&	CCONJ
bjp-29940	350	13	randomization	randomization	NOUN
bjp-29940	350	14	ratio	ratio	NOUN
bjp-29940	350	15	is	be	AUX
bjp-29940	350	16	2:2:1	2:2:1	NUM
bjp-29940	350	17	as	as	ADP
bjp-29940	350	18	follow	follow	VERB
bjp-29940	350	19	daclatasvir20	daclatasvir20	NOUN
bjp-29940	350	20	mg	mg	PROPN
bjp-29940	350	21	,	,	PUNCT
bjp-29940	350	22	60	60	NUM
bjp-29940	350	23	mg	mg	NOUN
bjp-29940	350	24	,	,	PUNCT
bjp-29940	350	25	placebo	placebo	NOUN
bjp-29940	350	26	groups	group	NOUN
bjp-29940	350	27	"	"	PUNCT
bjp-29940	350	28	comment	comment	NOUN
bjp-29940	350	29	:	:	PUNCT
bjp-29940	350	30	probably	probably	ADV
bjp-29940	350	31	done	do	VERB
bjp-29940	350	32	"	"	PUNCT
bjp-29940	350	33	patients	patient	NOUN
bjp-29940	350	34	were	be	AUX
bjp-29940	350	35	randomly	randomly	ADV
bjp-29940	350	36	allocated	allocate	VERB
bjp-29940	350	37	"	"	PUNCT
bjp-29940	350	38	low	low	ADJ
bjp-29940	350	39	random	random	ADJ
bjp-29940	350	40	sequence	sequence	NOUN
bjp-29940	350	41	generation	generation	NOUN
bjp-29940	350	42	(	(	PUNCT
bjp-29940	350	43	selection	selection	NOUN
bjp-29940	350	44	bias	bias	NOUN
bjp-29940	350	45	)	)	PUNCT
bjp-29940	350	46	quote	quote	INTJ
bjp-29940	350	47	:	:	PUNCT
bjp-29940	350	48	"	"	PUNCT
bjp-29940	350	49	using	use	VERB
bjp-29940	350	50	interactive	interactive	ADJ
bjp-29940	350	51	voice	voice	NOUN
bjp-29940	350	52	response	response	NOUN
bjp-29940	350	53	system	system	NOUN
bjp-29940	350	54	"	"	PUNCT
bjp-29940	350	55	comment	comment	NOUN
bjp-29940	350	56	:	:	PUNCT
bjp-29940	350	57	probably	probably	ADV
bjp-29940	350	58	done	do	VERB
bjp-29940	350	59	"	"	PUNCT
bjp-29940	350	60	central	central	ADJ
bjp-29940	350	61	allocation	allocation	NOUN
bjp-29940	350	62	"	"	PUNCT
bjp-29940	350	63	low	low	ADJ
bjp-29940	350	64	concealment	concealment	NOUN
bjp-29940	350	65	of	of	ADP
bjp-29940	350	66	allocation	allocation	NOUN
bjp-29940	350	67	(	(	PUNCT
bjp-29940	350	68	selection	selection	NOUN
bjp-29940	350	69	bias	bias	NOUN
bjp-29940	350	70	)	)	PUNCT
bjp-29940	350	71	quote	quote	INTJ
bjp-29940	350	72	:	:	PUNCT
bjp-29940	350	73	"	"	PUNCT
bjp-29940	350	74	double	double	ADJ
bjp-29940	350	75	blind	blind	ADJ
bjp-29940	350	76	"	"	PUNCT
bjp-29940	350	77	patient	patient	NOUN
bjp-29940	350	78	&	&	CCONJ
bjp-29940	350	79	study	study	PROPN
bjp-29940	350	80	site	site	NOUN
bjp-29940	350	81	were	be	AUX
bjp-29940	350	82	blinded	blind	VERB
bjp-29940	350	83	to	to	PART
bjp-29940	350	84	hcv	hcv	VERB
bjp-29940	350	85	-	-	PUNCT
bjp-29940	350	86	rna	rna	NOUN
bjp-29940	350	87	value	value	NOUN
bjp-29940	350	88	&	&	CCONJ
bjp-29940	350	89	patient	patient	ADJ
bjp-29940	350	90	randomization	randomization	NOUN
bjp-29940	350	91	"	"	PUNCT
bjp-29940	350	92	"	"	PUNCT
bjp-29940	350	93	comment	comment	NOUN
bjp-29940	350	94	:	:	PUNCT
bjp-29940	350	95	probably	probably	ADV
bjp-29940	350	96	done	do	VERB
bjp-29940	350	97	low	low	ADJ
bjp-29940	350	98	blinding	blinding	NOUN
bjp-29940	350	99	of	of	ADP
bjp-29940	350	100	participants	participant	NOUN
bjp-29940	350	101	&	&	CCONJ
bjp-29940	350	102	personnel	personnel	NOUN
bjp-29940	350	103	(	(	PUNCT
bjp-29940	350	104	performance	performance	NOUN
bjp-29940	350	105	bias	bias	NOUN
bjp-29940	350	106	)	)	PUNCT
bjp-29940	351	1	quote	quote	INTJ
bjp-29940	351	2	:	:	PUNCT
bjp-29940	351	3	"	"	PUNCT
bjp-29940	351	4	double	double	ADJ
bjp-29940	351	5	blind	blind	ADJ
bjp-29940	351	6	"	"	PUNCT
bjp-29940	351	7	sponsor	sponsor	NOUN
bjp-29940	351	8	was	be	AUX
bjp-29940	351	9	blinded	blind	VERB
bjp-29940	351	10	to	to	ADP
bjp-29940	351	11	treatment	treatment	NOUN
bjp-29940	351	12	assignment	assignment	NOUN
bjp-29940	351	13	"	"	PUNCT
bjp-29940	351	14	"	"	PUNCT
bjp-29940	351	15	comment	comment	NOUN
bjp-29940	351	16	:	:	PUNCT
bjp-29940	351	17	probably	probably	ADV
bjp-29940	351	18	done	do	VERB
bjp-29940	351	19	low	low	ADJ
bjp-29940	351	20	blinding	blinding	NOUN
bjp-29940	351	21	of	of	ADP
bjp-29940	351	22	outcome	outcome	NOUN
bjp-29940	351	23	assessors	assessor	NOUN
bjp-29940	351	24	(	(	PUNCT
bjp-29940	351	25	detection	detection	NOUN
bjp-29940	351	26	bias	bias	NOUN
bjp-29940	351	27	)	)	PUNCT
bjp-29940	352	1	quote	quote	INTJ
bjp-29940	352	2	:	:	PUNCT
bjp-29940	352	3	"	"	PUNCT
bjp-29940	352	4	modified	modified	ADJ
bjp-29940	352	5	intention	intention	NOUN
bjp-29940	352	6	to	to	PART
bjp-29940	352	7	treat	treat	VERB
bjp-29940	352	8	analysis	analysis	NOUN
bjp-29940	352	9	done	do	VERB
bjp-29940	352	10	to	to	ADP
bjp-29940	352	11	all	all	DET
bjp-29940	352	12	patient	patient	ADJ
bjp-29940	352	13	"	"	PUNCT
bjp-29940	352	14	low	low	ADJ
bjp-29940	352	15	incomplete	incomplete	ADJ
bjp-29940	352	16	data	datum	NOUN
bjp-29940	352	17	reporting	report	VERB
bjp-29940	352	18	(	(	PUNCT
bjp-29940	352	19	attrition	attrition	NOUN
bjp-29940	352	20	bias	bias	NOUN
bjp-29940	352	21	)	)	PUNCT
bjp-29940	352	22	the	the	DET
bjp-29940	352	23	protocol	protocol	NOUN
bjp-29940	352	24	is	be	AUX
bjp-29940	352	25	available	available	ADJ
bjp-29940	352	26	&	&	CCONJ
bjp-29940	352	27	all	all	DET
bjp-29940	352	28	pre	pre	ADJ
bjp-29940	352	29	-	-	ADJ
bjp-29940	352	30	specified	specified	ADJ
bjp-29940	352	31	outcomes	outcome	NOUN
bjp-29940	352	32	have	have	AUX
bjp-29940	352	33	been	be	AUX
bjp-29940	352	34	reported	report	VERB
bjp-29940	352	35	in	in	ADP
bjp-29940	352	36	pre	pre	ADJ
bjp-29940	352	37	-	-	ADJ
bjp-29940	352	38	specified	specified	ADJ
bjp-29940	352	39	way	way	NOUN
bjp-29940	352	40	low	low	ADJ
bjp-29940	352	41	selective	selective	ADJ
bjp-29940	352	42	outcome	outcome	NOUN
bjp-29940	352	43	reporting	reporting	NOUN
bjp-29940	352	44	(	(	PUNCT
bjp-29940	352	45	reporting	reporting	NOUN
bjp-29940	352	46	bias	bias	NOUN
bjp-29940	352	47	)	)	PUNCT
bjp-29940	352	48	unclear	unclear	ADJ
bjp-29940	352	49	others	other	NOUN
bjp-29940	352	50	hezode	hezode	PROPN
bjp-29940	352	51	,	,	PUNCT
bjp-29940	352	52	2015	2015	NUM
bjp-29940	352	53	author	author	NOUN
bjp-29940	352	54	judgment	judgment	NOUN
bjp-29940	352	55	(	(	PUNCT
bjp-29940	352	56	quoting	quote	VERB
bjp-29940	352	57	from	from	ADP
bjp-29940	352	58	the	the	DET
bjp-29940	352	59	text	text	NOUN
bjp-29940	352	60	)	)	PUNCT
bjp-29940	352	61	risk	risk	NOUN
bjp-29940	352	62	of	of	ADP
bjp-29940	352	63	bias	bias	NOUN
bjp-29940	352	64	domain	domain	NOUN
bjp-29940	352	65	quote	quote	NOUN
bjp-29940	352	66	:	:	PUNCT
bjp-29940	352	67	"	"	PUNCT
bjp-29940	352	68	multicenter	multicenter	NOUN
bjp-29940	352	69	phase	phase	NOUN
bjp-29940	352	70	3	3	NUM
bjp-29940	352	71	study	study	NOUN
bjp-29940	352	72	,	,	PUNCT
bjp-29940	352	73	randomization	randomization	NOUN
bjp-29940	352	74	using	use	VERB
bjp-29940	352	75	block	block	NOUN
bjp-29940	352	76	design	design	NOUN
bjp-29940	352	77	2:1	2:1	NUM
bjp-29940	352	78	to	to	ADP
bjp-29940	352	79	dcv	dcv	PROPN
bjp-29940	352	80	:	:	PUNCT
bjp-29940	352	81	placebo	placebo	NOUN
bjp-29940	352	82	within	within	ADP
bjp-29940	352	83	each	each	DET
bjp-29940	352	84	block	block	NOUN
bjp-29940	352	85	,	,	PUNCT
bjp-29940	352	86	stratified	stratify	VERB
bjp-29940	352	87	"	"	PUNCT
bjp-29940	352	88	comment	comment	NOUN
bjp-29940	352	89	:	:	PUNCT
bjp-29940	352	90	probably	probably	ADV
bjp-29940	352	91	done	do	VERB
bjp-29940	352	92	"	"	PUNCT
bjp-29940	352	93	patients	patient	NOUN
bjp-29940	352	94	were	be	AUX
bjp-29940	352	95	randomly	randomly	ADV
bjp-29940	352	96	allocated	allocate	VERB
bjp-29940	352	97	low	low	ADJ
bjp-29940	352	98	random	random	ADJ
bjp-29940	352	99	sequence	sequence	NOUN
bjp-29940	352	100	generation	generation	NOUN
bjp-29940	352	101	(	(	PUNCT
bjp-29940	352	102	selection	selection	NOUN
bjp-29940	352	103	bias	bias	NOUN
bjp-29940	352	104	)	)	PUNCT
bjp-29940	353	1	quote	quote	INTJ
bjp-29940	353	2	:	:	PUNCT
bjp-29940	353	3	"	"	PUNCT
bjp-29940	353	4	using	use	VERB
bjp-29940	353	5	validated	validate	VERB
bjp-29940	353	6	centralized	centralize	VERB
bjp-29940	353	7	interactive	interactive	ADJ
bjp-29940	353	8	voice	voice	NOUN
bjp-29940	353	9	response	response	NOUN
bjp-29940	353	10	system	system	NOUN
bjp-29940	353	11	for	for	ADP
bjp-29940	353	12	randomization	randomization	NOUN
bjp-29940	353	13	"	"	PUNCT
bjp-29940	353	14	comment	comment	NOUN
bjp-29940	353	15	:	:	PUNCT
bjp-29940	353	16	probably	probably	ADV
bjp-29940	353	17	done	do	VERB
bjp-29940	353	18	"	"	PUNCT
bjp-29940	353	19	central	central	ADJ
bjp-29940	353	20	allocation	allocation	NOUN
bjp-29940	353	21	low	low	ADJ
bjp-29940	353	22	concealment	concealment	NOUN
bjp-29940	353	23	of	of	ADP
bjp-29940	353	24	allocation	allocation	NOUN
bjp-29940	353	25	(	(	PUNCT
bjp-29940	353	26	selection	selection	NOUN
bjp-29940	353	27	bias	bias	NOUN
bjp-29940	353	28	)	)	PUNCT
bjp-29940	353	29	quote	quote	INTJ
bjp-29940	353	30	:	:	PUNCT
bjp-29940	353	31	"	"	PUNCT
bjp-29940	353	32	double	double	ADJ
bjp-29940	353	33	blind	blind	ADJ
bjp-29940	353	34	(	(	PUNCT
bjp-29940	353	35	reported	report	VERB
bjp-29940	353	36	in	in	ADP
bjp-29940	353	37	protocol	protocol	NOUN
bjp-29940	353	38	:	:	PUNCT
bjp-29940	353	39	blinded	blind	VERB
bjp-29940	353	40	patient	patient	NOUN
bjp-29940	353	41	&	&	CCONJ
bjp-29940	353	42	investigator	investigator	NOUN
bjp-29940	353	43	)	)	PUNCT
bjp-29940	353	44	"	"	PUNCT
bjp-29940	353	45	comment	comment	NOUN
bjp-29940	353	46	:	:	PUNCT
bjp-29940	353	47	probably	probably	ADV
bjp-29940	353	48	done	do	VERB
bjp-29940	353	49	low	low	ADJ
bjp-29940	353	50	blinding	blinding	NOUN
bjp-29940	353	51	of	of	ADP
bjp-29940	353	52	participants	participant	NOUN
bjp-29940	353	53	&	&	CCONJ
bjp-29940	353	54	personnel	personnel	NOUN
bjp-29940	353	55	(	(	PUNCT
bjp-29940	353	56	performance	performance	NOUN
bjp-29940	353	57	bias	bias	NOUN
bjp-29940	353	58	)	)	PUNCT
bjp-29940	354	1	quote	quote	INTJ
bjp-29940	354	2	:	:	PUNCT
bjp-29940	354	3	"	"	PUNCT
bjp-29940	354	4	double	double	ADJ
bjp-29940	354	5	blind(regard	blind(regard	NOUN
bjp-29940	354	6	protocol	protocol	NOUN
bjp-29940	354	7	sponsor	sponsor	NOUN
bjp-29940	354	8	is	be	AUX
bjp-29940	354	9	blinded	blind	VERB
bjp-29940	354	10	)	)	PUNCT
bjp-29940	354	11	"	"	PUNCT
bjp-29940	354	12	comment	comment	NOUN
bjp-29940	354	13	:	:	PUNCT
bjp-29940	354	14	probably	probably	ADV
bjp-29940	354	15	done	do	VERB
bjp-29940	354	16	low	low	ADJ
bjp-29940	354	17	blinding	blinding	NOUN
bjp-29940	354	18	of	of	ADP
bjp-29940	354	19	outcome	outcome	NOUN
bjp-29940	354	20	assessors	assessor	NOUN
bjp-29940	354	21	(	(	PUNCT
bjp-29940	354	22	detection	detection	NOUN
bjp-29940	354	23	bias	bias	NOUN
bjp-29940	354	24	)	)	PUNCT
bjp-29940	355	1	quote	quote	INTJ
bjp-29940	355	2	:	:	PUNCT
bjp-29940	355	3	"	"	PUNCT
bjp-29940	355	4	modified	modified	ADJ
bjp-29940	355	5	intention	intention	NOUN
bjp-29940	355	6	to	to	PART
bjp-29940	355	7	treat	treat	VERB
bjp-29940	355	8	analysis	analysis	NOUN
bjp-29940	355	9	done	do	VERB
bjp-29940	355	10	with	with	ADP
bjp-29940	355	11	patient	patient	NOUN
bjp-29940	355	12	with	with	ADP
bjp-29940	355	13	missing	miss	VERB
bjp-29940	355	14	hcv	hcv	NOUN
bjp-29940	355	15	rna	rna	NOUN
bjp-29940	355	16	at	at	ADP
bjp-29940	355	17	post	post	NOUN
bjp-29940	355	18	treatment	treatment	NOUN
bjp-29940	355	19	week	week	NOUN
bjp-29940	355	20	12	12	NUM
bjp-29940	355	21	considered	consider	VERB
bjp-29940	355	22	as	as	ADP
bjp-29940	355	23	failure	failure	NOUN
bjp-29940	355	24	"	"	PUNCT
bjp-29940	355	25	low	low	ADJ
bjp-29940	355	26	incomplete	incomplete	ADJ
bjp-29940	355	27	data	datum	NOUN
bjp-29940	355	28	reporting	report	VERB
bjp-29940	355	29	(	(	PUNCT
bjp-29940	355	30	attrition	attrition	NOUN
bjp-29940	355	31	bias	bias	NOUN
bjp-29940	355	32	)	)	PUNCT
bjp-29940	355	33	the	the	DET
bjp-29940	355	34	protocol	protocol	NOUN
bjp-29940	355	35	is	be	AUX
bjp-29940	355	36	available	available	ADJ
bjp-29940	355	37	&	&	CCONJ
bjp-29940	355	38	all	all	DET
bjp-29940	355	39	pre	pre	ADJ
bjp-29940	355	40	-	-	ADJ
bjp-29940	355	41	specified	specified	ADJ
bjp-29940	355	42	outcomes	outcome	NOUN
bjp-29940	355	43	have	have	AUX
bjp-29940	355	44	been	be	AUX
bjp-29940	355	45	reported	report	VERB
bjp-29940	355	46	in	in	ADP
bjp-29940	355	47	pre	pre	ADJ
bjp-29940	355	48	-	-	ADJ
bjp-29940	355	49	specified	specified	ADJ
bjp-29940	355	50	way	way	NOUN
bjp-29940	355	51	low	low	ADJ
bjp-29940	355	52	selective	selective	ADJ
bjp-29940	355	53	outcome	outcome	NOUN
bjp-29940	355	54	reporting	reporting	NOUN
bjp-29940	355	55	(	(	PUNCT
bjp-29940	355	56	reporting	reporting	NOUN
bjp-29940	355	57	bias	bias	NOUN
bjp-29940	355	58	)	)	PUNCT
bjp-29940	355	59	-protocol	-protocol	NOUN
bjp-29940	355	60	deviation	deviation	NOUN
bjp-29940	355	61	one	one	NUM
bjp-29940	355	62	patient	patient	NOUN
bjp-29940	355	63	with	with	ADP
bjp-29940	355	64	gt1a	gt1a	NOUN
bjp-29940	355	65	infection	infection	NOUN
bjp-29940	355	66	was	be	AUX
bjp-29940	355	67	incorrectly	incorrectly	ADV
bjp-29940	355	68	enrolled	enrol	VERB
bjp-29940	355	69	in	in	ADP
bjp-29940	355	70	dcv	dcv	NOUN
bjp-29940	355	71	plus	plus	CCONJ
bjp-29940	355	72	peg	peg	VERB
bjp-29940	355	73	ifn	ifn	PROPN
bjp-29940	355	74	/	/	SYM
bjp-29940	355	75	rbv	rbv	PROPN
bjp-29940	355	76	group	group	NOUN
bjp-29940	355	77	&	&	CCONJ
bjp-29940	355	78	was	be	AUX
bjp-29940	355	79	included	include	VERB
bjp-29940	355	80	in	in	ADP
bjp-29940	355	81	the	the	DET
bjp-29940	355	82	analysis	analysis	NOUN
bjp-29940	355	83	due	due	ADP
bjp-29940	355	84	to	to	ADP
bjp-29940	355	85	the	the	DET
bjp-29940	355	86	pre	pre	ADJ
bjp-29940	355	87	-	-	ADJ
bjp-29940	355	88	specified	specified	ADJ
bjp-29940	355	89	mitt	mitt	PROPN
bjp-29940	355	90	analysis	analysis	NOUN
bjp-29940	355	91	-the	-the	DET
bjp-29940	355	92	limitation	limitation	NOUN
bjp-29940	355	93	was	be	AUX
bjp-29940	355	94	a	a	DET
bjp-29940	355	95	limited	limited	ADJ
bjp-29940	355	96	sample	sample	NOUN
bjp-29940	355	97	size	size	NOUN
bjp-29940	355	98	unclear	unclear	ADJ
bjp-29940	355	99	others	other	NOUN
bjp-29940	355	100	supplementary	supplementary	ADJ
bjp-29940	355	101	data	datum	NOUN
bjp-29940	355	102	shows	show	VERB
bjp-29940	355	103	the	the	DET
bjp-29940	355	104	results	result	NOUN
bjp-29940	355	105	of	of	ADP
bjp-29940	355	106	risk	risk	NOUN
bjp-29940	355	107	of	of	ADP
bjp-29940	355	108	bias	bias	NOUN
bjp-29940	355	109	assessment	assessment	NOUN
bjp-29940	355	110	for	for	ADP
bjp-29940	355	111	included	include	VERB
bjp-29940	355	112	studies	study	NOUN
bjp-29940	355	113	22	22	NUM
bjp-29940	355	114	bangladesh	bangladesh	PROPN
bjp-29940	355	115	j	j	PROPN
bjp-29940	355	116	pharmacol	pharmacol	PROPN
bjp-29940	355	117	2017	2017	NUM
bjp-29940	355	118	;	;	PUNCT
bjp-29940	355	119	12	12	NUM
bjp-29940	355	120	:	:	SYM
bjp-29940	355	121	12	12	NUM
bjp-29940	355	122	-	-	SYM
bjp-29940	355	123	22	22	NUM
bjp-29940	355	124	your	your	PRON
bjp-29940	355	125	feedback	feedback	NOUN
bjp-29940	355	126	about	about	ADP
bjp-29940	355	127	this	this	DET
bjp-29940	355	128	paper	paper	NOUN
bjp-29940	355	129	1	1	NUM
bjp-29940	355	130	.	.	PUNCT
bjp-29940	355	131	number	number	NOUN
bjp-29940	355	132	of	of	ADP
bjp-29940	355	133	times	time	NOUN
bjp-29940	355	134	you	you	PRON
bjp-29940	355	135	have	have	AUX
bjp-29940	355	136	read	read	VERB
bjp-29940	355	137	this	this	DET
bjp-29940	355	138	paper	paper	NOUN
bjp-29940	355	139	2	2	NUM
bjp-29940	355	140	.	.	PUNCT
bjp-29940	355	141	quality	quality	NOUN
bjp-29940	355	142	of	of	ADP
bjp-29940	355	143	paper	paper	NOUN
bjp-29940	355	144	3	3	X
bjp-29940	355	145	.	.	PUNCT
bjp-29940	356	1	your	your	PRON
bjp-29940	356	2	comments	comment	NOUN
bjp-29940	356	3	dateprinted	dateprinte	VERB
bjp-29940	356	4	:	:	PUNCT
bjp-29940	356	5	this	this	DET
bjp-29940	356	6	article	article	NOUN
bjp-29940	356	7	was	be	AUX
bjp-29940	356	8	downloaded	download	VERB
bjp-29940	356	9	by	by	ADP
bjp-29940	356	10	you	you	PRON
bjp-29940	356	11	on	on	ADP
bjp-29940	356	12	:	:	PUNCT
bjp-29940	356	13	mar	mar	PROPN
bjp-29940	356	14	01	01	NUM
bjp-29940	356	15	,	,	PUNCT
bjp-29940	356	16	2017	2017	NUM
bjp-29940	356	17	text2	text2	NOUN
bjp-29940	356	18	:	:	PUNCT
bjp-29940	356	19	dropdown3	dropdown3	PROPN
bjp-29940	356	20	:	:	PUNCT
bjp-29940	357	1	[	[	X
bjp-29940	357	2	click	click	NOUN
bjp-29940	357	3	]	]	PUNCT
bjp-29940	357	4	dropdown4	dropdown4	PROPN
bjp-29940	357	5	:	:	PUNCT
bjp-29940	358	1	[	[	X
bjp-29940	358	2	0	0	X
bjp-29940	358	3	]	]	PUNCT